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ABSTRACT
An attempt has been made to purify an acid proteinase 
from human plasma, which is capable of dissolving fibrin 
clot in 1% (w/v) monochloroacetic acid.
On SDS gel electrophoresis the enzyme isolated from 
plasma contains two protein bands with molecular weights of 
approximately 9 0 , 0 0 0 and 5 4 ,0 0 0.
Different substrates were used to evaluate the 
proteolytic activity of the plasma enzyme, including fibrin 
clot, azo-casein, acid denatured haemoglobin (Hb), haemo­
globin polyacrylamide gel (insoluble Hb), haemoglobin 
electrophoresis (soluble Hb) and the synthetic substrate 
N-acety1-L-phenylalany1-L-d iiodotyros ine,
The plasma enzyme seems to belong to the group of 
aspartyl proteinases as its activity against the above 
substrates was maximal at low pH, and was inhibited by 
pepstatin which is a powerful inhibitor of aspartyl 
proteinases.
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CHAPTER 1
GENERAT. INTRODUCTION
1.
1.1. PROTEINASES
Proteinases were originally divided into exopeptidase 
and endopeptidases,
Bndopeptidases cleave bonds distant from the end of the 
polypeptide chain while exppeptidases cleave bonds only from 
the one or the other terminus of the polypeptide chain.
Generally proteins are first broken down by endopeptidases 
(proteinase), then followed by removal of amino acid residues 
from the ends of the fragments (one, two or three at a time) 
by exopeptidases (peptidases), (Barrett, 1977a). Exopeptidases 
are classified on the basis of the substrate specificity, 
while the endopeptidases are classified according to their 
essential catalytic groups.
Hartley (i960) divided the proteinases into four classes 
according to the amino acid or ion which is involved in the 
catalytic process.
The four groups are serine, thiol, acid and métallo 
proteinases, Tang (1970) used the term carboxyl protease 
rather than acid protease for two reasons, one was that the 
active site of the enzymes contains two carboxyl groups, and the 
other that some proteases like renin have pH optima near 
neutrality and the name acid protease is not appropriate.
Barrett and McDonald (1980a) introduced the terms 
"cysteine proteinases" and "aspartic proteinases" instead of 
"thiol proteinase" and "acid" or "carboxylproteinase" 
respectively. Also they added a fifth class to the existing
2.
four classes; it contains proteinases which cannot posi­
tively he classified. However, the terms aspartic, acid, 
carboxyl plus protease or proteinase all refer to the same 
class of enzyme and are categorised as 3.4.23 in the list 
of the Commission on Biochemical Nomenclature (1972).
1.2. ASPARTIC PROTEINASES
Aspartic proteinases generally have pH optima below 
6.0 and they have two specially protective aspartic groups 
of which one can be labelled with active site directed diazo 
compounds, and the other with epoxy compounds. Both label­
ling procedures inactivate the enzyme. Aspartic proteinases 
are also inhibited by pepstatin (Poltman and Pedersen, 1977).
Tang (1979) suggested that precursors of carboxyl protein­
ases can be divided into two groups,on the basis of the way 
in which they are activated. One group is irreversibly 
converted into active enzyme at acid pH, during which process 
the NHg-terminal segments of the peptide chains are released. 
The well known proteinases of this group are the gastric 
enzymes. The other group are not apparently converted to 
the active enzyme on acidification, but are activated by 
other proteases, e.g. renin is activated by several proteases, 
including kallikrein. No zymogens for microbial carboxyl 
proteases have been found to date.
1.3. FIBRINOLYSIS
Many proteolytic enzymes digest fibrin, but "fibrinolysis" 
is a more specific process in which the digestion of fibrinogen 
takes place, by splitting only a few peptide bonds (Astrup, 
1978), Fibrinolysis is a very complex system. It is
3.
involved in haemostasis, thrombolysis and spread of cancer. 
The mechanism by which thrombolysis take place is not well 
understood. Balkuvulutin (1978) reported that there is a 
homeostatic balance between coagulation and fibrinolysis. 
McNicol and Douglas (1976) however, believe that the two 
systems interact, but the concept of dynamic equilibrium 
between coagulation and fibrinolysis is not proven. 
Fibrinolysis tos been extensively studied and different path­
ways have been suggested, including Factor XII dependent 
pathway. Factor XII independent pathway and complement 
mediated fibrinolysis.
Ratnoff (1 9 7 7) reported that Hagsman factor acts in many 
systems to defend the body against injury, initiating clot­
ting, fibrinolysis, kinin formation, chemotaxis, and en­
hancement of vascular permeability. Moroz and Gilmore 
(1 9 7 6) studied the fibrinolytic activity of normal plasma, 
using I^^5 fibrin solidphase assay. Plasma enzymes were 
compared with plasminogen-plasmin fibrinolytic system, Hagman 
factor activation pathway and complement system.
Removal of plasminogen did not change the plasma 
activity, and plasmin inhibitors in concentrations which 
would inhibit pure plasmin had no effect. Proteolytic 
activity was detected in globulin and pseudoglobulin 
fractions, and contact factor inhibitors and activators did 
not effect the plasma enzyme. From these and other 
experiments Ratnoff concluded that plasmin and Hageman 
factor dependent pathway play a minor role in the spontaneous 
or basal fibrinolytic activity of normal plasma. This 
activity therefore is due to proteinases other than plasmin
4.
and might include proteinases from the complement system. 
However, the plasminogen-plasmin system has "been the most 
extensively studied. Most investigators believe that 
plasminogen plays a major role in fibrinolysis. Many 
biological pathways leading to plasminogen activation have 
been suggested. Under normal conditions no plasmin is 
detected in the blood, but activators of plasminogen are 
present in blood and tissues. However, the sites and the 
normal mechanisms of fibrinogen catabolism are not certain.
Larrieu et al. (197 8) suggested the theory of deposition 
of fibrin on the endothelial wall and dissolution of fibrin 
by fibrinolysis. They also mentioned that this pathway is 
not a major system for fibrinogen catabolism, and there are 
many other unknown factors. Sherman (1977) reported that 
fibrinogen may be catabolized in endothelial cells, fibrinogen 
fragments D and E in kidney, while the site of formation and 
degradation of fraction 1-6 is unknown, although it is the 
result of a proteolytic pathway other than plasmin. Sherman 
also believes that the pathways which have been mentioned so 
far cause only a small turnover of fibrinogen and the major 
catabolite site is not known.
Moroz and Gilmore (1976) reported that several factors 
are involved in fibrinolytic activity in blood. These include 
plasma factors, platelets, plasminogen independent enzymes 
of leucocytes and the complement pathway. Plow and 
Bdgington (1975) also reported that leucocytes contain a 
fibrinolytic pathway independent of the plasminogen system.
Two fibrinolytic proteinases were purified from the granular 
fraction of leucocytes. One of the proteolytic enzymes.
5.
responsible for GO-JOfo of fibrinolytic activity was similar 
to elastase, while the other was a chymotrypsin-like enzyme. 
Both enzymes digested fibrinogen fragments D and E as well as 
fibrinogen.
Gottlob et al,(1 9 7 8) reported that leucocyte enzymes 
which digest fibrin, elastase and collagen are present in the 
leucocyte's granules. The fibrinolytic action of leucocytes 
was studied by incorporation of leucocytes in plasma clots, 
and addition of streptokinase to washed clots. The enriched 
leucocytes clots were dissolved completely within 2-7 days. 
Addition of streptokinase enhanced the clot lysis, although 
very little plasminogen is present in the washed clot.
Prom their work, Gottlob et al.(1978) deduced that the 
leucocytes proteinase differed from plasmin in that it is less 
inhibited by serum and is less active towards the substrate 
casein. The enzyme is not inhibited by EDTA, EACA or 
trasylol, and the inhibition by oCgM is very weak.
Joist (1 97 7) reported that platelets play an important 
role in the maintenance of vascular integrity, forming the 
basis of the haemostatic plug which facilitates the inter­
action of coagulation factors involved in the formation of 
fibrin. Platelets can also activate, as well as inhibit, 
fibrinolysis.
Watada et al.(1977) using gel filtered platelets, showed 
that platelets contain a fibrinolytic enzyme which lyses 
plasminogen free fibrin. The activity of the enzyme 
increased when sonicated platelets were used and no activity 
was detected when platelet rich plasma was used. From these 
observations Watada et al.(1977) concluded that the fibrino­
lytic activity of platelets is masked by inhibitors in the
6.
plasma environment.
Aberg et al.(1975) analysed the coagulation and fibrino­
lytic components of wound secretions, and found high levels 
of fibrin degradation products and unclottable fibrinogen. 
Wound exudates also showed high fibrinolytic activity when 
tested on fibrin plates. As a higher activity was found when 
heated plates were used, and BACA had very little effect on 
the proteolytic activity, Aberg et al. (1975) deduced that 
the fibrinolytic activity was not due to plasmin but to some 
other proteinases.
Gaffney et al. (1976) compared fibrin subunits from 
venous and arterial thrombi. The SDS gel electrophoresis 
patterns showed not only B > Y-V and polymer, but subunits 
of molecular weight of 33j000. On further examination they 
reported that this subunit is a degradation fragment of 
/? or V chains, which may have been due to plasmin or other 
enzymes.
Apart from proteinases which act on fibrin(ogen) under 
physiological conditions, there is some evidence for the 
presence of acid proteinases in human plasma, which are 
capable of digesting fibrin(ogen), and their mode of action 
has been studied in vitro.
Shariberge et al.(1972) investigated the variation in 
fibrin clot stability in acid media between individuals and 
found that fibrin clots from females are more resistant to 
lysis in monochloroacetic acid (MCA). Fibrin clots made 
from the plasma of females on oral contraceptive are even 
more stable than those from males or females. They con­
cluded that the increased fibrin clot stability in acid media
7.
is not due to an increase in fibrinogen concentration or 
factor XIII level. In 1975, Shanberge et al.purified aniI
! enzyme with molecular weight of 44,000 and a pH optimum of
2,0, which they thought could be responsible for the 
dissolution of fibrin clot in acid media,
Ikemori et al.(1975) investigated the solubility of 
fibrin clots in acid media. From their observations, they 
concluded that the solubility of the clots in monochloro­
acetic acid is not only due to the lack of factor XIII, as 
previously thought, but other factors are involved. They 
observed that although newly formed fibrin clots will dissolve 
in MIGA, if older clots were washed free from serum before 
the addition of MCA, they become completely resistant to 
lysis. They suggested that an enzyme was present in plasma 
and serum and this was pepsinogen, because (a) it was 
activated at pH 2.0, (b) the activity was destroyed by 
heating to 60°C for 10 min., (c) when pepsinogen was added 
to M.GA it dissolved well cross-linked fibrin clots, (d) 
purified sample of the enzyme gave a reaction line with 
pepsinogen antiserum with slight crossover. Serum did not 
give a precipitation line due to low concentration.
Ikemori et al.(1975) also reported that fibrin clots 
formed from the plasma of a patient with pernicious anemia 
were resistant to lysis. They concluded that it was due to 
the low level of pepsinogen in patients’ serum rather than ab­
normally stable clots, as their washed clots were dissolved 
in acid media once they were exposed to normal plasma,
Ragaz et al.(1976) reported an unusual bleeding disorder 
in a female patient which clinically resembled factor XIII
8.
deficiency. The patient had a history of easy bruising from 
childhood, postoperative haemorrhage, delayed wound healing 
and abnormal scar formation. Laboratory results showed no 
coagulation abnormalities, except that her plasma fibrin 
clot dissolved completely in 1% (w/v) monochloroacetic acid 
(MCA) within 3 h, but remained insoluble in 5 M urea. Factor 
XIII deficiency or abnormal polymerization of her fibrinogen 
was ruled out. Patient plasma markedly enhanced dissolution, 
in acid media, of well cross-linked fibrin from normal plasma. 
Normal plasma "and patient plasma both hydrolysed denatured 
haemoglobin, but the enzyme activity in patient plasma was 
twice that of normal plasma. They concluded that patient 
had increased peps in-like proteinase activity in her plasma. 
Although acid proteinase activity is reduced in women 
taking oral contraceptive (Shanberge et al,,1972) this 
patient had a high level of acid protehase activity in her 
plasma despite being on oral contraception,
Laing (1975) partially purified the plasma enzyme(s) 
from the patient described by Ragaz et al,(1975) and normal 
plasma. From the elution pattern of column chromatography 
she concluded that there are three forms of acid proteinases 
in plasma, but was undecided as to whether they were entirely 
different enzymes or forms of the same enzyme. Taylor 
(1 97 6) followed the work of Laing and on assaying the plasma 
enzyme using a dyed fibrin assay method found that the 
plasma enzyme had 10 times greater activity than pepsin. 
However, pepsin had higher activity on denatured haemoglobin, 
and on this basis Taylor suggested that the plasma enzyme 
was not pepsin.
9.
Law and Kemp (1977) purified the plasma enzyme even 
further and reported that the semi-purified enzyme on SDS 
gel electrophoresis revealed a major hand with molecular 
weight of 51j000 and a minor hand of 86,000. Immuno­
electrophoresis showed that the sample was contaminated 
with albumin.
Law (197 8) followed the purification and characteriz­
ation of the plasma enzyme further and concluded that the 
enzyme with highest activity had molecular weight of about 
64,000, but was still contaminated with albumin. Law 
suggested that the enzyme digested the albumin and formed a 
complex,with degraded albumin. The plasma enzyme had pH 
optimum of 2,4, and its activity against denatured haemoglobin 
was inhibited by pepstatin. Therefore Law classed it as a 
carboxyl (aspartyl) proteinase.
The aim of the project was to assess and develop assay 
systems suitable for the investigation of fibrin dissolution 
in acid environment. Such assay methods would then be used 
to attempt the purification and more significantly, the 
characterization of the enzyme system(s) responsible. The 
characterization will provide a rigorous test of the hypo­
thesis (Ikemori et al., 1975) that the enzyme responsible is 
pepsin.
Factor XII 
4----- -1
F XII a
Plasminogen plasminogen F XI XIa Prekallikrein Kallikreir proactivator activator ^
Fix. IXa Kininogen
^  Kinin
Plasminogen Plasmin
Prothrombin
FX Xa
thrombin
Fibrinogen fibrin
Fragments
Pig. 1.1 Interrelationships among three plasma activation 
systems, i.e. the coagulation, fibrinolysis and 
kallikrein systems.
From Neurath and Walsh (1977)*
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2.1. Sodium Dodecyl Sulphate (SDS) Disc Gel Electrophoresis
The method used was a modification of that described by 
Weber and Osborn (1 9 6 9).
REAGENTS
2.1.1. Chamber buffer
0.1 M Tris-HGl, pH 7.4 containing 0.2^ ' (w/v) SDS,
2.1.2. Gel buffer
0.1 M Tris-HCl,pH 7.4 containing 0.2^ (w/v) SDS and 
6 M urea
2 .1 .3 . Acrylamide/N'.N' methylbisacrylamide (bisacrylamlde) 
stock solution gel solution
Acrylamide 9.5 g
Bisacrylamide 0.5 g
Gel buffer 200 ml
Stock solutions were stored at 4^0.
2.1.4. Ammonium persulphate
1 .0% (w/v) in distilled water, made up fresh for use.
2 .1 .5 . N, N, N ’,N’, Tetra methyl ethylene diamine (TEMSD)
2.1.6. Staining solution
Coomassie brilliant blue R250 2-3 g*
Distilled water 450 ml
Methanol 450 ml
Glacial acetic acid 100 ml
The solution was filtered before use.
»* for reagent of 70% purity
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2.1.7. Destaining solution
Methanol 250 ml
Glacial acetic acid 75 ml
Distilled water 675 ml
2.1.8. Tracking dye
0 . 0 5  S bromophenol blue in 100 ml distilled water
2 .1 .9 . Standards
Suitable proteins such as:
Human serum albumin (Sigma)
Egg albumin (Sigma)
Myoglobin (Sigma)
Phosphorylase (Sigma)
Standard stock solutions
2.0 mg protein was dissolved in 1.0 ml of chamber 
buffer in thin walled glass tubes. The tubes were 
placed in a boiling water bath for 2 min. After 
cooling they were stored at -20°C.
Standard working solutions
50 ^1 of each stock solution of standards were mixed 
with 0 , 2 5  ml of chamber buffer in thin walled glass 
tubes. 0 , 2 5  ml solution of 8 M urea/3% (w/v) SDS/
3% (v/v) mercaptoethanol was added and the tubes were 
placed in a boiling water bath for 2 min. 25 p.1 of 
each standard was used per run.
2.1.10. Gel preparation
19 ml of acrylamide/bisacrylamide stock solution was 
mixed with 1.0 ml of 1% (w/v) ammonium persulphate, and 
the mixture was degassed, 20 ^ 1 of TEMED was added.
12.
and the gel was poured immediately into the 5 mm x 
80 mm glass tubes, and layered the geia with distilled 
water. After the gels were polymerized, the water 
was replaced by gel ■ buffer and the gels were stored 
at 4°C,
2.1.11 Sample preparation
Samples were dialysed against chamber buffer to 
ensure complete equilibration. They were then 
applied to the gels either reduced or non-reduced.
Preparation of reduced samples
To reduce the samples, equal volume of 3% (w/v) SDS/
3% (v/v) mercaptoethanoi/8 M urea was mixed with 
the sample and the mixture was boiled for 5 min.
Preparation of non-reduced samples
Equal volume of sample and 3% (w/v) SDS/8 M urea
were mixed and incubated at room temperature for 5
min.
2.1.12 Gel electrophoresis
Samples and standards were mixed with a drop of a 
mixture of tracking dye and glycerol, and applied to 
the gels. The gels were electrophoresed at a current 
of 5-8 mA/gels from cathode to anode. The electro­
phoresis of the gels continued until the tracking dye 
reached about 5 mm from the bottom of the gel, which 
took approximately 1-^ -2 h. The amount of samples 
applied to the gels was usually between 5 -2 5 The
gels were removed from the tubes and the length of the 
gels and the distance which the tracking dye had
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travelled were measured, or the tracking dye bands 
were marked with Indian ink. The gels were stained 
for 3 0 -6 0 min. and destained overnight with several 
changes of destaining solution.
2 .1 .1 3  Molecular weight estimation
_ distance of protein migration  xy length of the gel after destaining
length of the gel before staining distance of the dye migration
or distance of protein migrationMotility = cllstanoe of dye migration
The mobility of standards are plotted against their 
molecular weight on a semi logarithmic scale. The 
molecular weight of unknown is read from the graph,
2.2, Polyacrylamide Gradient Gel Electrophoresis
The gel gradients (3-27%) were very kindly provided by 
Dr. Kemp.
Gel electrophoresis
Gradient pore U.niscil electrophoresis unit with a pump 
was used for the circulation of the buffer. Gels were 
electrophoresed at constant voltage of 150 for 2 h. in 
0.1 M Tris-HClAO06 M boric acid, pH 9.2. The gels were removed, 
and 1% (w/v) molten agar (in chamber buffer) was layered on 
the top of the gel and an "inverted comb" was placed on the 
hot agar. After the agar had set, the comb was removed and 
samples were applied as 2.1.12. Samples were electrophoresed 
for approx. 18 h. then gels were removed, stained and destained 
as 2,1.12.
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2.3. Immunoelectrophoresis
Method
0 . 2 4  g Agarose (BDH) was dissolved in 24 ml of 2% (w/v) 
sodium "barhitone buffer, pH 8.2 by boiling. Six microscope 
slides were covered uniformly with the molten agarose, on a 
horizontal table, and allowed to set. Samples were placed 
in the well punched in the agarose along with tracking dye 
(Bromophenol Blue). The samples were run at a constant 
voltage of 150 V, until the tracking dye had run to the end 
(about 3-4 h.). Specific antisera were placed in each trough 
and allowed to diffuse into the agarose in a humid chamber 
for 18 h. at room temperature.
Slides were either (a) washed in 1% (w/v) NaCl for 48 h., 
followed with overnight wash in distilled water, before drying 
at 37°C or (b) dried by pressing with thick layers of filter 
paper between two heavy blocks. In this way time spent on 
washing in salt and water was eliminated. Slides were 
stained in Coomassie Blue (2,1.6) and destained (2.1.7) 
overnight.
2.4. Immunodiffusion Technique
Agar plates were prepared as (2.3). Rosette patterns 
were cut in the gels and the wells were filled with different 
concentrations of samples with the antiserum in the centre 
well. The plates were left at room temperature or incubated 
at 37°G for 24h, Antigen and antibody placed in wells diffuse 
towards each other and precipitate is formed as an opaque 
line in the region where they meet in optimal proportions.
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2.5. Protein Estimation
The method used was based on that of Bradford (1976). 
Coomassie brilliant blue G-250 binds to protein and causes a 
shift of maximum absorption from 465 nm to 595 nm. The 
increase in absorption at 595 nm is monitored.
2.5.1. Preparation of protein reagent
100 mg of Coomassie brilliant blue (Sigma) was 
dissolved in 50 ml of 95% (v/v) ethanol. 100 ml of 
85% (w/v) phosphoric acid was added, and the total 
volume was made up to 1 1, The solution was mixed 
and filtered through Whatman No. 1 filter paper.
2.5.2, Assay
A standard curve was constructed using solutions of 
bovine serum albumin (Sigma BSA), Varying concen­
trations (100-1000 pg/ml) of standard were prepared. 
To 0.1 ml of each concentration, 5 ml of protein 
reagent was added, mixed and left at room temperature 
for 2 min., for the colour to develop. The absor­
bance was measured at 595 nm against a blank which 
has been prepared the same way as the standard except 
BSA was replaced by 0.1 ml of buffer of choice. The 
test sample was prepared in the same way as the stan­
dard and the concentration of the test sample was 
determined from the standard curve. The response 
was linear up to 60 yig protein. Reagent supplied 
by Bio-Rad and reagent made in the laboratory gave 
very similar results. Pig, 2.1. The home-made 
reagent being cheaper, was preferred.
Ec
m(7)in
1.0
0*8
0*6
0*4
0*2
40 80 120
protein
Fig, 2,1 STANDARD CURVE FOR PROTEIN ESTIMATION USING 
BSA AS STANDARD PROTEIN
-• Bio-Rad kit reagents
■o Home-made reagent
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2.6. PlbrInogen/PlbrIn Estimation
The method used was based on.that of Dacie and Lewis 
(1975a).
2.6.1. Assay procedure
Fibrin clots were made as (3.2,14.) and were washed in 
0.85/to (w/v) NaCl 3 times, 1.0 ml of 2.5 M NaOH 
was added to each clot and boiled for 15 min. to 
dissolve the clot. The solution was cooled, then
1.5 ml of Polin-Ciocalteau reagent were added. The 
mixture was incubated at room temperature for 20 min,, 
for the colour to develop.
The absorbance was read at 650 nm. The blank 
was prepared as above by omitting the fibrin clot.
At the same time, standard was prepared using 0.2 ml 
of 0.2 rag/ml tyrosine in 0.1 M HCl, in place of 
fibrin clot,
2.6.2. Calculation of the results
~ x v s  X cs X ^  X 11.7 = mg/ml concentration of
fibrinogen.
t = absorbance of the test solution - blank
8 = absorbance of the standard solution - blank
vs = volume of the standard in ml
08 = concentration of the standard in mg/ml
vt = volume of the original sample which was used to
make the fibrin clot 
11.7 = conversion factor for liberated tyrosine to fib­
rinogen concentration.
Standard curve was constructed using different 
volume of the precipitate of 2 ^  Ammonium sulphate
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gel fractionation (25 AS) of plasminogen free bovine usedplasma/to make fibrin clot. The standard curve is 
shown in Pig. 2.2.
2.7. Plasminogen Assay
2.7.1. Pibrinogen plate substrate
The method used was a modification of Noren et al, 
(1975), 0.1 g of agar was dissolved in 8 ml of
0.05 M Tris-HGl,pH 7.U by boiling. The temperature 
of agar was brought to 56°C, 20 mg of human fibrino­
gen (Kabi Vitrum, London) was dissolved in 2 ml 
buffer, and mixed with the agar. The mixture was 
poured into a glass petri dish, and allowed to set at 
room temperature on a level surface. At the same 
time another plate was prepared as above except the 
fibrinogen was added to the agar at 7 0°G to inactivate 
the contaminating plasminogen. 5 -2 5 /il of samples 
were placed towards the centre of each quarter of the 
plates which were then incubated at 37*^ G for 2h h.
2.7.2. oC-Gasein substrate
The method used was based on that of Alkjaersig et al,
(1959).
2.7.2.1, Reagents preparation
1'5 g of04-casein (Hammarsten) was dissolved in 
100 ml of 0.05 M phosphate/O.1 M NaCl buffer,pH 7,4 
and the volume was brought to 250 ml with distilled 
water.
36 mg of tyrosine was dissolved in 900 ml of
0-8
Ec 0-6
oin(O
0-4
0-2
2-41-8120*6
mg Fibrinogen
Pig. 2.2. STANDARD CURVE FOR PIBRIN CONTENT OP CLOT
Variation of absorbance at 650 nm, A graph 
of variation of absorbance at 650 nm versus 
the concentration of fibrinogen used to make 
fibrin clot.
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of 0,1 M HCl/ 1 0 0  ml of isopropanol.
The tyrosine was used as a standard.
2.7 .2.2. Assay method
0 . 5  ml of sample was mixed with 0.1 ml of 0.1 M 
harhitone/HGl buffer,pH 7.4. 0.1 ml of 2000 units
streptokinase (Behring) was added to the sample, 
followed by the addition of 2,0 ml of o«-casein.
The mixture was incubated in a water bath at 37^0, 
and the time was noted. After 2 min. 1 .0  ml of 
incubation mixture was transferred to a tube con­
taining 1 ml of 10% (w/v) TGA, After 60 min. the 
subsampling was repeated. The two samples were 
centrifuged at 1500 g for 10 min. The precipitates 
were discarded and 2.5 ml of 0.5 M NaOH, 0.75 ml 
of 5% (w/v) TGA and 0.75 ml of Polin-Ciocalteu 
reagent were added to the supernatents. The mix­
tures were left at room temperature for 15 min. 
for the colour to develop. The absorbance was 
read at 65O nm. The two min. sample served as a 
blank for the 60 min. sample.
2.7 .2.3 . Plasminogen standard curve
Standard curve relating absorbance at 650 nm to 
concentration of tyrosine was constructed, Pig. 2.3. 
Definition of units/ml plasminogen 
Tyrosine standard containing 0.5 ml of stock 
solution 3 . 6  mg % (w/v) in assay system has been 
given an arbitrary value of 4 plasminogen units.
0 5
0 4
o  0 3
0.2
51 2 3 4
u n i t s / m l
Pig. 2,3 STANDARD CURVE FOR PLASMINOGEN ESTIMATION
Variation of* absorbance with concentration of 
tyrosine (units of plasminogen).
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2.7.3. Synthetic substrate 8-2251
The chramogenic substrate 8-2251 (H-D-val-Leu-Lys- 
pNA) is a sensitive and specific substrate for plasmin 
and streptokinase-activated plasminogen, 8-2251  
is a soluble and stable substance and is also very 
sensitive to small amounts of plasmin (< ^ 1 0 ^^  moles) 
(Priberger et al,, 1978),
2,7.3.1. Assay method
Substrate stock solution was prepared by dissolving 
25 mg of 8 -2 2 5 1 (Kabi Vitrum, London) in 15 ml 
distilled water, A Cecil spectrophotometer with 
cell carriage at 37°C was used. The spectro­
photometer was set at U05 nm and zeroed with dis­
tilled water. Plasminogen buffer (O.0 5 M Tris- 
HGl, 0,012 M NaCl,pH 7.4 was eq.uilibrated at 37°C, 
100>ul of the sample and 100 jal of streptokinase 
(2 0 0 0 units/ml) were mixed in 1 ml plastic cuvette 
and incubated at 37°C for 10 min, 700^ul of 
buffer and 100/il of substrate were added to the 
mixture, and the absorbance was recorded until 
plateau formation,
2 .7 .4 . Estimation of bovine plasminogen
Summaria et al. (1974) reported that bovine plasminogen 
(0 .1 mg) could not be activated to plasmin even with 
as much as 100,000 units of streptokinase. However, 
addition of small amount of human plasminogen could 
trigger the activation of bovine plasminogen to plasmin. 
To estimate bovine plasminogen, a known concentration
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of human plasminogen was added to the bovine plas­
minogen and the mixture was assayed as 2,7.3.1. To 
calculate the activity of bovine plasminogen in the 
mixture, the activity due to the human plasminogen 
added originally was subtracted from the total.
2.8. Fluorometric Measurement of Fibrin-Stabilizing Factor 
(F XIII).
Some amines inhibit the crosslinking of fibrin, by acting 
as a pseudo substrate and blocking the acceptor group of 
normal crosslinking,
H„K.F.Co.Y + H„N.F.Co.Y H„N.P.CoF.CoY + HYCa
Fibrin Fibrin Ca Cross linked fibrin
H oN.P.Go.Y + H„HE ) HoN.F.Co.NH.HN. + HY2 2 Ga++ ^
Fibrin pseudosubstrate ,
Monodansyl cadaverine was used as the amine donor, and 
fibrinoligase was measured fluorometrically.
2.8.1. The assay
Method used was based on that of Lorand et al,(l969).
2.8.2, Reagents
(I) 0,2 M glutathione was prepared in 50^ (v/v) 
aq.ueous glycerol and the pH was adjusted to 7.5, 
with 3 M NaOH, (ll) 125 NIH units/ml thrombin 
(Sigma) was made in 25^ (v/v) aqueous glycerol, and 
made 0.02 M with respect to CaCl^jPH 7.5. (ill) 2 mM 
monodansyl cadaverine was prepared in 0,05 M tris- 
HCl,pH 7.5, containing 3 mM CaClg, (IV)
21 .
(w/v) casein was made in a mixture containing 10%
(v/v) glycerol, 3 mM GaClg and 0.05 M Tris-HCl, 
pH 7.5, then it was dialysed against the same buffer. 
The dialysed solution was centrifuged at 1500 g for 
60 min. (V) The solution for measuring the protein 
bound amine was prepared using 8 M Urea, 0.5% (w/v)
Na dodecyl sulphate in 0.05 M Tris-HCl, pH 8.0.
2.8.3. Assay procedure
0.2 ml of plasma and 0.05 M (v/v) aqueous glycerol 
were mixed, and brought rapidly to 56°C, and kept at 
that temperature for 2.5 min (“desensitization'* of 
fibrinogen by heat) . The mixture was cooled by 
immersing the sample in an ice bath. 0 . 0 5  ml of 
0.2 M glutathione solution and 0.2 ml of thrombin 
were added to the mixture and after mixing the solution 
was left at room temperature for 20 min. 0.5 ml of 
2 mM dansylcadaverine solution and 1.0 ml of 0.4%
(w/v) casein were added. The mixture was incubated 
for a further 30 min.
The incorporation of amine was stopped by addition 
of 2 ml of 10% (w/v) TCA. The protein precipitate 
was washed with ethanol/ether (1:1 v/v) and dried.
The dried precipitate was dissolved in 2 ml of 
8 M Urea solution for protein bound amine measurement. 
Fluorescence intensity was measured at an emission 
wave length of 518 nm and excitation of 335 nm.
Calculation of units of F XIII per ml of plasma
^ 1 X - L  iT - IB0.2 * 3 0.9 iR - iS
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20~2 =ï 10 dilution factor for sample in test system
= assay in 10 min incubation instead of 30 min.
= 10% correction for loss of Factor XIII during the 
heating of plasma,
IT = fluorescent intensity of test
iB = fluorescent intensity of blank
iR = 1 ju mol/liter monodansyl cadaverine in solvent 
system
iS = solvent system, fluorescent intensity.
Blank = same as the test without monodansyl cadaverine 
Solvent system = 8 M Urea, 0.5% (w/v) SDS in 0.05 M
Tris-HCl,pH 8.0.
2.9. Prothorombin Estimation
2.9.1. Preparation of brain thromboplastin
Method used was based on that of Dacie and Lewis 
( 1975b). Fresh rabbit brain was used. The membrane 
and blood vessels were removed from the brain which 
was macerated in 5-10 times volumes of acetone. The 
acetone was changed at least 3 times, until the gran­
ular material was grease-free. The granular material 
was air dried and stored in an evacuated desiccator 
at 4°C. For use in the assay system, 5 ml of 0.85% 
(w/v) NaCl was added to 30g of the dry brain powder. 
The mixture was incubated at 37°C for 15-30 min. 
with occasional mixing. The coarse particles were 
left to sediment, or centrifuged at lOOg for 5 min.
The supernatant (thromboplastin) was used in the
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assay of prothrombin.
2,9.2. Performance of the assay
The method used was based on that of Dacie and Lewis 
(1975). To a 75 mm X 12 mm tube containing 0,1 ml 
thromboplastin, 0,1 ml of the sample was added. The 
mixture was incubated at 37°C for 1-2 min. 0.1 M 
of prewarmed (37°G) 0.025 M CaClg was added to the 
mixture, and a stopwatch started simultaneously, and 
the time taken for fibrin clot to form was noted.
2.10. Purification of fibrin stabilizing factor (P XIII) 
from bovine plasma
The method used was based on that of Lorand and 
Gotoh (1970).
6 1 of bovine blood was mixed with 0,08 M potassium 
oxalate (ratio of 9:1), and centrifuged at 200 g for 
2 h. The plasma was separated and recentrifuged to 
remove any remaining red blood cells. 2 1 of 
plasma was mixed with 500 ml of saturated ammonium 
sulphate and stirred at 4^0 for 1 h. The solution 
was centrifuged at 10,000 g for 30 min. at 4°0.
The precipitate was dissolved in 0.15 ^ KCl, 
and the pH adjusted to 5.4 with 1 M acetic acid.
312.5 ml of solution was mixed with 60 ml of 
saturated ammonium sulphate, stirred and centri­
fuged as before. The precipitate was dissolved in 
0,05 M Tris-HGl/O.1 M NaCl, pH 7.0. To remove 
fibrinogen the solution was mixed with equal volume 
of 0.05 M Tris-HCl/0.1 M NaCl, pH 7.0.
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The mixture was heated at 56° for 3 min. by rapid 
immersion of the solution in a water bath at 80°C. 
Denatured fibrinogen was removed with the help of 
glass rod, and the supernatant centrifuged at 2000 g 
for 15 min. to remove any residual fibrinogen.
The supernatent (200 ml) was cooled to 4°G, mixed 
with 60 ml of saturated ammonium sulphate, and cen­
trifuged as before. The precipitate was dissolved 
in 10 ml of 0.05 M Tris-HGl/.001 M BDTA, pH 7.5, and 
dialysed against the same buffer for 18 h at 4°G.
2.10.1 Ion-exchange chromatography
2.10.1.1 DBAS-cellulose 82 (Whatman) .
The DEAE-cellulose resin was precycled and de­
gassed. A column of 40 cm x 2.5 cm was then packed 
with the resin, and allowed to equilibrate by pumping 
0.05 M Tris-HCl/0.001 M BDTA, pH 7.5 at a flow rate 
of 36 ml/h. The semi-purified sample of Factor XIII 
which has been dialysed against the above buffer, was 
applied. The column was eluted with equilibration 
buffer, until no protein was detected in the effluent 
A linear gradient to a final concentration of 0.3 M 
NaCl, and with a total volume of 600 ml was then 
applied.
2.10.2 Cel filtration
2.10.2.1 Sephadex C 200
Sephadex G 200 (Pharmacia) was swollen for two 
days at room temperature in an excess of buffer 
(0.05 M Tris-HCl, 0.001 M BDTA, 0.1 M NaCl, pH 7.5 . 
The resin was degassed and packed into a column of
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35 cm X 2.2 cm. The buffer was allowed to go through 
the column by gravity, at the rate of 6.8 ml/h.
The sample was applied to the column and fractions 
were collected every 20 min.
2.10.3. P XIII -purification results
2.1 0,3.1 DBAS cellulose
Three major peaks were obtained. Pig. 2.4.
Samples under each peak were pooled separately and 
assayed for P XIII, The P XIII activity was 
measured using fibrin clot assay 3-2.5 (Fibrinogen 
Grade L Kabi Vitrum, London) which had been passed 
through lysine sepharose column and also shown to be 
lacking in P XIII, activity was used as a source of 
fibrin clot. Peak II and Peak III both showed 
activity, with the highest concentration in Peak II. 
SDS gel electrophoresis was performed on an aliquot 
of each pool, using 5%, 10% SDS gels and using reduced 
and non-reduced samples. P XIII was detected in 
both peaks. As the SDS gel revealed the presence 
of other proteins, a further purification step was 
necessary.
The pool from Peak II was concentrated by 
ammonium sulphate precipitation (35% saturation) as 
before. The precipitate was dissolved in 2.0 ml of 
0.05 M Tris-HClA001 M BDTA, 0.1 M NaCl, pH 7-5, and 
dialysed against the same buffer, before being sub­
jected to gel filtration.
2.10.3.2 Sephadex G 200.
Elution pattern from Sephadex G 200 column showed two
Pig. 2.U DBAS CELLULOSE COLUMN CHROMATOGRAPHY 
OP BOVINE FACTOR XIII
-# absorbance at 280 nm
salt gradient applied(section 2.10.1,1.)
------ 1 fractions pooled
Pool II and III had Factor XIII activity 
with highest concentration in Pool II.
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peaks. Pig. 2,5, Fractions 20-30 were assayed for 
Factor XIII as 2.8.3 • All fractions showed 
activity with the highest levels in fractions 21-26.
SDS gel electrophoresis was performed as 2.1.12 , and 
fractions 21 , 22 and 23 showed no contamination.
These fractions were pooled, concentrated as 2.10 ,
using ammonium sulphate, and dialysed against 0 , 0 5  M 
Tris-HC 1/0.001 M EDTA/),01 M NaCl, pH 7.5. Glycerol 
was added to a final concentration of 20^ (v/v) and 
the sample was stored at -20°C.
2,11, Purification of Bovine Fibrinogen
The method used was based on that of Lawrie et al.(1979). 
Bovine blood was collected at slaughter, and allowed to run 
into a solution of 0,106 M Tri-sodium citrate 9:1 (v/v) 
blood to anticoagulant , The blood was centrifuged at 
1200-1500 g for 1 h. The clear plasma was applied to a 
lysine-sepharose column (U.U-.1.2) for preparation of plasmino­
gen-free plasma,
2.11,1 Ammonium sulphate fractionation (AS)
Plasminogen-free plasma was brought to 25% saturation 
with ammonium sulphate, and after 1-2 h. the suspension 
was centrifuged at 1500 g for 20 min. The super­
natant was discarded and the precipâbate was washed 
with 23% saturated ammonium sulphate. The suspension 
was centrifuged as before, and the precipitate was 
suspended in 0,05 M Tris-HO1/0.05 M NaCl, pH 8,6 and 
dialysed against the same buffer for 2U h, with 2
changes of buffer.
The sample was applied to DBAE cellulase column.
o
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Pig. 2.5 SBPHADBX G 200 COLUMN CHROMATOGRAPHY OP 
BOVINE FACTOR XIII
absorbance at 280 nm
I-----1 fractions with activity
Sample applied was the pool from Peak II of 
DBAS cellulose, which has been concentrated and 
dissolved in the equilibrating buffer 0 . 0 5  M 
Tris-HCl/0.001 EDTA, 0.1 M NaCl, pH 7.5.
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2.11.2. DBAS-cellulose 52 (Whatman)
The DBAS cellulose resin was precycled and degassed.
A column 24 cm x 1.6 cm was packed with the resin and 
allowed to equilibrate with 0.05 M Tris-HGl/),05 M 
NaCl, pH 8.6, at the flow rate of 50 mi/h. The 
sample which had been dialysed in the same buffer was 
applied to the column, and fractions were collected 
every 6 min. The starting buffer was pumped through 
until the effluent had an absorbance of less than 
0.1 at 280 nm. Then 0.05 M Tris-HCl/O.1 M NaCl, 
pH 8.6 was applied and fractions were collected as 
before.
2.11.3. Results
Two peaks were obtained from DEAE cellulose column.
Pig, 2,6, Both peaks were tested for fibrinogen, 
using thrombin clotting time. Most of the fibrinogen 
was in Peak II, SDS gel electrophoresis was performed 
on the fractions, using gel. Practions 29-33 
showed one single band on non-reduced samples, and 
three bands on reduced sample. Pig. 2,7.
2,12. Purification of plasminogen
The method used was based on that of Deutsch and 
Mertz (1970) and Rickli and Cuendent (1971). To 
prepare human and bovine plasminogen, fresh frozen 
plasma was applied to the lysine sepharose column as
4.4.1.2, Once the plasminogen-free plasma was 
collected, the column was washed with 0,05 M Tris- 
HCl/O.3 M NaCl, pH 7,5 until the effluent had absor­
bance of less than 0,05. Plasminogen was eluted
Pig. 2.6 DEAB CELLULOSE COLUMN CHROMATOGRAPHY OP 
BOVINE FIBRINOGEN
absorbance at 280 nm
I 1 fractions with pure fibrinogen
Sample applied in equibibrating buffer 
0.05 M Tris-HCl/0.05 M NaCl, pH 8.6, and 
fractions were eluted with 0.05 M Tris- 
HC1/0.1 M NaCl, pH 8.6.
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Pig. 2.7. SODIUM DODBCYL SULPHATE (SDS) POLYACRYLAMIDE 
GEL ELECTROPHORESIS OF BOVINE FIBRINOGEN
I Non-reduced 
II Reduced
( I
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from the column with 100 ml of 0.2 M ^.-aminocaproic 
acid (BACA) and fractions with absorbance of more 
than 0.2 at 280 nm were collected. Then 100 ml of 
0.05 M Tris-HCl/0.2M BACA, 1 M NaCl, pH 7.5 was 
applied to clean the column.
2.15. Preparation of Fragments 
D and B from Fibrinogen 
The method used was based on that of Lawrie et al,
(1979). Fibrinogen was prepared as 2.11, The fibrinogen 
was dialysed against 0.05 M Tris-HCl,pH 7.5. overnight at 
i+°C, The flow chart of the purification. , Fig. 2.9.
2.13.1. Fibrinogen digestion
To 0.5 M plasminogen, 50 pi of 5000 units/ml 
streptokinase was added and incubated at 37°C for 
15 min. Then the activated plasminogen (plasmin) 
was added to bulk of fibrinogen at 37°C. After 
approximately U h, an aliquot of the mixture was 
subjected to electrophoresis to determine the extent 
of the digestion.
When the digestion was completed, the sample was 
applied to DEAB 52 cellulose column.
2.13.2. DBAS cellulose
A DEAB 52 cellulose column was prepared as 2.11.2 
and was equilibrated with 0.05 M Tris-HCl/0.05 M 
NaCl, pH 8.6.
Degraded fibrinogen was applied to the column and 
fractions were collected until no protein was detected 
in the effluent. This peak contained fragment D
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Pig, 2.8, To elute fragment B, a linear salt gradient 
was applied from 150 ml of 0,05 M Tris-HCl/l mM 
CaClg, pH 7.5 to 150 ml of 0.05 M Tris-HCl/l mM 
GaClg, 0.5 M NaCl, pH 7.5, (Fig. 2.8).
2.14, Purification of Pepsin and Gas triesin from Gastric 
Juice
Gastric juice was generously supplied by Ninewells
Hospital (Dundee).
2.14.1. Preparation of sample
The method used was based on that of Tang (1970).
250 ml of gastric juice was filtered through glass 
wool, and dialysed at 4°C against distilled water for 
48 h. with several changes of distilled water. The 
dialysed sample was freeze dried.
2 .1 4.2 . Amberlite IRC-50(H) column chromatography
The freeze dried gastric juice was dissolved in 12 ml 
of 0.2 M citrate buffer,pH 3.0 and centrifuged at
3 0 ,0 0 0  rpm for 2 h. The clear supernatant was applied 
to the equilibrated column as 4.2 . Three peaks 
were obtained, Peak: I at pH 3.2, Peak II at pH 4.0 
and Peak III at pH 4.4, (Pig. 2.10).
Samples under the Peak II and III showed 
proteolytic activity, using haemoglobin and fibrin 
clot as substrates. Samples under Peak II and III 
were pooled separately and dialysed at 4°C for 72 h, 
against 5-IO times changes of distilled water. After 
dialysis each pool was freeze dried separately.
Pig. 2.8. DBAS CELLULOSE COLUMN CHROMATOGRAPHY OP 
FIBRINOGEN FRAGMENTS D AND E
o o Absorbance 280 nm
*I Practions with pure fragment D
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2.14.3. Identification of proleolvtio enzymes of Peaks
II and III of Arriberlites column.
2.14.3.1 Molecular weight determination
A sample from Peaks II and III were electrophoresed 
on 3% and 105^  gels (2,1) in reduced and non-reduced 
form.
2.14.3.2.Amino acid analysis
A sample of both, peaks were subjected to complete 
hydrolysis in 6 M HCl. The amino acid composition 
of hydrolysates were determined using automated 
ion-exchange chromatography, in amino acid analyser, 
(The amino acid analysis was performed very kindly 
by Mr, Angus Grieve.)
2,14.3.5.Enzyme assay
Proteolytic activity of both peaks were measured 
using a) haemoglobin assay at pH 2,0 and 3.0; 
b) synthetic substrate, N-acetyl-L-phenylalany1- 
L-diiodotyrosine (APDT); c) fibrin clot assay.
2.14.4. Results
Molecular weights of Peak II and Peak III were 
39»000 and 3U,000 respectively, values which are 
higher than those recorded in the literature for 
pepsin and gastricsin. However, commercial hog 
pepsin (Sigma, Victrum, London) with a stated 
molecular weight of 3 4 ,7 0 0 gave a molecular weight 
of 39,000 in this system. The amino acid com­
position of both peaks were similar to that of pepsin
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and gastricsin respectively. Proteolytic activity 
of Peak II, using haemoglobin as/substrate was highest 
at pH 2.0 and of Peak III at pH 3.0. Both were
inhibited with pepstatin but, when fixed concentration 
of both enzymes were treated with different amounts 
of pepstatin, the results indicated that Peak II was 
X 100 more sensitive towards inhibition with pepstatin 
than Peak III,
Peak II hydrolysed synthetic substrate (APDT), 
but Peak III had no effect. By comparing the 
different parameters with that of Tang’s(l9?0) work, 
it was clear that Peak II was pepsin and Peak III 
gastricsin.
CHAPTER 5
SUBSTRATS
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3,1. General Introduction to Substrates
The fact that there are many different types of sub­
strate in the literature, indicates the problem of 
finding a substrate which is best for a particular 
enzyme.
There are many criteria which one should consider, 
and it is not always possible to find a substrate with 
all the necessary parameters. Sometimes there is a 
need to use more than one type of substrate to overcome 
the inefficiency of the system. There are different 
types of substrates such as protein substrates and 
synthetic substrates which are used in the assay of 
proteolytic enzymes. Protein substrates include 
natural substrate proteins, "other proteins" and 
artificial substrate proteins (Bohley and Langner,
1982).
(i) Natural protein is the substrate which has been 
isolated from the same cell or tissue as the proteinase 
enzyme. The advantages of using natural substrates 
is that a direct comparison to the in vivo system is 
possible. However, it is difficult to create the 
physiological conditions in vitro, and unfortunately 
many experiments are set up .in very low or high pHs. 
Although these pH values are optimal for the activity 
of the enzyme, they create an artificial condition, i.e. 
expose sensitive regions of the protein by conformational 
changes.
The main disadvantages of using protein substrates
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is that they are unsuitable for kinetic studies of 
proteinases, for they present multiple sites of 
cleavage, and peptide products probably change con­
stantly, creating a mixture of secondary substrates 
and inhibitors (Knight, 1977). Another problem with 
protein substrate is that, no matter how precisely 
the protein concentration has been measured, none of 
the protein estimations are perfect. Usually the 
extent of hydrolysis is determined after acid pre­
cipitation of protein with TCA and measuring the 
absorbance of the supernatent (which contains cleaved 
small peptides)at 280 nm. This, however, depends on 
the presence of aromatic amino acids (Reimerdes and 
Klostermeyer, 1976). Sometimes the substrate is 
attacked by the enzyme in a rather limited way, and the 
resulting fragments are only partially soluble in acid 
solution. In addition, it is possible that some of 
the proteolytic products do not contain aromatic amino 
acids,
"other protein" substrates are proteins such as 
haemoglobin, casein, albumin, etc., which are widely 
used without being a natural substrate. The disad­
vantages of these substrates are similar to those of 
natural substrates.
Artificial substrates are proteins coupled to a 
matrix such as sepharose or agarose, or free soluble 
protein, which can be labelled with a chromogenic or 
radioactive group, and used in vivo or vitro. The 
advantages of matrix-coupled proteins lie in the 
possibility of determination of the splitting of peptide
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bonds without the use of TCA.
Synthetic substrates have well defined chemical 
structures. Their advantages compared to the natural 
substrate are: they can have better solubility; and
their enzymic cleavage can be easily followed by photo­
metric or fluorometric methods (Claeson et al., 1978). 
Synthetic substrates can be highly specific and sensi­
tive. They are useful for the investigation and 
characterisation of an enzyme,especially once the 
enzyme has been purified. However, the hydrolysis of 
these substrates is not necessarily an accurate 
reflection of an enzyme's activity against protein 
substrates (Lin et al., 1969).
The important points to consider, regardless of 
the type of substrate, are availability, sensitivity, 
specificity and lability. The substrate must be 
hydrolysed by the enzyme at a reasonable rate, and its 
products measured easily (Knight, 1977).
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3.2. Fibrin Clot Substrate
3.2.1. Introduction
A blood clot is formed after a chain of enzymic 
reactions. The last stage is the conversion of the 
soluble plasma protein fibrinogen into a visible 
insoluble network of the fibrin clot (Ratnoff, 1977).
Fibrinogen has a dimeric structure, in which the 
two halves of the molecule are made up of three 
polypeptide chains (A4, B/), and Y ) .
Fibrin monomers are formed by the proteolytic 
action of thrombin, which cleaves two pairs of small 
peptides, (A and B) from the amino terminus of [a >] o<. 
and [b] chains respectively. Once the fibrin 
monomers form, they link up spontaneously to form a 
fibrin polymer. The monomers are held together by 
weak forces such as electrostatic and hydrogen bonding. 
The clot formed is not very stable and would disperse 
in denaturing media such as 1% (w/v) monochloro- 
acetic acid (MCA) or 5 M urea (Doolittle, 1977).
A more stable fibrin clot is formed by the catalytic 
action of another plasma protein. Factor XIII (fibrin 
stabilizing factor)• Factor XIII catalyses a 
transpeptidation reaction between the lysine of one 
chain (donor) and the glutamine residue of another 
chain (acceptor), leading toY -glutamyl-^ -lysine 
bridges, cross-linking the two chains covalently 
(Lorand et al., 1968). Factor XIII cross-linked 
fibrin does not dissolve in (w/v) MCA or 5 M urea
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and is more resistant to enzymic dissolution than is 
a fibrin clot formed in the absence of Factor XIII 
(Lorand et al., 1981). Gross-linking of fibrin 
monomers takes place between V-chains of adjacent 
molecules, within the first few min. of polymeriz­
ation, while the o(^ -chains take much longer to form 
polymers. The/2-chains are not involved in this 
process. Although a fibrin clot formed in this way 
is very stable, it would dissolve eventually in 
physiological condition (in vivo) and in acid solution 
in vitro in the presence of plasma enzymes (Doolittle, 
1981).
In addition to the major role of thrombin and 
F XIII in the formation of a stable clot, the environ­
ment (pH and ionic strength) in which the fibrin 
polymerization takes place, is also important (Crum, 
1977). The pH of the media affects the kind of clot 
which is formed and the ionic strength of the medium 
affects the rate of polymerization. Steiner and 
Laki (1931), using the light scattering method, found 
that fibrin clot formed at high pH and ionic strength 
is a "fine clot" which has low opacity, relatively 
high rigidity, while at low pH or ionic strength, the 
clot is coarse with high opacity and less rigidity.
At pH values below 5.1 or greater than 10.1, no gel 
is formed and gelation time as a function of pH 
showed that there is a minimum clotting time between 
pH 6.0 and 8.5. The gelation time is further depen­
dent on the ionic strength.
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3.2.2. Purified fibrinogen preparation
Human fibrinogen (Kabi V'itrum, London) was passed 
through lysine-sepharose 4B as 4.4.1.2 to remove 
any plasmin(ogen) contamination. Most commercial 
preparations are contaminated with plasmin(ogen)
(Dacie and Lewis, 1975c). Bovine fibrinogen was 
purified as 2.11. Fibrin clots were prepared as 
3.2,4 except GaCl^ solution contained 25 units/ml 
thrombin.
3.2.3. Semi purified fibrinogen preparation
Bovine blood was treated as 2,11 up to the stage of 
ammonium sulphate precipitation. The precipitate 
was dissolved in and dialysed against 0.85^ (w/v)
NaCl at 4°C for 24 h. The NaCl was changed at least 
3 times. The dialysed solution was stored at -20'*^ C 
if it was not to be used immediately. To prepare 
fibrin clots, the dialysed fibrinogen was diluted with 
0.85% (w/v) NaCl to give a final fibrinogen concen­
tration of 2-3 mg/ml. Fig, 3.1 i
3.2.4. Fibrin clot formation
The method used was based on that of Ikemori et al,,
( 1 975} .
0,6 ml of the sample was placed in a 75 mm x 12 mm 
glass tube, in 37°C water bath. Clotting was initiated 
by the addition of 0.2 ml of pre-warmed (37°G) 0.05 M 
CaClg, and the fibrin clot was collected by winding on 
a glass rod. It was then incubated at 37°G for 
4-5 h in its own serum. The clot was removed from 
the glass rod and washed in 0,85% (w/v) NaCl for 18 h.
Pi#.-3.1
DENSITOMËTRIC SCAN OF AN ALIQUOT OF CRUDE 
FIBRINOGEN SEPARATED BY SDS PAGE
Peak I = fibrinogen
fO
38.
with at least 3 changes of NaCl. To remove the salt, 
the clot was washed and left in distilled water for 
ahout 3 h.
3 .2 .5 , Fibrin clot assay
The method used was based on that of Ikemori et al.,
(1 9 7 5).
2 . 6  M of 1% (w/v) monochloro-aoetic aoiâ (MCA) 
was added to the washed clot in a centrifuge tube.
Test solution (0,05-0.3 ml) was added, and the mixture 
incubated at 37°G for 16 h. The solution was cen­
trifuged at 200 g for 20 min. The supernatant was 
removed and discarded. The remaining clot was washed 
with saline 3 times, and the protein content of the 
remaining clot was assayed as 2,6.
3 .2 .6 , Fibrin clot substrate result
Clots prepared from purified fibrin dissolved rapidly 
(within 5 min.) in 1% (w/v) monochloro-acetic acid 
(MCA)^ în the absence of a p^teolytic enzyme, 
indicating that fibrin clots had not been cross-linked,
' 4*4*As Ga and thrombin had been added in excess, this 
suggested a lack of Factor XIII. To overcome the 
Factor XIII deficiency, partially purified bovine 
fibrinogen was used. Factor XIII precipitates at 
approximately 17^ saturation with ammonium sulphate 
(Lorand and Gotoh, 1970), and fibrinogen at about 
25^ saturation (Lawrie et al., 1979). Therefore a 
25^ ammonium sulphate precipitate has sufficient 
Factor XIII and fibrinogen for the purpose of 
preparing a fibrin clot substrate.
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Fibrin clots formed from partially purified 
fibrinogen were stable in 1% (w/v) MCA, indicating 
that sufficient Factor XIII and prothrombin were 
present. The clots, however, were also resistant to 
lysis in MCA in the presence of plasma enzyme.
To investigate the cause, plasminogen which had 
been removed from the original plasma was added back 
to the crude fibrinogen in varying amounts, before 
clot formation. As the results (Table 3.1) show, 
the addition of plasminogen made the clot more 
susceptible to lysis by plasma enzyme in MCA.
Theoretically, plasminogen should not have any effect
at low pH, so the buffer (0.05 M Tris-HCl/O.02 M 
lysine/O.I M NaCl, pH 9.0) against which the plasmino­
gen had been dialysed was tested as well as plasminogen 
before dialysis (plasminogen in 0.1 M EACA from 
lysine-sepharose column). In addition the plasminogen 
solution was examined for the presence of plasmin.
As Table 3.2 shows, the change in the susceptibility 
of the clot to lysis was not due to the action of the
plasminogen as the clots become less resistant to lysis
with the addition of buffer only. The next step was 
to investigate the reason for the change in the 
susceptibility of the clot by the buffer. The
buffer was made without the addition of lysine 
(0.05 M Tris-HCl/O.15 M NaCl, pH 9.0), The results 
did not change significantly. Different amounts of 
buffer without lysine were added to the crude 
fibrinogen, and the pH of the solution was measured
Uo.
Substrate mg fibrin dissolved by 0.2 ml enzyme in 16 h.
Crude bovine fibrinogen /0.15 M NaCl 9:1 (v/v) 0.12
Crude bovine fibrinogen /plasminogen 9:1 (v/v) 1.92
Crude bovine fibrinogen /plasminogen 19:1 1.55
Table 3.1. Effect of the presence of plasminogen (in 
crude fibrinogen preparation) in the 
susceptibility of fibrin clot to lysis by 
plasma enzyme in acid media.
U1.
prior to clot formation.
As the results show (Table 3.2) the addition of 
buffer changes the pH of the solution. As mentioned
before (3.2.1) the pH of the media has an effect on
the type of clot formed. From the above experiments 
it was concluded that with the correct environment for 
fibrin clot formation it was possible to make a fibrin
clot which was stable enough to resist lysis in 1^
(w/v) monochloro acetic acid, but which would lyse 
readily in the presence of plasma enzyme. The method 
adapted for the preparation of substrate is described 
in detail in Section 3.2.4.
To have a standard substrate the above method was 
used to prepare fibrin clots. However, during the 
course of this work it was found that although the 
same procedure was followed each time, there was a 
wide variation in the susceptibility of clots formed 
from different batches of bovine plasma. As there 
is a wide range for the normal levels of coagulation 
factors, it is probable that different batches of 
plasma have different amounts of Factor II (prothrom­
bin) and Factor XIII, both of which are directly 
involved in the type of clot formed (3.2,1), The 
concentrations of both factors were studied (3.2,7 
and 3.2.8).
3,2.7. The effect of prothrombin concentration on the 
susceptibility of the fibrin clot to lysis 
One stage prothrombin time assay was performed on 20 
different bovine plasmas as 2.9.2. The clotting times
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Substrate pH mg fibrin dissolved by 0.2 ml enzyme in 16 h.
Fibrinogen + NaCl v/v (9:1) 6. 5 0.3
Fibrinogen + buffer o r- v/v (9:1) 1.6
Fibrinogen + buffer o  ^v/v (19:1) 1 .0
Table 3.2, Effect of the pH of crude fibrinogen on
the susceptibility of fibrin clot lysis by 
plasma enzyme in acid media.
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were within 1 6 + 3  secs, suggesting no significant 
differences between the test plasmas. Crude fibrin­
ogen samples were also tested. All the results were 
above 60 secs., indicating low levels of at least one 
of Factors II, V, VII or X, As the prothrombin time 
was above 60 secs., the sensitivity of the test is lost 
and comparison between the different batches of plasma 
is not valid.
However, the addition of excess thrombin to crude 
fibrinogen had no effect on the fibrin clot suscepti­
bility to lysis, indicating that crude fibrinogen 
preparation had enough prothrombin.
3.2,8, Effect of F XIII on the susceptibility of fibrin 
clot to lysis
Clots prepared from pure fibrinogen dissolved in 
1% (w/v) monochloroacetic acid within 5 min., but 
became resistant to lysis after the addition of 
purified F XIII, The concentration of Factor XIII 
in crude fibrinogen was measured fluorometrically 
as 2.8, The results were unsatisfactory. There 
was a wide variation (0-l6 units) within the duplicate 
tests,
The inaccurate results were not due to the in­
efficiency of the assay system, as F XIII concen­
tration in normal human and bovine plasma ranged from 
18-20 units in accordance with the literature. The 
problem was due to a high concentration of fibrinogen, 
which precipitated at 56°C, and the precipitate 
interfered with the reading of the results in
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the fluorimeter.
Because of the above technical problems, the 
presence of Factor XIII in crude fibrinogen preparation 
was measured indirectly.
The cross-linking of fibrin was measured by the 
observation of gel electrophoretic patterns of reduced 
fibrin clots, as 3.2.9.
3.2.9. Use of SDS gel electrophoresis in the assessment of 
fibrin clot stability
3.2.9.1. Method
The method used was based on that of Schwartz et 
al., (1971).
Fibrin clots were prepared as 3.2.4, from 
different batches of crude bovine fibrinogen.
Fibrin clots were made in triplicate . One clot 
was used to estimate fibrin concentration and 
another was used in fibrin clot assay. The third 
fibrin clot was reduced as 2.1.11 and was electro- 
phoresed as 2.1. on 3% gel. The gels were scanned 
and the formation of dimer and disappearance 
of oL and V chains were measured by dividing the 
height of the appropriate peak by that of the /2 
chain, which does not change during the course of 
polymerization (Table 3.3) . Figs.3.2,3,4 and 5*
3.2.9.2. Results
Samples with V  chain present were very susceptible 
to lysis in 1% (w/v) monochloro acetic acid in the 
presence of plasma enzyme and also to eventual
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Table 3.3. DENSITQMETRIC ANALYSIS OF THE RATIO OP oLANPY
CHAIN TO /3 CHAIN OF BOVINE FIBRIN( OGEN)
V '^ 2
rs ft ft
Crude bovine fibrinogen 0.98 0 0.62
Fibrin made from bovine plasma 0 0.62 0
Fibrin made from crude fibrinogen (S^) 0 0.35 0.14
Fibrin made from crude fibrinogen (S^) 0.8 0.2 0.5
Fibrin made from crude fibrinogen (S^) 0 0.5 0.48
S. - Fibrin clot which was medium resistant to lysis in acid
Q ~ Partially cross-linked stable in acid medium fibrin clot which was not
S -2 - Partially cross-linked 
^ system fibrin clot used in assay
Fig. 3.2
DENSITOMBTRIC SCAN OF AN ALIQUOT OF PURE 
REDUCED BOVINE FIBRINOGEN
Peak 1 ^  chain
Peak 2 f t chain
Peak 3 V  chain
ro
F_ig, 3>3
DENSIODMETRIC SCAN OF AN ALIQUOT OP REDUCED 
FIBRIN CLOT
(fibrin clot which was resistant to lysis in 
acid medium)
Peak 1 - ^  polymer
Peak 2 and 3 - ^polymer (intermediate)
Peak U - dimer
Peak 5 - chain
Peak 6 - degradation of fibrin
+
Pi#. 3.4
DENSITOMETRIC SCAIi OP AN ALIQUOT OP 
REDUCED PIBRIN CLOT
(partially cross-linked fibrin clot which 
was not stable in acid medium)
Peak 1 - dimer
Peak 2 - oL chain
Peak 3 - chain
\ chainPeak U
N5
Fig. 3.5
DBNSITOMBTRIC SCAN OF AN ALIQUOT OF 
REDUCED FIBRIN CLOT
(partially cross-linked fibrin clot used 
in assay system)
Peak 1 -  cL polymer intermediate
Peak 2 - V - Y dimer
Peak 3 “ chain
Peak U -  f t chain
CO
U6*
lysis in the absence of the plasma enzyme. Samples 
with no chain, and an ( ^ ) ratio of less than 
0 . 2 5  were very resistant to lysis in acid media.
The results were in accordance with the work of 
Schwartz et al., (1973). They reported that pro­
longation of lysis times coincided with the appear­
ance of extensively cross-linkedoCchains, and those 
clots with the longest lysis times had virtually 
all of their cL chains cross-linked.
3 .2 ,1 0. Effect of salt concentration on the susceptibility of 
fibrin clot to lysis by plasma enzyme in acid media 
During the course of fibrin clot assays, it was
noticed that fibrin clots in (w/v) monochloro-
1acetic acid become swollen, elongated, and translucent. 
On the addition of NaCl, the fibrin clots became 
shrunken and opaque. These physical changes had a 
great effect on the susceptibility of the clot to 
lysis in the presence of plasma enzyme. As the con­
centration of NaCl was increased (1^0,05 M) the 
fibrin clot became completely resistant to lysis by 
the enzyme (Pig, 3.6). Presumably the swelling of 
the fibrin clot caused the exposure of the enzyme to 
the susceptible bonds , Bowes and Kenten (1950) 
studied the swelling of the collagen in hydrochloric 
acid and sodium hydroxide with the pH range of 
0 ,5-lU. The swelling of the collagen increased 
sharply at approximately pH 2,0, 11.5 and 13. In 
the presence of different concentrations of NaCl 
(0 .0 5-0 . 5  M) in acid solution, the swelling of the
Pig. 3.6. EPPBCT OP S.ALT CONCENTRATION ON THE
SUSCEPTIBILITY OF PIBRIN CLOT TO LYSIS 
IN ACID MEDIA
A graph of enzyme unit of activity versus 
the final salt concentration in the 
assay system.
2-5 o-
0*5
5-0 10
sal t  conc. (x iO ^ m )
k l .
collagen decreased progressively as the concentration 
of NaCl increased, and at a concentration of 0.5 M, 
the swelling was completely suppressed. Swelling 
of filDrous proteins in acid and alkaline solution 
depends on two factors. The first of these, the 
Donnan effect, is due to differences in the osmotic 
pressure between protein phase and the external 
solution due to protein salt formation. This is in 
turn a consequence of the concentration of diffusable 
ions between the protein and external phases. The 
other factor is the cohesive force within the protein, 
which restricts the swelling. The cohesive factors 
include the interweaving of the molecules, the inter 
molecular forces and bonds both covalent and non- 
covelent. Therefore the extent of swelling depends 
on the balance between the osmotic pressure and the 
cohesive forces (Bowes and Kenten, 1950),
Sodium chloride effects the swelling of different 
fibrous proteins differently. For example, NaCl 
completely suppresses the swelling of gelatin at 
alkaline pH, but not collagen. The reason for this 
is that with gelatin the uptake of water is much 
higher than with collagen, due to weaker cohesive 
forces, and the concentration of the diffusable ions 
in the gelatin phase is low. Therefore, a very 
small amount of NaCl is needed to reduce the difference 
in the concentration of ions in the external and 
internal phase.
Yasukouchi et al., (1979) measured the fibrino-
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lytic action of plasmin in the presence of NaCl 
(0-1.5 M), using fibrin agar plate, and clot lysis 
time. In both methods the higher the concentration 
of NaCl the higher the enzyme activity. Prom their 
results, they concluded that the sodium chloride 
causes conformational changes in plasmin rather than 
in the fibrin clot.
Buckell and Truscott, (l959)> reported that 
sodium chloride in low concentration 0.2-0,4% (w/v) 
shortens the clot lysis time, but in higher concen­
tration 0.4-1% (w/v) prolongs the clot lysis time. 
Weiner (1959) diluted blood in phosphate buffer and 
sodium chloride (0-0.075 M). In both systems the 
higher the molarity of the salt the higher the 
fibrinolytic activity.
In this project it was observed that even a very 
low concentration of NaCl (final concentration 
0.05 M) is needed to suppress the swelling of the 
fibrin clot, with a consequent inhibition of proteo­
lysis.
3.2,11, Reproducibility of fibrin clot assay
Since the preparation of fibrin clot is rather time- 
consuming, a large number of fibrin clots were made, 
and kept in 0.9% (w/v) NaCl at 4°C. Fibrin clots 
were tested at different intervals for a period of 
3 weeks. There was no change in the rate of fibrin 
clot lysis by plasma enzyme.
To determine the stability of fibrin clots in an 
acid environment, in the absence of plasma enzyme.
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20 fibrin clots were made, and incubated in 1%
(w/v) monochloro acetic acid for 24 h at 37°C,
Fibrin concentration was measured in all the clots 
as 2.6, and results were statistically analysed.
Mean = 0.50
Standard deviation = + 0,03
To study the reproducibility of the assay 
system, 15 fibrin clots were incubated in 1% (w/v) 
monochloro acetic acid in the presence of identical 
plasma enzyme concentrations at 37°C for 24 h. The 
amount of fibrin clot remaining was estimated as
3.2.5.
Result - Mean = 0.126
Standard deviation = 0,021
3.2.12. Precision
Coefficients of variation were determined by duplicate
measurements of the same samples in the same assay
and in different assays.
The coefficient of variation (CV) was determined
2using the formula CV = d
2 m
where m = number of duplicate determination
ov.a  ^ _ highest value of each duplicate _ . -v- -innlowest value of sample duplicate
Abraham et al., (1971).
10 duplicate determinations were carried out with the 
same batch of substrate, but different enzyme con­
centrations. (Residual fibrin concentration ranged 
from 0,6-2.6 mg.) The coefficient of variation was
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8.0%.
In addition 30 duplicate determinations were 
carried out with different batches of substrate and 
different enzyme concentrations.(Residual fibrin 
concentration ranged from 0.4-3.0 mg) The 
coefficient of variation was 12%,
3.2,13. Comment
During the course of study the fibrin clot assay was 
used for the enzyme purification. Meanwhile the 
search for a better substrate continued, because of 
the general problem of using protein substrates and 
also because of particular problems directly associ­
ated with this substrate, such as inter-batch 
variation, and the tedious nature of the assay.
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3.3. Azocasein Substrate
3.3.1. Introduction
Almost all known proteolytic enzymes hydrolyse casein, 
and it is often used as a substrate for the determin­
ation of proteolytic activity (Reimerdes and 
Klostermeyer, 1976). The extent of proteolysis is 
measured in the supernatant after acid precipitation. 
If the acid soluble fragments of the casein contain 
aromatic amino acids, it is possible to measure the 
amount of hydrolysis at 280 nm. However, there are 
disadvantages in using casein as a substrate: 
a) casein is a cow’s milk product, and there is a 
batch to batch variation according to the way in which 
it has been prepared and stored. A good sample of 
purified casein contains //-casein, 0^ 5»-casein and 
K-casein. There are other minor components such as 
y-casein, R~, S-, TS-, and cst^a-s -casein. Some 
samples are even contaminated with albumin and 
globulin. Acidic proteinases such as chymosin 
specifically hydrolyse the Phe23-Phe24 bond in 
<x-casein and the Phe105-Met I06 in k-casein, but 
only the latter fragment is acid soluble, 
b) Acid precipitation can lead to another problem in 
that not all the acid soluble fragments contain 
aromatic amino acids, and other fragments are only 
partially soluble in acid solution. c) Casein 
is not soluble at acid pH and is not a very suitable 
substrate for acid proteinases.
To attempt to produce a more sensitive and
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versatile sutstrate, Charney and Tomarelli (19U7) used 
azocasein as a colourimetric method,
3.3.2, Principle of the assay
Diazotized sulpharaLic acid is coupled to the side 
chains of histidine and tyrosine residues of casein 
in alkaline solution to form a chromoproteide, 
Hydrolysis of this azo protein with proteolytic en­
zymes results in the formation of coloured components 
which are soluble in TCA, The absorbance of the 
acid soluble peptides containing the chromophore is 
measured at 366 nm.
The increase in colour in TCA filtrate is thus 
the function of enzyme activity.
3.3.3. Preparation of .azocasein
The method used was based on that of Barrett and 
Kirschke (1981) and Kirschke et al,, (1982), 50 g
of c-l-casein (Hammarsten) was dissolved in 1 L of 
distilled water by heating and adjusting the pH to 
approximately 9.0, The solution was centrifuged at 
2000 g for 20 min. to remove undissolved casein,
50 g of sulphanilic acid was dissolved in distilled 
water containing 6 ml of 5 M NaOH and 32,2 g cf 
NaNOg. Then 18 ml of 5 M HCl was added to the 
sulphanilic acid solution to form the diazotized 
sulphanilic acid. The solution was stirred for 
2 min,, and 18 ml of 5 M NaOH added. This solution 
was then added to the casein, while stirring. On 
mixing the two solutions a dark purple colour was 
developed. The mixture was stirred for 1 h. The
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azo-protein was precipitated out by acidifying the 
solution with 25^ (v/v) acetic acid. The solution 
was centrifuged at 2000 g for 20 min.
The supernatant was discarded and the precipitate 
dissolved by dropwise addition of 1 M NaOH, The 
precipitation procedure was repeated twice for further 
purification. The precipitate was then suspended in 
ethanol and filtered. The washing with solvent was 
repeated 3 times or until the filtrate was colourless. 
To obtain a very pure substrate with low blank, acid 
precipitation and washing with ethanol was repeated 
once more. The precipitate was air dried at room 
temperature,
3 .3 .U. General assay method
(w/v) azocasein was freshly prepared in the 
appropriate buffer. In a plastic tube 100^1 of 
enzyme solution was mixed with 100yU.1 of azocasein 
solution in an ice bath. The tubes were incubated 
at 37^0 for an appropriate time. The reaction was 
stopped by the addition of 200^1 of 105?o (w/v) TCA,
The tubes were kept at room temperature for 10 min.
The absorbance of the supernatant read at 366 nm.
The blank was prepared in the same way except that 
the enzyme solution was replaced by buffer.
In this project a modified method which has been 
used for cathepsin D assay (Kirschke et al,, 1982) 
was used,
3 .3 .5 . Assay method
2^ (w/v) azocasein was made in 0,U M sodium citrate
buffer, pH 3.5. Two volumes of buffer, one volume 
of enzyme solution and one volume of azocasein were 
mixed and incubated at 37°C for different time 
intervals. The reaction was stopped by addition of 
four volumes of iO^ o (w/v) TCA, After 10 min, the 
mixture was centrifuged at 200 g for 20 min. and the 
absorbance of the supernatant read at 366 nm.
3.3.6. Results
Different concentrations of plasma enzyme which showed 
proteolytic activity in the fibrin clot assay system 
were used.
Each concentration of enzyme was incubated with a 
fixed amount of azocasein substrate at 37°C for a 
period of 1-18 h. None of the concentrations showed 
any proteolytic activity. The experiment was repeated 
using the same buffer at different pH’s, Plasma 
enzyme exhibited maximal activity towards the azocasein 
substrate at pH 3.1, Pig. 5.6.
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5.4. Synthetic Substrate N-acetyl-L-phen.vla.lanyl-diiodotvro- 
sine (APDT)
3.4.1. Introduction
Pruton and Bergmann (1939) used different synthetic 
substrates to measure the specificity of pepsin. They 
concluded that the substrate to be hydrolysed by pepsin 
should contain aromatic amino acid residues tyrosine 
or phenylalanine, preferably combined with glutamic 
acid. They showed the best substrate was carbo- 
benzoxy-l-glutamyl-l-tyrosine, but carbobenzoxy-1- 
glutamyl-l-diiodotyrosine was resistant to pepsin 
action. In contrast Baker (1951) found that the 
diiodotyrosine peptide was hydrolysed much more 
rapidly than the tyrosine peptide, at all.pH values.
She concluded that N-substituted dipeptides with two 
residues of the L forms of the aromatic amino acids, 
tyrosine, diiodotyrosine or phenylalanine will be 
hydrolysed by pepsin. Peptides containing D forms 
of these amino acids or amino acids with their phenolic 
group blocked are not hydrolysed by pepsin, Ryle
(1970) used N-acetyl-l-phenylalanyl 1-diiodotyrosine 
(APDT) to assay minor pepsins and pepsin. The 
activity of the enzyme was measured colorimetrically, 
using ninhydrin. The substrate APDT is hydrolysed 
by pepsin liberating diiodotyrosine, which gives a 
colour reaction with ninhydrin.
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O'
CHg OHg
CH,-GO-NH-CH - CO-NH-GH-COOH
IIpepsin hydrolysis
3.4.2. The APDT assay
The method used was based on that of Moore and Stein 
(1954) and Tang (1970).
3.4.3. Substrate preparation
2 mM APDT in 5 mM sodium hydroxide was prepared by 
dissolving 62.2 mg of APDT in 2.5 ml of 0.1 M NaOH 
and taking the volume to 50 ml with distilled water,
3.4.4. Ninhydrin preparation
Oxygen free nitrogen gas was bubbled through 750 ml 
of 2 methoxy ethanol (methyl cellosolve), to remove 
any peroxides which may have been formed during storage. 
The following procedure was used to test for the 
presence of peroxides. A small crystal (approximately 
1-2 mg) of potassium iodide was added to 1-2 ml of 
methyl cellosolve. In the presence of peroxides the 
colour changed from straw to yellow. 250 ml of 4 M 
Na acetate buffer, pH 5.5, was prepared and oxygen 
free nitrogen bubbled through for about 30 min,
20 g of ninhydrin and 3 g of hydrindantin were added 
to the mixed solution of methyl cellosolve and 
Na acetate buffer. Nitrogen gas was bubbled through
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and the solution stored in a dark bottle at 4°G.
3 .4 .5 . Assay procedure
0 . 5  ml of the test sample, O . 2 5 ml of 0.208 M HGl 
and 0 . 2 5  ml of APDT substrate were mixed and the 
solution incubated at 37^0 for 1 h. 1 . 0 ml of 
ninhydrin solution was added and the mixture boiled 
for 15 min. After cooling, 0.5 ml of 60^ (v/v) 
ethanol was added and the solution thoroughly mixed 
(vortex mixer) for 30 secs.
The absorbance was read at 570 nm against a blank 
prepared the same way as the test except APDT was 
added after ninhydrin. All the tests were carried 
out in duplicate.
3.4.6. Results
Normal plasma gave very high blank, and it was almost 
impossible to record the absorbance. With samples 
from later stages of plasma enzyme purification, it 
was possible to obtain reasonable reading at 570 nm, 
but the tests and blanks were identical. Increasing 
the enzyme concentration and the incubation time did 
not improve the results, indicating that there is no 
detectable hydrolysis of the synthetic substrate APDT. 
To verify the assay, commercial hog pepsin (BDH) 
was used. Pepsin also showed very high blank.
To find out the cause of the high blank, indi­
vidual reagents were tested, and tyrosine was used to 
prepare a standard curve for the ninhydrin reagent. 
Results were satisfactory and a linear relationship 
between tyrosine concentration and colour development
58.
obtained. This suggests that the high blank value 
is due to pepsin and not to the reagents.
To verify this, a) pepsin was extensively 
dialysed to remove any peptides, b) pepsin v/as 
prepared fresh prior to the test. Two samples of pepsin 
which had been incubated at 25°C and 37°C respectively 
were also tested. Dialysis reduced the high reading 
of the blank, but not completely.
Freshly prepared pepsin had a lower blank, in­
dicating some self digesting of pepsin had taken place 
at 25°C and 37^C. However, even with high blank it 
was possible to obtain a straight line with different 
concentrations of pepsin. From the above results it 
can be deduced that plasma enzyme does not hydrolyse 
synthetic substrate APDT. Therefore its action is 
similar to cathepsin D, and unlike pepsin (Chiang 
et al,, 19 6 6).
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3.5. Haemoglobin (Hb) Substrate
3 .5 .1 . Denatured haemoglobin
3.5 .1.1. Principle
The proteinase digest denatured haemoglobin, and 
small peptides are released (Mycek, 19?0). Undi­
gested fragments are precipitated with TCA and the 
soluble peptides can be estimated spectrophoto- 
metrically at 280 nm.
3 .5 .1 .2. Method
The method used was based on that of Aoyagi et al,
(1971).
0 .5?^ (w/v)bovine haemoglobin in 0.03 M HCl was 
prepared, 0,8 ml of 0.02MKC1/HC1 buffer, pH 2.0, 
was added to 1.0 ml of the haemoglobin solution.
The mixture was incubated at 37^0 for 3 min. Then 
0.1 ml of enzyme was added, and the mixture incubated 
for further 25 min. The reaction was stopped by 
the addition of 2.0 ml of 1.7 M perchloric acid or 
10% (w/v) TCA, The mixture was incubated at room 
temperature for 1 h before being centrifuged at 200 g 
for 30 min. The absorbance of the supernatant (acid 
soluble fraction) was read at 280 nm.
3 .5 .2 . Haemoglobin-polvacrylamide gel (Hb-gel)
The haemoglobin assay can be adapted for the detection 
of proteinase activities in polyacrylamide gels either 
by incorporating denatured haemoglobin into the gel 
before polymerization, or by diffusing soluble 
substrate into the gel, after electrophoresis 
(Andary and Dabich, 1974).
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3.5.2.1. Hb-gel electrophoresis (Insoluble-Hb)
The method used was based on that of North and 
Harwood (1979).
3.5.2.2. Gel preparation 
Separating gel
2.5% (w/v) bovine haemoglobin in 0,1 M Tris-HCl, 
pH 7.5, was prepared and incubated at 70°C for 5 
min., followed by approximately 5 min. sonication 
(until the particles stay in suspension while the 
gel sets).
1% (w/v) ammonium persulphate was prepared in 
distilled water just before use. The gel solution 
was prepared to give a final concentration of 12% 
(w/v) acrylamide, 0.075% (w/v) bisacrylamide, 0.2% 
(v/v) denatured haemoglobin, and 0 .05% ammonium 
persulphate. The reagents were mixed quickly, 
deareated, and TEMBD added to a final concentration 
of 0.05% (v/v). The solution was poured into the 
gel holder, until the liquid level was about 1.5 cm. 
from the top of the tubes. Distilled water was 
layered on the top of the gels and they were left at 
room temperature for 30-60 min. to allow poly­
merization.
Stacking gel
The stock solution of riboflavin was prepared by 
adding U mg of riboflavin to 100 ml distilled water. 
The stacking gel solution was prepared to give a 
final concentration of 2.5% (w/v) acrylamide, 0.6% 
(w/v) bisacrylamide, and 1% (v/v) riboflavin. The
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pH of the mixture was adjusted to 6.8 and it was 
degassed. 0.01% (v/v) TEMBD was added and the 
solution was poured on the top of the separating gel 
(0 . 5  cm), replacing the water on the top of the gel. 
Distilled water was again layered on the top of the 
stacking gels. The gels were exposed to fluor­
escent light for 30-45 min. to allow photopoly­
merization to take place. Once the gels were set, 
water was replaced by chamber buffer, and the gels 
were stored at 4°C if not in use immediately.
3 .5 .2.3 . Gel electrophoresis
The upper chamber (cathode) buffer consisted of 
0 . 0 3 M sodium tetraborate, containing 0.002% (w/v) 
bromophenol blue, while the lower chamber (anode) 
buffer was 5 mM Tris-HCl/38.5 i# glycine, pH 8.5.
Samples in 20% sucrose were placed on the top 
of stacking gels, and were electrophoresed at 4°C 
at 1 mA/gel until the tracking dye entered the 
separating gel. Thereafter the current was raised 
to 2 mA/gel.
3 .5 .2.4. Assay for proteolytic activity
The proteinase bands were developed in 0.1 M glycine/ 
HCl buffer, pH 2.5-2.8 for 6 h. The buffer was 
changed at least twice in the first 30 min. The 
proteolysis was stopped by placing the gels in the 
staining solution 0.1 M Tris-HCl buffer, pH 7.5 
containing 0.1% (w/v) nigrosine for 5-6 h.
The gels were washed in destaining solution 
(0 .1 M Tris-HCl buffer, pH 7.5) for at least 48 h 
before the clear bands were visible.
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3.5.3. Hb-gel electrophoresis (soluble haemoglobin)
The method used was based on that of Andary and Babich 
(1974).
3.5.3.1. Gel preparation
7 . 7 6 g acrylamide and 0 , 2 4  g bisacrylamide were 
dissolved in 100 ml of 25 mM citric acid buffer, 
pH 3.1» and stored at 4°C (stock solution). To 
prepare 8% gel, 7.5 ml of gel stock solution, 2.5 ml 
of 3% (w/v) ammonium persulphate and *0.1 ml of 
TEMED were mixed, degassed and poured in a) sets 
of tubes, b) sets of plates (12 cm x 12 cm). The 
top of the gels were covered with 50% (v/v) ethanol 
and left at room temperature to polymerize, then 
ethanol was replaced with the above buffer, and the 
gels were stored at 4°G in a humid chamber.
3 .5 .3 .2 . Gel electrophoresis
Samples were dialysed against chamber buffer 
( 2 5 mM citric acid, pH 3.1). Dialysed samples were 
mixed with glycerol and bromophenol blue, before 
being applied to the gels. Gels were electrophor­
esed at 200 volts for about 5 h at room temperature.
3 .5 .3 .3 . Detection of proteolytic activity
The method used was based on that of Ryle (198O). 
Tube gels were immersed in 0.65% (w/v) bovine haemo­
globin in 0.2 M citric acid. The gels from plates 
were covered with No. 3 Whatman paper which had
been soaked in haemoglobin solution (0.3 ml haemo-
2globin/cm paper).
* High percentage of ammonium persulphate and TEMBD were used to facilitate gel formation at low pH.
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The gels and Whatman paper were covered with 
cling film, and were incubated at 37°C for 30 min.
Gels were fixed in'5% (v/v) acetic acid in 50%
(v/v) ethanol (Samloff, 1969) overnight. . Then 
they were stained in coomasie blue solution, and were 
destained in a solution of ethanol, acetic acid, and H^O 
(20:5:75).
3.5.4. HaemoglOb in-agar (Hb-agar)
The method used was based on that of Samloff (1969).
1.5 g I.D, agar (Oxoid), was added to 0 . 0 5 M 
barbitone buffer, pH 8.6, and dissolved by boiling.
The molten agar was poured onto a glass plate 
( 1 5 cm X 15 cm), and left at room temperature to set. 
Plates were stored at 4°C in a humid chamber. For
use, slots of 1 cm X 0.1 cm were made on the gels and 
filled with the mixture of dialysed sample and bromo­
phenol blue. Electrophoresis was carried out long 
enough for the marker dye to travel to the end of the 
gel(r^ 4 h). The electrophoresis was run at 112 volts/ 
cm. Because of the rather high voltage, a tank with 
cooling system was used.
3.5 .4 .1 . Detection of proteolytic activity
Plates were immersed in 0.65% (w/v) bovine haemo­
globin in 0 . 0 6  M HCl, pH 1.6, for 20 min, at 37°G 
and then left in a humid chamber for a further 2 h. 
Plates were fixed, stained and destained as (3.5.3.3.).
3 .5 .5 . Preparation of N.N-Dimethyl haemoglobin
The method used was based on that of Lin et al,,
(1969).
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1,5 g of 'bovine haemoglobin was dissolved in 
150 ml of 0,1 M borate buffer, pH 9.0. 5-10 drops of
hydrogen peroxide were added to the solution, which 
was warmed gently to reduce its visible absorbance,
300 mg sodium borohydride was added followed by 
5-10 drops of 2-octanol to stop the production of 
foam. 3.0 ml of formaldehyde was added in a period 
of 30 min. (100 ^1 formaldehyde at a time), 5 min,
after the addition of all the formaldehyde, the pH 
of the solution was brought to pH 6.0 with 50% (v/v) 
acetic acid. Methylated haemoglobin was dialysed 
against distilled water. It was then freeze dried 
and stored at -20^0.
3.5.6. Haemoglobin-substrate results
3.5.6.1. Denatured haemoglobin
Samples from different stages of plasma enzyme 
purification were tested as (3.5.1.2). No 
proteolytic activity was detected. Hog pepsinogen 
was used as a control, and it digested Hb at con­
centration of 1 p.g/m.1, A set of experiments 
was performed to find the optimum condition for the 
plasma enzyme. Once the incubation time was 
extended to 18 h, some proteolytic activity was 
detected. At the end of 18 h incubation, a linear 
relationship was found between enzyme concentration 
and the absorbance of the supernatant. Pig. 5.2.
The optimum activity was detected at pH 3.0 - 3.2, 
Although plasma enzyme hydrolysed denatured haemo­
globin, the absorbance readings were very low.
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High concentrations of enzyme were needed and the 
incubation time was long. These factors made the 
Hb-substrate unsuitable for routine use and for the 
detection of enzyme during the purification procedure,
3.5.6.2. Insoluble haemoglobin-polvacrylamide gel
Different volumes (5-50 j i l )  of normal plasma were 
applied to the Hb-gels (3.5.2.1). Plasma volume 
of 30 pi showed a clear zone with the mobility 
(relative to marker dye) of 0.82-0,86. Hog 
pepsinogen was used as a control, and clear bands 
were detected with mobilities of 0.95-0.98, (Pig.
3 .7). Some plasma samples showed up to four clear 
bands, with the mobilities of 0.82-0.95, with the 
prominent clear band always at 0.82-0.86. Samples 
from different stages of purification of plasma 
enzyme showed the same characeristic clear band. 
Samples which were treated with pepstatin showed no 
activity (Pig. 3.8). The plasma samples which did 
not give any proteolytic activity with fibrin clot 
assay also had no activity in this system.
Comment
The haemoglobin gel assay is extremely sensitive 
in detecting very small amounts of plasma enzyme.
It has, however, some disadvantages. It is time 
consuming, it takes at least 48 h for the clear bands 
to become visible, it is difficult to carry out 
densitometric scanning or even photography.
Clear zones are much more readily detected by eye.
It is not possible to measure the proteolytic
Pig. 3.7 DENSITOMETRIC SCAN OP ALIQUOTS 
PROM A Normal plasma
B 23-75% (AS) step
C Blue-sepharose step, Table 4.7
D DEAE-cellulose step. Table 4.7 
trough I clear band on Hb polyacrylamide 
gel.
a o 00
Pig. 3.8 DENSITOMETRIC SCAN OP Hb-GEL
A Control electrophoresis of the gel 
with no sample
B An aliquot of plasma added to the 
gel before electrophoresis
C Pepstatin was added to the plasma
before the application of the sample 
to the gel
trough I clear band on Hb-polyacrylamide
gel.
Ui
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activity of the enzyme in the later stages of 
purification, as the gels are electrophoresed at 
alkaline pH and the enzyme, having "been in acid 
pH, will he inactivated hy the pH change. To 
investigate the possibility of improving the visi­
bility of the zone against the dark background of 
the gel, and also shortening the destaining time, 
two different types of nigrosine were used, 
a) water soluble; b) alcohol soluble. Different 
concentrations of each dye 0,01-0.1% (w/v) were 
used, and the incubation time of the gels in the 
staining solution was varied. The best results 
were achieved by using 0.1% (w/v) alcohol soluble 
nigrosine with 6 h incubation in the staining sol­
ution.
3.5»6.3. Hb-gel (soluble haemoglobin)
Normal human plasma, samples from different stages 
of purification and hog pepsinogen which had shown 
the same level of proteolytic activity with the 
fibrin clot substrate, were tested. No activity 
was detected with plasma enzyme. Although 
pepsinogen showed proteolytic activity, the sensi­
tivity was lOOx less than the insoluble haemoglobin­
polyacrylamide gel.
Comment
The plates and tube gels were very heavily coloured, 
even with extensive destaining. The concentration 
of the staining solution was reduced, incubation 
time of the gels in haemoglobin was varied, as
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was the pH of the chamber buffer. None of these 
procedures improved the method.
3.5.6.1+. Haemoglob in-agar
This did not prove to be a very satisfactory method, 
the results were very similar to 3.5.7.3; even with 
varying the different parameters of the assay system 
no improvement was detected.
3.5.6.5. Methylated Hb
To overcome the dark background of the soluble 
Hb-gel (3.5.6.3), methylated haemoglobin was used. 
Clear bands were visible with pepsin and the 
sensitivity of the results was comparable with that 
of Hb gel (insoluble Hb). However, plasma enzyme 
did not show any proteolytic activity, which made 
the method inappropriate.
3.5.7. Summary
Haemoglobin was used in different ways in an attempt 
to find a sensitive method for the detection of plasma 
enzyme. None of the methods was entirely satisfactory.
Acid denatured haemoglobin was used as a sub­
strate for the detection of proteolytic activity of 
the plasma enzyme. The method proved insensitive, as 
the amount of proteolysis was low, giving a very low 
absorbance reading at 280 nm. To improve the tech­
nique, insoluble Hb was incorporated into polyacrylamide 
gels, before polymerization. The sample-was 
electrophoresed at alkaline pH, and the gels were then 
incubated in acid media. The enzyme activity was
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detected by the development of a clear band. The 
method was sensitive to the enzyme's proteolytic 
activity, but the problem was that the gels were 
electrophoresed in alkaline pH, and once the enzyme 
had been in acid pH, it was not possible to measure 
its activity as a change of pH from acid to alkaline 
caused the loss of enzyme activity. To overcome 
this difficulty, the plasma enzyme was electrophoresed 
in acid pH, using polyacrylamide, agarose and agar. 
Then haemoglobin was diffused into the gels. The 
technique lost its sensitivity. When methylated 
haemoglobin was used no proteolytic activity was 
detected with plasma enzyme.
On using methylated haemoglobin a clear back­
ground was achieved but did not improve the sensi­
tivity of the assay system.
3.6. General Discussion on Substrate
Laing (1975) and Taylor (1976) used dyed fibrin as the 
substrate in preliminary investigations of the plasma 
enzyme on the grounds of the similarity with the 
phenomenon which brought the enzyme to light. Their 
assay system had its limitations and was improved by 
Law (1 9 7 8), However, doubts still remain as to the 
specificity of the system she developed, as reliable 
quantitative results were not easy to obtain.
In this project the fibrin clot assay was used 
throughout the purification and for much of the enzyme 
characterization. Quantitation with this assay is 
possible, but the protein nature of this substrate
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makes a study of the kinetics of the enzyme impractical.
Although denatured haemoglobin is widely used as a 
substrate for acid proteinases it was not an effective 
substrate for this enzyme. Haemoglobin incorporated 
into polyacrylamide gel was an effective and sensitive 
means of comparing the plasma with other enzymes. This 
method is, however, time-consuming and purely quali­
tative ,
Azo-casein was not very sensitive as a substrate 
for this enzyme. Its insolubility at acid pH makes 
it generally unsuitable, N-acetyl-L-phenylalanyl-L- 
diiodotrosine did not appear to be cleaved by the plasma 
enzyme to any detectable degree.
In spite of its technical drawbacks the fibrin 
clot assay remains the more suitable assay for this 
particular enzyme, although there is scope for further 
work with a range of synthetic substrates to clarify 
the kinetics and specificity of the plasma enzyme.
CHAPTBR U
PURIFICATION
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U.1.1. Ammonium sulphate fractionation
The sample was brought to 25% and 75% saturation with 
solid ammonium sulphate.
The suspension was stirred gently at U°C for 8h, 
then it was centrifuged at 10,000 g. for 1 h. The 
precipitate was dissolved in and dialysed against 
0 .9^ 0 (w/v) NaCl for 1+8 h, with at least 1+ changes of 
NaCl. To prepare (25-75%) saturation another 
aliquot of the sample was first brought to 25% 
saturation with ammonium sulphate, and then the 
supernatant was brought to 75% saturation, and treated 
as above.
1+. 1 • 2 . Akmdnium hydroxide .Al(OH)^ gel fractionation
1+.1.2.1. Gel preparation
The method used was based on that of Ikemori et al., 
(1975). 50 ml of 0.2 M aluminium sulphate was heated
at 63^0 . 5 ml of 58% (w/v) ammonium hydroxide was
added to 1+5 ml of distilled water at 67°C.
The aluminium sulphate was mixed with ammonium 
hydroxide, and the temperature of the mixture was 
maintained at 62-63°C for 10 min. The gel was 
washed with d istilled water several times, until 
no free sulphate was detected by testing with 1% 
(w/v) barium sulphate.
U.1 .2 .2 . Fractionation
1 volume of aluminium hydroxide was mixed with
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10 volumes of sample. The mixture was stirred at 
room temperature for 1 h. or at 37^0 for 10 min.
The suspensions were centrifuged at 2500 g for 
30 min. The supernatant was kept separate and the 
precipitate was washed with Q,Sfo (w/v) NaCl until 
no protein was detected in the wash.
The gel was then extracted twice with 0,05 M 
phosphate, pH 7.0, and the eluted material was 
collected.
4.1.3. Pol.v(ethylene glycol) 6000 fractionation
The method used was based on that of Barrett et al., 
(1979).
1 volume of sample was mixed with 0.28 volume of 
25% (w/v) poly(ethylene glycol) 6000 (B.D.H.) in 
0.05 M Tris-HCl, pH 7.0 final concentration of poly 
(ethylene glycol) 5.5% (w/v) ,
The mixture was stirred at room temperature for 
30 min. and centrifuged at 12,000 g for 30 min. The
precipitate was dissolved in 0.1 volume of the above
buffer, and kept separately, 0 .7 2 volume of poly 
(ethylene glycol) 6000 was added to the supernatant 
final concentration of poly(ethylene glycol) 12.5% 
(w/v) .
The mixture was treated as before, and the
precipitate was dissolved in 0,1 volume of 0.05 M
Tris-HCl, pH 7.0.
The two precipitates and the supernatant were 
dialysed against 0.05 M Tris-HCl, pH 7.0.
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4.2. Ion Exchange Chromatography
4.2.1. Sulnhopropvl Sephadex (SP-Sephadex)
The SP-Sephadex (Pharmacia) resin was precycled and 
degassed. A column of 25 cm x 1.8 cm was packed with 
the resin and it was equilibrated with 0 . 0 5  M sodium 
acetate, pH 4.0. The flow rate was adjusted to 
40 ml/h. The sample was dialysed against above buffer 
at 4°C for 48 h, and applied to the column. Fractions 
were collected every 10 min. The starting buffer was 
pumped through until no protein was detected in the 
effluent at 280 nra. Then 0.05 M sodium acetate, pH
5.0 was applied until again no protein was detected 
in the effluent, and the pH of the effluent was 5.0. 
Then 0.05 M sodium acetate, pH 6.0 was applied until 
the pH of the effluent reached 6.0.
4.2.2. CM-Cellulose 52 (Whatman)
GM-cellulose resin was precycled and degassed. A 
column of 25 cm x 1.8 cm was packed with the resin, 
and was equilibrated with 0 .0 5  M sodium acetate buffer, 
pH 4.0. The flow rate was adjusted to 40 ml/h. The 
sample which had been dialysed against the above buffer 
was applied to the column. Fractions were collected 
every 10 min. The starting buffer was pumped through 
until no protein was detected in the effluent at 
280 nm. Then 0.05 M sodium acetate, pH 5.0 was 
applied until again no protein was detected in the 
effluent and the pH was 5*0. Next 0,05 M sodium 
acetate, pH 6.0 was applied in the same way.
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4.2.3. PEAS-Cellulose 52 (Whatman)
The PEAS-cellulose resin was precycled and degassed.
A column of 26 cm x 2 cm was packed with the resin and 
it was equilibrated with 0.05 M Tris-HCl, pH 8.0.
The sample was dialysed against the above buffer and 
applied to the column at the rate of 30 ml/h.
Fractions were collected every 6 min., until no protein 
was detected in the effluent. Then 0.05 M Tris-HCl/ 
0.05 M phosphoric acid, pH 3.8 was applied.
4.2.4 Amberlite IRC-50(H)
4.2.4.1. Generation of Amberlite IRG-50 resin
The method used was based on that of Hirs et al.,
( 1953).
300 ml of distilled water was added to 100 g 
of resin, and stirred for 20 min. The suspension 
was left undisturbed for the resin to settle. The 
supernatant was removed and washing was repeated 
four times, until the supernatant was clear. The 
resin was filtered through a Buchner funnel and 
200 ml acetone was added, stirred and left for 3 h. 
The resin was filtered, washed with 500 ml acetone, 
followed with 5 ml of distilled water to remove the 
acetone. Once the resin was cleaned, 200 ml 
distilled water was added followed by 95 ml of 
40% (w/v) NaOH solution, which was added gradually 
within 30 min., and stirred for 3 h (pH 11),
The sodium form of resin was washed with 
distilled water until the pH of filtrate was 10.
The resin was washed with 1 1 of 2 M HCl over a 4h
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period, followed by washing with the buffer to be 
used in the experiment.
4.2.4.2. Amberlite IRC-50 chromatography
A column of 38 cm x 2.5 cm was packed with the 
resin and equilibrated by pumping 0.2 M citrate 
buffer pH 3.0. Plow rate was adjusted to 30 ml/h. 
The sample was dialysed against the starting buffer 
or in the case of freeze dried sample, which had 
been dialysed against water, dissolved in the above 
buffer and applied to the equilibrated column. The 
column was eluted with the starting buffer (0.2 M 
citrate buffer, pH 3.0). Fractions were collected 
every 10 min. The elution was continued until the 
eluate had a constant absorbance of less than 0.1 
at 280 nm. Then 0.2 M sodium citrate buffer pH 3.8 
was applied until the absorbance of the effluent was 
less than 0.05 at 280 nm. Then 0.2 M sodium citrate 
buffer pH 4.2 was applied ilntil the effluent pH 
reached 4.2, after which 0.2 M sodium citrate buffer 
pH 4.6 was applied.
4.3. Gel filtration
4.3.1. Sephadex-G200 (Pharmacia)
Sephadex-G200 resin was swollen in excess 0,02 M 
phosphate, pH 5.5 for 48 h at room temperature. The 
resin was degassed and packed in a 45 cm x 2 cm 
column.
The sample was dialysed against the above buffer, 
freeze dried, and then dissolved in the minimum amount
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of distilled water before applying to the column.
The column was eluted by gravity flow at the rate of
14 ml/h, and fractions were collected every 30 min.
4.4. Affinity Chromatography
4.4.1. Lysine-Sepharose 4B
4.4.1.1. Coupling lysine to Sepharose
The method used was based on that of Chibber et al,, 
(1974).
40 g of Sepharose 4B was suspended in 100 ml 
of distilled water. 5% (w/v) cyanogen bromide was 
prepared in cold water (4°C) and added to the 
Sepharose. The mixture was stirred gently. The 
reaction was allowed to proceed for 10 min. Meanwhile 
the temperature of the reaction was kept at l8-2 0 °0  
with the addition of ice, and the pH of the reaction 
was kept constant at 11.0 by the addition of 5 M 
sodium hydroxide. The reaction was stopped by 
washing the mixture in a Buchner funnel with cold 
(4°G) 0.1 M sodium biocarbonate buffer,pH 8.9.
The activated sepharose was mixed with lysine 
(lO.O g in 25 ml distilled water pH 8.9), and stirred 
gently for 18 h. 10 g glycine in 50 ml distilled 
water was added to the mixture and stirred for a 
further 2-3 h.
The lysine-Sepharose was washed with 1.0 1 
of 1.0 M sodium chloride, 2,0 1 of distilled water and 
it was stored at 4°C in 0,02% (w/v) sodium azide.
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4.4.1.2, Lysine Sepharose column
A column of 18 cm x 1,8 cm was packed with lysine- 
Sepharose and allowed to equilibrate by pumping 
0.05 M Tris-HCl buffer, pH 7*5 through at a flow 
rate of 36 ml/h. The sample was applied to the 
column and fractions were collected every 10 min. 
Starting buffer was ppmped through until the eluate 
had an absorbance of less than 0.05 M at 280 nm.
Then 0 . 0 5  M Tris-HCl/o.05 M NaCl,pH 7.5, was applied 
and fractions’were collected as before. Next,
0.2 M £ -amino caproic acid (EACA) was applied, 
followed by 0.05 M Tris-HCl/0.2^SACA/l .0 M NaCl.
4.4.2, CibcTcon Blue-Sepharose column
The method used wasbased on that of Virca et al.,(1978).
The blue Sepharose resin was very kindly provided 
by Dr. Wray (Biochemistry Department, St. Andrews 
University). A column of 25 cm x 2 cm was packed with 
the resin, and washed with 0.05 M Tris-HCl, pH 8.0,
The sample was dialysed against the above buffer, and 
applied to the column. Fractions were eluted from 
the column by gravity flow at the rate of 8 ml/h. 
Fractions were collected every 20 min, until no 
protein was detected in the effluent at 280 nm. The 
column was washed with 0.15 M NaCl, 2 M NaCl, and 
fractions were collected as before.
4.4.3. Haemoglobin (Hb)-Sepharose
4.4.3.1. Cel preparation
The method used was based on that of Smith and
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Turk (1974).
Sepharose 4B resin was activated as (4.4.1.1.).
6.0 mg bovine haemoglobin was added per 1 ml of wet
Sepharose at pH 6.4.
The resin was stirred gently at 4*^ 0 for 24 h.
The resin was washed with 1 1 of i M NaCl and 2 1
(w/v)of distilled water, and stored in 0.02%^sodium azide 
at 4°C if not in use.
4o4.3.2. Haemoglobin-Sepharose column
Haemoglobin-Sepharose-4B resin was washed extensively 
with 0 . 0 5  M sodium acetate, 1 M NaCl, pH 3.5, and 
degassed. A column of 23 cm x 1 cm was packed with 
the resin and was equilibrated by pumping through 
the above buffer. The flow rate was adjusted to 
18 ml/h. The sample was dialysed against the 
starting buffer and applied to the column. Fractions 
were collected every 10 min. After the application 
of the sample the column was washed with 0,1 M sodium 
acetate, 1 M NaCl, pH 5.0, until the effluent had an 
absorbance less than O .0 5 at 280 nm. Then 0.1 M 
Tris-HCl/l M NaCl, pH 8.6 was applied and fractions 
were collected until the pH of the eluate reached
8.6.
4.5 . Results
4 .5 .1 . Removal of plasminogen
Normal fresh frozen plasma was applied to lysine- 
Sepharose column as 4.4.1.2, and plasminogen free plasma, 
obtained from the column, was kept frozen at -20°C 
if not used immediately.
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4.5.2, Ammonium sulphate (AS) fractionation (batch test)
Small aliquots of plasminogen free plasma were 
fractionated as 4.1.1. The precipitates and super­
natants from 25%, 75%, and 2 5-75% were dialysed 
against 0.45% (w/v) NaCl and they were examined for 
enzyme activity, using fibrin clot assay results 
Table 4.1.
Table 4.1
Fractions 25% (AS) 75% (AS) 25-75% (AS) 75% (AS) 25-75% # )  
(a) . a (a) (b) (b)
% Activity 2 90 94 6 1.4
a = precipitate 
b = supernatant
* % activity of the original sample recovered.
The results showed (Table 4.1) that the 75% and 25-
75% (AS) precipitates had high activity. The
2 5-75% (as) was used for further purification as it
had the advantage over 75% (AS) in that fibrinogen had
been removed at 25% (AS) precipitation.
4.5.3. Aluminium hydroxide gel fractionation (batch test)
A small aliquot of 25-75% (AS)was fractionated as
4.1.2.2. Two fractions were obtained: a) material 
whichdid not bind to the Al(OH)^ gel and b) material 
eluted from the Al(OH)^ gel. As the results show 
(Table 4.2) material which did not bind to the gel 
had the higher activity and was used for the further 
purification.
Table 4.2
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Fraction % Activity
Material did not
bind to the Al(OH)^ gel
Eluate 2.0%
Comment The unbound material had to be dialysed 
to remove the high concentration of* salt 
before it could be assayed.
4.6, Purification of plasma enzvme (first batch)
The flow chart of the purification method is summarized 
in Pig, 4.1. and results in Table 4.3.
100 ml of fresh frozen plasma was applied to lysine- 
Sepharose column as 4.4.1.2. 140 ml of plasminogen
free plasma was obtained. To 100 ml of plasminogen 
free plasma, ammonium sulphate was added as 4.1.1.
90 ml of 25-75% (AS) fraction was subjected to 
Al(OH)^ gel fractionation as 4.1.2.2. Specific 
activities of the above steps are shown in Table 4.3.
4.6.1. Ion exchange chromatography 
SP-Sephadex
Unbound material from Al(OH)^ gel (80 ml fraction) 
was dialysed against 0.05 M sodium acetate, pH 4.0 
and applied to the colum (4.2.1). Material which 
did not bind to the column. Peak I, Pig, 4.2, had 
the greatest activity. Table 4.3.
Fresh frozen human plasma (1) 
Lysine-Sepharose 
Plasminogen free plasma (2)
i
25% (NH^)2 80^
(Discard) Precipitate
(Discard) Material bound
Supernatant
i
75^ (NH4)g 80^ (3)
Precipitate Supernatant (discard) 
A1(_0H)3 (4)
Material not houndISP-Sephadex (5)
Peak I 
CM-Cellulose Il(a)
(7) Peak IiDiscard
Peak I Peak II
I \CM-Cellulose I (6) Discard
Peak II
half halfI (10) I
CM-Cellulose 11(b) G200 III (12)
(8)
Peak II
G200 I (9)I I I % G 200 IV (13)Peak I Peak II Peak III Peak IV1G 200 II (11)
Fig. 4.1 Flow chart for the plasma enzyme purification 
(first hatch).
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Fig. 4.2 SP-SEPHADEX COLUMN CHROMATOGRAPHY OP PLASMA. 
ENZYME (Step 5, Table 4.3)
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•--- * mg fibrin clot dissolved by0.2 mi enzyme in 16 h.
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As the enzyme did not hind to the column, and 
very low yield was achieved, the fractions from 
Peak I were pooled and applied to a CM-cellulose 
column.
U.6,2. CM-cellulose I
Unbound material from SP-Sephadex column (85 ml of 
fractions) %-gg applied to the column as U.2.2. Two 
peaks were obtained. Pig. U.3. ••oaterial * <3id
not bind to the column (Peak I), and material eluted 
at about pH 5*0 (Peak II). Both peaks had activity. 
Obtaining two peaks with activity could be due to the 
existence of two distinct enzymes, one of which was 
retarded at pH U.O, or to the fact that the Peak I 
was caused by over-loading the column. To solve the 
problem, fractions from Peak I were pooled and applied 
to another CM-cellulose column, under the same con­
ditions .
U.6.3. CM-cellulose 11(a)
78 ml of pool fractions from Peak I of CM-cellulose I 
was applied to the column as ^.2.2. Two peaks were 
obtained. Pig. l+.U. The first peak was small and with 
low activity, and Peak II which was eluted between 
pH 5-8 had the highest activity. Therefore the Peak I 
of CM-cellulose I (U.6.2) was due to over-loading.
h.6.4. Sephadex C200 (l)
Practions of Peak II of CM-cellulose 11(a) (4.6.3) 
were pooled, dialysed against 0.02 M phosphate, pH 6.8, 
and freeze dried. The sample was then dissolved inV
Pig. 4.3 CM-CELLULOSE (l) COLUMN CHROMATOGRAPHY OP 
PLASMA ENZYME (Step 6, Table 4.3)
Absorbance 280 nm
«• mg fibrin dissolved by 0,2 ml enzyme in 16 b
o
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Pig. k M  CM-CELLULOSE (lla) COLUMN CHROMATOGRAPHY 
OP PLASMA ENZYME (Step 7, Table U.3)
-o Absorbance 280 nm
0____ , mg fibrin clot dissolved by
0 . 2  ml enzyme in 16 h.
pH of eluate
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5.0 ml of distilled water and applied to the column 
as 14.3.1* Practions 8 and 9 had activity, but the
yield was poor (Table U.3). SDS gel electrophoresis
of an aliquot of each fraction showed four distinct 
protein bands with apparent molecular weights of 
54,000, 92,000 and two bands with molecular weights
of higher than 120,000, Fig. 4.6.
Immunoelectrophoresis of fractions 8 and 9 against 
antihuman antiserum showed one and three precipitation 
lines respectively. Both showed a precipitation line 
in a position similar to that expected for albumin. 
However, neither of the two fractions gave precipi­
tation line with antialbumin antiserum. Both fractions 
showed a faint line with anti- dg-macroglobulin anti­
serum.
4.6.5. CM-cellulose (lib)
Fractions 67-90 from Peak II of CM-cellulose I, Pig.
4.3, were pooled and half of the sample (60 ml) was 
dialysed against 0.05 M sodium acetate, pH 4.0 and 
applied to the column as 4.2.2. The column was eluted 
with a stepwise salt gradient. Pig. 4.7. Pour peaks 
were obtained. Practions under each peak were 
pooled, desalted and freeze dried. The highest 
activity was detected in the sample from Peak II,
Table 4.3° 8DS gel electrophoresis on Peak II 
pools showed two major bands with molecular weights 
of 55,000 and 90,000 and one minor band with mol­
ecular weight of ^ 100,000, Pig. 4.8.
Pig. 4.5 SEPHADEX G200(l) COLUMN CHROMATOGRAPHY OP 
PLASMA ENZYME (Step 9 , Table 4.3)
Absorbance at 280 nm
mg fibrin clot dissolved by 0.2 ml enzyme in 16 h.
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Pig. h . 6 DENSITOIvIETRIC SCAN OF AN ALIQUOT FROM 
FRACTION NO. 8 OF SEPHADEX G200(l) 
GOLUm.
Estimated molecular weights are 92,000 
Peak 3, 34,000 Peak 4.
ro
Pig. 4.7 CM-CELLULOSE (lib) COLUMN CHROMATOGRAPHY 
OF PLASMA ENZYME (Step 10, TaLle 4.3)
o o Absorbance at 280 nm
#---- * mg fibrin clot dissolved by0.2 ml enzyme in 16 h.
I 0.05 M Na Acetate/0.1 M NaCl, pH 4.0 applied
II 0.05 M Na Acetate/O.2 M NaCl, pH 4.0 applied
III 0.05 M Na Acetate/0.3 M NaCl pH 4.0 applied
IV 0.05 M Na Acetate/O.4 M NaCl pH 4.0 applied
V 0.05 M Na Acetate/0.5 M NaCl, pH 4.0 applied
VI 0.05 M Na Acetate, 1.0 M NaCl, pH 4.0 applied
280  nm
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Pig. 4.8 DENSITQMETRIC SCAN OP AN ALIQUOT FROM POOLS
OP FRACTIONS OP PEAK II OP CM-CBLLULQSE (lib)
Estimated molecular weights are 100,000 
Peak 1, 90,000 Peak 2, and 55,000 Peak 3
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4.6.6. Sephadex G200(ll)
Fractions from peak 11 of CM-cellulose 11(b) , 4.6.5 
were pooled (42.ml) and dialysed aginst 0.05 M sodium 
acetate, pH 5.5, and freeze dried. The sample was 
dissolved in 5 ml . distilled water, and applied to the 
Sephadex-G200 column as 4.3*1. Two peaks were 
obtained (Fig, 4.9). Fractions 16-18 had activity.
Table 4.3.
4.6.7. Sephadex 0200(111)
Half of the pool of peak 11 of CM-cellulose 1 (Fig.
4,3) v/as dialysed aginst 0.05 M sodium acetate, pH
5.5 and freeze dried. The samnle was dissolved in
5 ml distilled water and applied to the Sephadex column
as 4.3.1. One peak was obtained (Fig,4.10),
Fractions with activity were pooled and an aliquot
was subjected to SDS gel electrophoresis, which showed
at least seven protein bands. Therefore the sampleXwas applied to another Sephadex G200 column,
4.6.8. Sephadex G200(1V)
Fractions pool of Sephadex G200(lll) (4.6.7.) was 
freeze dried, dissolved in 2 ml of distilled water , and 
applied to another Sephadex G200 column as 4.5.1 (Fig 4.11) 
Specific activity:-Table 4.3. SDS gel electrophoresis 
of an aliquot from fraction No. 12 G200 ^ Fig.4.12.
4.7, Plasma Enzyme Purification (second batch)
A flow chart of purification steps is given in Fig.4 .13. 
The purification steps were similar to the first 
batch,but' with the -following minor changes.
In the first batch material did not bind to the 
SP-Sephadex column at pH 4 .O (Fig,4.2), therefore 
a larger column
Pig. U.9 SEPHADEX a200(ll) COLUMN CHROMATOGRAPHY 
OP PLASm ENZYME (Step 11, Table U-3)
o o Absorbance at 280 nm
^ ^  mg fibrin clot dissolved by 0.2 ml enzyme in 16 h
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Pig. 4.10 SEPHADEX~G200( III) COLUMN CHROMATOGRAPHY
OP PLASMA ENZYME (Step 12, Table 4.3)
o o Absorbance at 280 nm
^ mg fibrin clot dissolved by 0,2 ml enzyme in 16 h.
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Pig. U.11 SEPHADEX G2 0 0(IV) COLUMN CHRQI/ATOGRAPmr 
OP PLASm ENZYME (Step 13, Ta^ ble i+.3)
Absorbance at 280 nm
#---- # mg fibrin clot dissolved by0,2 ml enzyme in 16 h.
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Fig. 4.12 DBNSITQîÆTRIC SCAN OF AN ALIQUOT FROM 
FRACTION UP. 12 G200(17) CQLUM
Estimated molecular weights are 
Peak 3 9 0 ,0 0 0
Peak 5 5 2 ,0 0 0
+
8U.
(UO cm X 1,8 cm) was used to reduce the possibility of 
over-loading. With the new column, two peaks were 
obtained, Pig, U.iU. Most of the activity was in 
Peak I which was eluted at pH U.O without being bound 
to the column. The second peak with a lower activity 
was eluted between pH 5.3-5.8, Pig. U.1U, with the 
highest activity at pH 5*5. The fractions with 
activity from Peak I were pooled and applied to a CM- 
cellulose column (ho cm x 1,8 cm), (larger than previous 
batch), This time most of the material was bound to 
the column and was eluted at pH 5-6 (Pig, h.15).
However, a small amount of the material did not bind to 
the column (Peak I, Pig, 4.15). The fractions under 
this peak were pooled and applied to another CM-cellulose 
column. All the material was bound to the column, and 
fractions eluted at pH 5.0 were active (Pig. 4.16), 
with a better specific activity than in the last batch. 
However, the yield was rather poor, Table 4.4.
Practions from the second CM-cellulose were pooled, 
freeze dried and applied to a Sephadex G200 column, 
Practions collected from the Sephadex G200 column,
(Pig. 4.1%) had low activity, even after concentration 
by freeze drying or pressure filtration (Table 4.4).
Comment
Although a larger column of SP-Sephadex was used in this 
batch of purification, still most of the material did 
not bind to the column. Either the column was still 
over-loaded or SP-Sephadex is not a suitable resin for 
the purification of plasma enzyme.
Fresh frozen human plasma lys ine-Sepharose
Plasminogen free plasma 1
25-75^ (NH^)g 30k
Precipitate
Aa(OH)
Supernatant (discard)
Material hound (discard) Material not hound SP-Sephadex
jr
Peak I
CM-cellulose I %Peak I 
irCM-cellulose II
Peak II
Peak II
Discard
r ~Peak I Peak II 
!Sephadex G200
Pig. 4.13 PLOW CHART PGR THE PLASMA. ENZYME 
PURIPICATIOH (Second hatch).
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Pigo 4.14 SP-SBPHADBX COLUMN CHROMATOGRAPHY OF
PLASIvîA ENZYME
-o Ahsorbance at 280 nm
#---- # rag fibrin clot dissolved by0.2 ml enzyme in 16 h.
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Pig. 4.15 CM-GBLLULOSE COLUMN CHROMATOGRAPHY
OF PLASMA ENZYME
o o Absorbance at 280 nm
#____   mg fibrin clot dissolved by0.2 ml enzyme in 16 h.
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Pig. 4.16 CM-CBLLULQSE (II) COLUMN CHRQ?.iATOGRAPHY
OP P L A S m  ENZYME
Absorbance at 280 nm
#____ # mg fibrin clot dissolved by0,2 ml enzyme in 16 h.
I 0.05 M Na citrate buffer, pH 5.0 applied
II 0,05 M Na citrate buffer, pli 6.0 applied
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Fig. 4.17 SEPHADEX-G200 CQLUM CHROMATOGRAPHY OF
PLASMA ENZYME
-o ALsorUance at 280 nm
«____ # mg fibrin clot dissolved by0,2 ml enzyme in 16 h.
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Prom these two "batches of purification as well as other 
attempts in small hatch purifications, it seems that the 
enzyme activity is lost at the stage of gel filtration. 
This suggests that the enzyme is more stable in the 
presence of other proteins.
87.
Table U. 5
POLY(ETHYLENE GLYCOL) 6000 FRACTIONATION
Procedure
Enzyme TotalVolume activity enzyme(ml) (units/ml) activity
Plasminogen free plasma 15 23 3U5
PEG 1st precipitate 
(5.5^) 2.85 5.7
PEG 2nd precipitate (5 - 12.5%) U.5 9.0
PEG supernatant of 12.5% precipitate 50 7.0 350
Pig. U..18 PT.nW CHART POP THE PLASMA ENZYME (third
batch)
Plasminogen free plasmaIpoly(ethylene glycol) 6000
precipitate supernatant5.5 - 12.5^ discard i(NHj^ )g SOi+1CM-cellulose
0200
Pi%. h.19 DENSITQMBTRIC SCAN OF AN ALIQUOT FROM 
THE SUPEHNATENT AT 12.5% (w/v)
POLY(ETHYLENE) CLYCOL 6000
Estimated molecular weights are:
Peak 3 approximately 90,000
Peak U approximately 53,000
m
8 8 .
4.8. Plasma Enzyme Purification (third batch)
4.8.1 . Pol.v(ethylene glycol) 6000 (PEG)
In the last two hatches of plasma enzyme purification, 
a very high molecular weight hand was present which 
might he o(,2_macroglohulin M) . A poly( ethylene
glycol) precipitation has heen used hy Barrett et 
al,, (1979)> for ^ 2  M precipitation. This might 
prove a similar initial procedure in the purification 
of this enzyme.. Purification flow chart Fig. 4.18.
4.8.1.1. Procedure
15 ml plasminogen free plasma was added to poly 
(ethylene glycol) as 4.1.3, and the precipitate at 
5»5% (w/v) PBG plus the supernatent and precipitate 
following adjustment of the 5»5% (w/v) PKG to 
12,5^ 0 (w/v) PEG, were assayed for proteolytic 
activity, using the fihrin clot assay. More than 
95/- of the activity remained in the supernatent at 
12.5?C (w/v) PEG (Tahle 4.5). However, 0(2 M is 
present in the precipitate at this concentration of 
PEG (Barrett et al., 1979).
SDS gel electrophoresis was performed on an 
aliquot from the active fraction, and as Pig. 4.19 
shows, there ard many contaminating protein hands.
For further purification, it was necessary to 
remove PEG. Because of its high molecular weight 
and structure, it was not possible to remove it hy 
dialysis, gel filtration or pressure filtration.
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Ammonium sulphate was used to precipitate proteins.
With 709^  saturation it was possible to separate 
proteins, but not as a precipitate. After centri- 
fugation, the proteins ’’floated" on the top of 
the solution. However, there was not a very clearcut 
boundary between the two phases even after prolonged 
(4-5 h) centrifugation at 1200 g. The ’’ floating’’ 
material was dissolved and dialysed against 0,05 M 
sodium acetate, pH 4.0. The ’’liquid’’ phase was also 
dialysed against the same buffer. Both fractions 
were assayed for prot^lytic activity, using fibrin 
clot assay. The ’’floating’’ fraction had fibrinolytic 
activity. Table 4.6, This fraction was applied to 
GM-cellulose column.
4.6.2, CM-cellulose
30 ml of 70% AS, (floating m;terial) 4.8. which had 
been dialysed aginst 0.05 M sodium acetate, nH 4.0, 
was applied to a CM-cellulose column which had been 
equilibrated with the above buffer. The material 
bound to the column and was eluted between pH 5.3 
and 5 .9 with the highest activity at pH5.5, Fig. 4.20, 
SDS gel electrophoresis of an aliquot from fraction 
66 of CM-cellulose column, Fig. 4.21.
Fractions with activity were pooled and freeze- 
dried. The sample was dissolved in 2 ml of distilled 
water and applied to a Sephadex G200 column, Fig.22.
No activity was recovered.
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Fig. 4.20 CM-CELLULOSE COLUMN CHROMATOGRAPHY OF 
PLASMA ENZYME
absorbance 280 nm
#----- # mg fibrin clot dissolvedin 0,2 ml enzyme in 16 h.
pH O f  eluate
2 8 0  n m
ON) o OÔ) 900 ÎO
û)o
ô3
3Ow
o
hJo
coo
c»
enO
O)O -o-
00o
O O oo
Unit of Activity
Fig. a.21 DBNSITQMETRIC SCAN OP AN ALIQUOT 
FROM FRACTION 66 OP CM-CBLLULÜSB 
COLUMN
Estimated molecular weights are 
Peak 2 approximately 91,000
Peak 3 approximately 54,000
ro
Fig. 4.22 SEPHADEX G 200 COLUMN CHROMATOGRAPHY OF
PLASMA ENZYME
o o absorbance at 280 nm
mg fibrin clot dissolved by 0.2 ml enzyme in 16 h.
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U .9• Blue-Senharose Column Chromatographv
In the previous hatch purification, an attempt was made 
to remove ^ « Although M was removed hy poly 
(ethylene glycol) PEG a problem arose in the removal of 
the PEG, Blue-sepharose was used instead to remove 
0(2 M (Virca et al,, I9 7 8). The 2 5-75% precipitate 
of ammonium sulphate (AS) fraction of normal plasma 
was used as starting material, 11 ml of 2 5-75% (AS) 
fraction was dialysed against 0,05 M Tris-HCl buffer, 
pH 8,0, and applied to the column as 4.4.2, As 
the results show. Pig. 4.24, fractions that did not hind 
to the column contained proteolytic activity. The 
specific activities of the above steps are given in 
Tahle 4.7. and the SDS gel electrophoresis pattern of 
the pool of fractions with activity is shown in Fig.
4 .2 5.
Immunoelectrophoresis of an aliquot from Peak I 
pool (containing activity) against anti-^^ macroglohulin 
antiserum showed no precipitation line, Pig. 4.26. As 
the Blue-Sepharose column proved to he a useful step 
in purification, plasma was purified under the same con­
ditions up to the Blue-Sepharose fractionation step.
The fractions with activity from Blue-Sepharose were 
used as starting material for further purifications.
A flow chart of the further purification steps 
tried are given in Pig. 4.23,
Pig. 4.23 PLOW CHART OP PLASMA ENZYME PURIPICATION
Normal plasma
lys ine-Sepharose 
plasminogen free plasmai
2 5 -7 5 (AS)
precipitateiBlue-Sepharose supernatent
Sepharose (II) \ \/ Hb-Sepiarose1 DEAE-cellulose DBAE-cellulose ^
4/
Sephadex-G200 Al(OH)^
amberlite
Pig. 4.24 BLUE-SEPHAROSE COLUMN CHROMATOGRAPHY OP
PLASMA ENZYME
absorbance at 280 nm
mg fibrin clot dissolved by 0.2 ml enzyme in 16 h.
-> I 0,1 M NaCl applied
II 2 M NaCl applied
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Pig, a.26 DBNSITQMETRIC SCAN OP AN ALIQUOT OP THK 
POOL PROM BLUB SEPHAROSE
Estimated molecular weight of peaks 
3 and 5 are approximately 9 0 ,0 0 0  
and 34,000
+a*
en
Vig. h.26 IMMUNODIFFUSION PATTERN ÜF ALIQUOTS OF
THE POOL FROM BLUE-SEPHAROSE AGAINST ANTI
012--M ANTISERUM
Anti ^ 2 -M antiserum in centre well
Well 1 Normal plasma
Well 2 25-75% (AS) step Table U.1
Well 3 Blue-Sepharose step Table U.7
Well U DEAE-cellulose step Table U.7
Well 5 Pure 0 2^-M
Well 6 DEAE-cellulose step Table U.7
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U. 1 0. Plasma Bnz.vme Purification (fourth batch)
Plasma enzyme was purified up to the stage of Blue- 
Sepharose ,
The specific activities are given in Table U.7, 
and a summary of the purification is given in Pig.
U.27.
U.10.1. DEAE-cellulose
The fractions with activity from Blue-Sepharose column 
were pooled (12 ml) and applied to a DBAE-cellulose 
column, which had been equilibrated with 0,05 M Tris- 
HCl, pH 8,0.
The sample was applied to the column, and eluted 
with a different buffer, (0.05 M Tris/0.05 M phos­
phoric acid, pH 5,8) as U.2.3.
As Pig, U.27a. shows, three peaks were obtained, 
fractions under each peak were pooled and concentrated 
by Amicon ultrafiltration. The pool from Peak III 
(pH approximately U.O) contained the activity, Table 
U.7. Immuno electrophoresis of an aliquot of the 
sample with activity against bovine antiserum showed 
no precipitation line. However, when human antiserum 
was used a precipitation line in the position of 
albumin was detected. Pig. U.28. SDS ge 1. Fig, 4,29.
U.10,2, Sephadex G 200
The pool of Peak III of DEAE-cellulose column was 
concentrated (freeze-drying or ultrafiltration) to 
2 ml volume and the sample applied to sephadex G 
200 column, Practions were collected, but no 
activity was detected even after concentration.
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Pig. U.27 FLOY/ CHART OF PLASMA ENZYME PURIFICATION 
(fourth batch)
Normal human plasma
lys ine-Sepharos e
plasminogen free plasma
2 5 -7 5 (AS) fractionation
supernatant(discard) precipitate
Blue-Sepharose
DEAE celluloseI_________
Sephadex G 200 Al(OH)
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Fig. U.27a DBAE-CELLULOSE COLUMN CHROMATOGRAPHY OF
PLASMA ENZYME
absorbance at 280 nm
#---- # mg fibrin clot dissolved by0,2 ml enzyme in 16 h.
0.05 M Tris, 0.05 M phosphoric acid, pH 3.8, applied
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pH of eluate
280 nm
Ow O0) oCD
0)o
o3
3O0)
—o-
enO
enO
loOO
9 6
Unit of Activity
Pig. U.28 IMNTUNO ELECTROPHORESIS ON ALIQUOTS OF TUP 
MATERIAL ELUTKD FROM DEAE CELLULOSE
a) Anti-human antiserum in the trough
b) Anti-albumin antiserum in the trough
r .3o
c... . )
0
Fig. U.29 DENSITOMETRIC SCM OF AN ALIQUOT FROM POOL 
OF PEAK III FRACTIONS OP DEAE-CELLULOSE 
COLUMN. ESTIMATED MOLECULAR WEIGHTS ARE 
APPROXIMATELY 90.000 and 52.000
ro
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U.10.3. Al(o h)^ gel fractionation
As the activity of semi-purified plasma enzyme from 
DBAS-cellulose column was lost following further 
purification on Sephadex G 200, another sample of 
plasma was purified up to the stage of the DEAE- 
cellulose column, and the fractions with activity 
from DBAS-column were pooled, concentrated and 
subjected to Al(OH)^ gel fractionation (U.I.S).
No activity was detected in the material adsorbed 
to the gel nor did the unbound material have any 
activity.
96.
4.11. Plasma Enzyme Purification (fifth batch)
In the previous batch purification, plasma enzyme 
activity was lost after the Al(OH)^ fractionation 
(4.10.2). It was decided to change the order of the 
DEAE-cellulose column and the Al(Off)^ steps.
The flow chart of purification steps is given in 
Fig, 4 .3 0 . and the specific activity in Table 4 ,8 .
A sample from Blue-Sepharose column was subjected 
to the Al(OH)^ gel. Material which did not bind to the 
gel had activity. SDS gel electrophoresis of an aliquot 
from unbound material to Al(OH)^ showed two major bands 
with molecular weights of 90,000» and 33,000 and one 
minor band, Fig. 4.31.
The sample with activity was dialysed aginst 0.03 M 
tris-HCl buffer, pH 8.0, and applied to DEAE-cellulose 
column which had been equilibrated with the same buffer. 
Samples were collected until no protein was detected in 
the eluate. Then 0.3 M.NaOH was apl.ied to the column, 
Fig. 4 .3 2 .
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Fig. U.30 FLOW CHART OF PLASIvlA ENZYME (fifth batch)
25 - 75 (AS) fraction
YBlue Sepharose
YAl(OH)?
material which did not bind material bound (discard)
DEAE-cellulose
Fig. 4.31 DBNSITOMBTRIC SCAN OF AN ALIQUOT FROM 
UNBOUND MATERIAL TO Al(OH)^
Estimated molecular weights are
Peak 1 approximately 90,000
Peak 3 approximately 53,000
+
Pig, a.32 DBAB-CBLLULQSE COLUMN CHROmTOGRAPHY 
OP PLASMA ENZYME
o o absorbance at 280 nm
I 1 pool of* fractions withproteolytic activity
-> 0.5 M NaOH applied
280 nm
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4.12. Plasma Enzyme purification (sixth batch)
The purification of the fifth hatch was not any 
improvement on the fourth hatch (4.10). It was 
decided to use Blue-Sepharose column chromatography 
twice before the application of the sample to DEAE- 
cellulose column. A flow chart of purification 
steps is given in Pig. 4.33 and the specific 
activities in Tahle 4.9.
Pig. 4.35 PLOW CHART OF PLASKIA. ENZYME (sixth hatch)
Blue Sepharose I
Blue Sepharose II
DEAE-cellulose
Elution pattern from Blue-Sepharose column 11.
Fig. 4.34.
SDS gel electrophoresis of an aliquot from fractions 
pool of Blue-Sepharose column 11. Fig. 4.35.
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Pig. 4.34 BLUB-SEPHAROSE II COLUMN CHROMATOGRAPHY
OP PLASMA ENZYME
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Pig. U.35 DBNSITOMETRIC SCAN OF AN ALIQUOT FROM 
FRACTIONS POOL OF BLUE-SEPHAROSE II
Estimated molecular weight of Peaks 
3 and 5 are approximately 9 0 ,0 0 0  
and 5i+,000.
CO
1 0 0 .
U.13. Plasma Enzyme Purification (seventh hatch)
In the last three purification hatches of plasma 
enzyme, the SDS gel electrophoresis patterns at the 
penultimate stage showed two protein hands with 
molecular weights of approximately 34,000 and 9 2,0 0 0, 
hut on further purification the enzyme activity was 
lost. It was decided to use a different ion 
exchange resin.
Amherlite resin CG-50 (H) was used as it is a useful 
step in the purification of pepsin and gastricsin 
from gastric juice (2,14,2).
4.13.1 Amherlite resin CG-50 (H)
A sample from Blue-Sepharose column was used as 
starting material.
8 ml of sample- from Blue-Sepharose with activity 
was dialysed against 0.2 M sodium citrate, pH 3.0, 
and applied to the Amherlite column as 4.2.4.2.
The plasma enzyme was eluted between pH 3.4 - 5.6,
Pig. 4.37 As Tahle 4.10 shows, the percentage 
recovery of plasma enzyme was good, hut SDS gel 
electrophoresis showed contamination with other 
proteins. Pig, 4.38. Amherlite column step was 
abandoned as it took a very long time for the pH 
to change from 3 to 6, In addition, fractions had 
to he pooled, desalted and concentrated before assay.
Pig. 4,36 PLOW CHART OP PLASMA ENZYME(hatch seven)
Blue Sepharose
Amherlite
Fig. 4.37 AMBERLITB CG-50 (H) COLUMN CHROMATOGRAPHY
o f h a s m a b n z y m e
absorbance at 280 nm
I---------------1 pool of fractions withproteolytic activity
280 nm
o6 oà o6 o6
0)
o
5*3
3OW
enO
w
roo
fk03O
O)
101 .
o
<DH
SR
-4->
g
0o■H
•4J
Cd
O
•H VO.
T5 *H -r-
rH P40 dpq A
'dH 0  lA0 0  00•H
ü  >J•H +3
%4 *H T—•H î>0 «H rA m
0 4-3
A 0en 0
0A Ë
0 >j cO LA+3 tSl co r-0 dR  (D
0Ë LA>jrH •
N S -r- r^
d0
ü■H
A 0 co lACd 4-3 A T-A 00 SP
EH A
•H G OHPI
o \ oP4 MCO Ph a CM
(DG
3 HrH
>
(D
’O<DüSPh
m
00
0
CQo
aPi09 i0 0 
3 H H O fP O
in
o
0+3•HH y
0 d 
<< o
Pig. U.38 DENSITORMBTRIC S C m  ÜP AN ALIQUOT OP 
THE POOL FRACTIONS FROM AIvIBBRLITB 
SBPARATBD BY SDS-GEL ELECTROPHORESIS
Estimated molecular weight of Peaks 
3 and U are approximately 91,000 
and 53,000.

1 0 2 .
4ol4 Plasma Enzyme Purification (eighth batch)
Hb-Sepharose was used, as it proved successful in 
the purification of acid proteinases such as renin 
and cathepsin D, (Smith and Turk (197U) and Chou 
et al., (1978)).
The flow chart of purification is given in 
Pig. 4 .3 9 , and specific activities in Table 4.11.
Pig. 4.39 PLOW CHART OP PLASNIA ENZYME (batch eight)
Blue-Sepharose
Hb-Sepharose (1)
4.14.1. Hb-Sepharose 4B (1)
Fractions from the Blue-Sepharose column with 
activity were pooled and used as starting material. 
5 ml of the sample was dialysed against 0 . 0 5  M 
sodium acetate 1 M NaCl, pH 3.5> and applied to 
the Hb-sepharose column as 4.4.3.2. After the 
column was washed with 0,1 M sodium acetate/lM 
NaCl, pH 5 .0 , the proteins were eluted with 0,1 M 
Tris-HCl 1 M NaCl buffer, pH 6.6, Three peaks 
were obtained. Pig. 4.40 . Fractions under each 
peak were tested for proteolytic activity using
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Hb-assay, Also after dialysis against 0.05 M 
sodium citrate, pH 3.5? (to remove salt) they were 
assayed using the fibrin clot assay.
Fractions from Peak I and II did not show any 
activity in either assay system, nor did they have 
any activity after being concentrated.
Fractions No. 40 and 41 of Peak III had very 
low activity. The low activity could be due to 
the fact that the fractions with activity had a pH 
in the vicinity of 6.5? but the pH changed very 
rapidly (within three fractions) to 8.5. Some 
of the activity might have been eluted at the 
higher pH and the activity destroyed by the alkaline 
environment.
4.14.2. Haemoglobin-Sepharose 4B (II)
The method used was based on that of Chou et al., 
(1978).
Fractions from the Blue-Sepharose column with 
activity were used as starting material.
5 ml of the sample was dialysed against 0,05 M 
sodium acetate/l M NaCl, pH 3.5? and applied to the 
Hb-sepharose column which had been equilibrated 
with the same buffer as 4.4.3.2. The proteins 
were eluted with 0.1 M Tris-HCl/M NaCl, pH 6.5.
Plasma enzyme bound to the column at pH 3.5 
and was eluted between pH 5.9 - 6.5 with the 
highest activity at pH 6.3? Fig. 4.41.
Hb-sepharose column had a major disadvantage, 
as the SDS gel electrophoresis shows. Fig. 4.42.
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There are many contaminating protein hands and 
also, some of the haemoglobin had been eluted 
from the column.
Fig. a.41 Hb-SBPilARQSE UB (ll) COLUMN CHROMATOGRAPHY
OF PLASMA ENZYME
absorbance at 280 nm
#-----# mg fibrin clot dissolvedby 0.2 ml enzyme in 16 h
^  0.1 M Tris-HCl/1 M NaCl,pH 6.5 applied
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Fig. U M 2 DENSITQMBTRIC SCAN OF AN ALIQUOT FROM 
POOL OF FRACTIONS PROM Hb-SEPHARQSB 
UB (II)
Estimated molecular weights are 
Peak 3 approximately 90,000
Peak 5 approximately 55,000
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U.iS. Conclusion
Different methods were used to purify plasma enzyme 
in the final stage of each purification, before the 
loss of enzyme activity. There were always two 
protein bands on SDS gel electrophoresis with 
molecular weights of approximately 9 0 ,0 0 0 and 5U,000.
Law (1 9 7 8) attempted the purification of the same 
enzyme, and also reported the molecular weights of 
approximately 91,000 and 54,000 with the highest 
activity associated with the protein with the molecular 
weight of 54,000. Law discovered that her prepar­
ations were contaminated with albumin and was not 
able to separate the enzyme from albumin.
During conformational investigation on bovine 
plasma albumin (BPA) Wilson and Poster (I97l) noted 
the presence of a proteolytic enzyme which cleaved 
BPA in the P form and hydrolysed several bonds in 
acid expanded BPA. Partial purification revealed 
a preparation with bands of molecular weights of 
4 6,7 0 0, 1 4 ,3 0 0 and a high molecular weight component 
on SDS gel electrophoresis.
After crystalization of BPA the proteolytic 
enzyme was still present but in smaller quantity, 
and the protein with molecular weight of 46,000 was 
still present. They concluded that the enzyme was 
not trypsin, chymotrypsin or pepsin, as it did not 
hydrolyse the native form of BPA, which is relatively 
easily attacked by the above proteolytic enzymes.
The plasma enzyme electrophoretic pattern was
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similar to that of Low (1978) and Wilson and Poster 
(1971), and the Immunoelectrophoresis results showed 
a precipitin line with human antiserum in the position 
of albumin.
However, anti-albumin antiserum gave no pre­
cipitin line in the later purification stages.
Pig. 4.28.
The concentrated pool fractions from DEAB- 
cellulose column, fourth batch of purification 
(4.10) was used for characterization of plasma 
enzyme. As it had high specificity, it was stable 
on storage and only two bands were present on BDS 
gel electrophoresis. Pig. 4.2 9.
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4.16. Further Work
4.16.1.Purification of plasma enzyme using radioiodinated 
derivative of pepstatin
As the carboxy group of pepstatin is not involved in 
its effectiveness as an inhibitor, it can be modified 
or coupled to different reagents. Matthews et al., 
(1 9 8 1), synthesised N-pepstatinyl-S-bimanyl-2-amino- 
ethane thiol, a fluorescent probe for the subcellular 
location of cathepsin D. Pourmotabbed et al.,
(1 9 8 1), coupled pepstatin to dextran by the cyanogen 
bromide activation procedure, and the pepstatin- 
dextran conjugate retained the high water solubility 
of dextran and the inhibitory effect of pepstatin.
The fact that this compound is water soluble makes 
it extremely useful for in vivo investigation of 
acid proteinases.
Workman and Burkitt, (1979), prepared radioiodin­
ated pepstatin, by coupling L-tyrosine methyl ester.
Then pepstatin-L-tyrosine' methyl ester was iodinated 
1 28with ■'^T and chloromine-T radioiodinated pepstatin 
reacted with pepsin similar to unmodified pepstatin.
As pepstatin inhibited plasma enzyme, it was 
decided to use radiolabelled pepstatin to locate the 
plasma enzyme on gel-chromatography or SDS gel 
electrophoresis, also to determine the dissociation 
constants for the binding of pepstatin to plasma 
enzyme.
4.16.2.Preparation of pepstatin L-tvrosine methyl ester 
The method used was based on that of Workman and
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Burkitt, (1 9 7 9).
Pepstatin, tyrosine mathylester and dicyolo- 
hexylcarbodiimide were added to 8 ml of dichloromethane 
in molar ratio of 1.4.4, (30 mg, 34.3 mg, 36.25 rag).
The mixture was stirred at room temperature for 96 h. 
The solvent was removed by evaporation, and the residue 
was dissolved in 2 ml of methanol, and applied to 
L-H^q column (1 Cm x 110 Cm). The samples were eluted 
by gravity flow using methanol. Fractions were 
collected until the absorbance at 280nm was less than 
0 .0 5 . Three peaks were obtained. Fractions from 
the first peak containing pepstatin-L-tyrosine methyl 
ester were pooled. The solvent evaporated and re­
dissolved in 1.5 ml of chloroform, methanol, ammonia 
75:24:1, and applied to silica gel (silicar CC-4) 
column (1 Cm x 25 Cm), to separate tyrosine methyl 
ester from unreacted pepstatin. Methanol was used as 
solvent fractions containing pepstatin .methyl ester 
were pooled, and the solvent evaporated to dryness, 
ready for iodination.
The iodination of pepstatin-L-tyrosine methyl 
1 28ester with I and chloromin-T was not carried out 
for personal reasons.
CHAPTER 5
CHARACTERIZATION
1 1 0 .
5.1. Enzyme Kinetics
In Chapter 3 (substrate) it was concluded that none of 
the substrates used were ideal. Although the fibrin 
clot assay proved to be the most suitable for plasma 
enzyme, it had its problems. The fact that it is a 
protein substrate made kinetic studies rather diffi­
cult. Kinetic studies became even more complicated 
as the enzyme was not 100^ pure. However, an attempt 
was made to find out the limitations of the system and 
the best possible conditions which may help to establish 
a certain order in the plasma enzyme characterization.
5.1.1. Effect of substrate concentration
Fibrin clots were prepared as 3.2.4 using a series 
of different concentrations of crude fibrinogen 
(1-6 mg/ml). Plasma enzyme was added to the fibrin 
clots as 3.2.5.
A graph of units of activity versus substrate 
concentration was plotted. Pig. 5.1. As the graph 
shows, a straight line was obtained up to 6 mg/ml 
fibrinogen, which suggests that the enzyme activity 
is proportional to the substrate concentration, i.e. 
the region of first order kinetics [sj<^ 0.01 Km,
(well below Km),
Although this is not an ideal range to work 
with, in all the assays performed with a given batch 
of substrate the concentration of fibrin was kept 
constant.
The need for a very high concentration of
Pig. 5.1 THE EFFECT OF SUBSTRATE CONCENTRATION.
A GRAPH OF UNITS OF ACTIVITY VERSUS CON­
CENTRATION OF FIBRIN
S - mg/ml fibrinogen
enzyme - DEAE cellulose step Table 4.7
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substrate could be a reflection of the restricted 
specificity, i.e. enzyme cleaves only at a limited 
number of sites in fibrin.
5.1.2, Effect of enzyme concentration
To study the effect of enzyme concentration, a range 
of plasma enzyme volumes was chosen and all made up 
to the total volume of 0.8 ml (highest volume of 
plasma enzyme). Assays with fibrin clots were per­
formed in duplicate. A graph was plotted of 
activity versus plasma enzyme concentration, Fig.
5.2 A and B.
As results show, Pig. 5.2a,a linear relation­
ship between the enzyme activity and concentration 
was achieved up to the point in which to f of the 
fibrin clot had been dissolved, which could be due 
to the exhaustion of the substrate. When crude 
enzyme (plasma) was used, an inhibitory effect was 
obtained. Pig. 5.2 B, at the point where the graph 
levels off in Pig. 5.2 A. This could be due to the 
presence of fibrinogen in the plasma, which competes 
with the fibrin. Once the fibrinogen was removed, 
the graph of the enzyme activity versus enzyme con­
centration became similar to the other graphs from 
different stages of purification.
5.1.3. Effect of period of hydrolysis
Fibrin clots were incubated in 1% (w/v) monochloro 
acetic acid in the presence of the plasma enzyme 
at 37°0 for various time intervals. The amount of 
fibrin clot being hydrolysed was estimated at each
Pig. 5.2(A) THE BPPECT OP ENZYME CONCENTRATION
A graph of* units of activity versus a 
range of plasma enzyme dilution
substrate - fibrin clot
enzyme - DEAE-cellulose step Table 4.7
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time interval. Tests were carried out in tripli­
cate, A graph of enzyme proteolytic activity versus 
time was constructed, Pig. 5*3. As the results 
show, after a short lag period a linear relationship 
between time and enzyme activity was found to be 
maintained up to about 16 h,
5*1.4. The effect of temperature on the proteolytic 
activity of plasma enzyme
Plasma enzyme was added to fibrin clots in acid 
media in different tubes and each one was incubated 
at different temperatures for 16 h. At the end of 
the incubation time the extent of enzyme proteolytic 
activity was measured and plotted against different 
temperatures. As results show (Pig. 5.3) the 
plasma enzyme was not stable at a high temperature, 
and all its activity was lost at 60°G.
5.1.5. Effect of temperature on enzyme sbability
Plasma enzyme at 3 different stages of purification 
was dialysed against 0,05 M sodium citrate, pH 3.5, 
and kept at different temperatures for 2 and 4 h.
The residual activity of these samples were 
estimated using fibrin clot assay as 3.2.5.
Results
Incubation at 4°C and 22°C had no effect on the 
enzyme proteolytic activity. At 37°C a high per­
centage of enzyme activity was lost in the case of 
the most purified plasma enzyme. Table 5.1.
Pig. 5.3 EFFECT OP PERIOD OP HYDROLYSIS
A graph of plasma enzyme units of activity 
versus time intervals (h)
substrate - fibrin clot
enzyme - DEAE cellulose step Table 4.7
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PROTEOLYTIC ACTIVITY OF PLASMA ENZYME
A graph of units of activity versus a 
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Table 5.1 EFFECT OF TEMPERATURE ON EMZYME STABILITY
Plasma enzyme ($!&) losses of enzyme 2 h 37°C activity 4 h 37°C
25-75# (AS) 0 0
Blue-sepharose step 5 21
DEAE-cellulose Table 4.7 step 57 62"
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3.1.6. Stability of enzyme In the presence of substrate
Plasma enzyme at 3 different stages of purification 
was dialysed against 0,05 M sodium citrate, pH 3.5. 
Fibrin clots were added to each solution and were 
incubated at 37°G for 2 and 4 h. At the end of the 
incubation period a sample of plasma enzyme was removed 
and added to new fibrin clot in 1^ (w/v) monochloro 
acetic acid, and proteolytic activity in each case 
was determined. As results show, Table 5*2, most 
of the enzyme activity is lost, which could be due to 
the adsorption of the enzyme to the fibrin clot,
5.2 The Effect of pH on the Proteolytic Activity of Plasma 
Enzyme
Azocasein, denatured bovine haemoglobin and fibrin clots 
were used as substrate, and proteolytic activity of enzyme 
was measured at range of pH using all 3 substrates.
As the results show. Pig. 5.6 A, B and C, the pH 
optimum for proteolytic activity of plasma enzyme was 
approximately 3.0.
Table 5.2 STABILITY OF ENZYME IN THE PRESENCE OF 
SUBSTRilTE
Plasma enzyme % losses of enzyme activity
2 h (37°C) U h (37°c)
25-73% (AS) Cfo 30f.
Blue-Sepharose step 67%
DEAE-cellulose step 100^ 100JJ
Pig. 5.6 (A) PROTEOLYTIC ACTIVITY OP PLASMA ENZYME 
DEFENDING ON pH
Substrate - azocasein
I Normal plasma
II 25-75f- (AS)
III Blue-Sepharose step Table U.7
IV DBAB-cellulose step Table 4.7
Buffer- 0.4M sodium citrate/HCl
(A)
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Pig. 5.6 (B) PROTEOLYTIC ACTIVITY OP PLASMA ENZYME 
DEPENDING ON pH
Substrate - denatured bovine-haemoglobin
enzyme - Blue Sepharose step Table U .7
Buffer- 0.1M sodium citrate/HCl
(B)
Ec
0-14
0-10
o00
CM<  0-06
0 02
3 4 5
pH
Pig. 5.6 (C) PROTEOLYTIC ACTIVITY OP PLASMA ENZYME 
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5.3. Inhibitors
The endopeptidases are the only group of enzymes for 
which classification and identification on the basis of 
substrate specificity seems impossible,(Barrett^ 1977).
Hartley (196O) classified the endopeptidases on 
the bases of catalytic mechanism. He divided them 
into four distinct groups according to the amino acid 
or ion which is involved in the catalytic process, serine, 
aspartate, métallo and cysteine proteinases.
Inhibitors give a clear evidence as to the type, 
the physical and chemical architecture of the active 
site and the kinetic mechanism of the reaction. They 
also help in the identification of an individual pro­
teinase and in the investigation of its biological 
functions (Barrett, 1977).
A large number of proteinase inhibitors are present 
in many tissues of animals and plants, as well as 
micro organisms. Their major physiological role is to 
prevent unwanted proteolysis and in plants act as a 
defence by inhibiting the insect proteinases to prevent 
insect infestation (Laskowski and Kato, 1980). Protein­
ase inhibitors can be either reversible or irreversible.
For complete inhibition with reversible inhibitor 
large molar excesses may be needed, and if the binding 
is not very tight the inhbition may be reversed by gel- 
chromatography or dialysis. Irreversible inhibitors 
can completely inactivate the enzyme by an equimolar or 
slight excess in concentration. There are two groups
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of proteinase inhibitors, one group of inhibitors are 
those with class specific reactive sites, which inhibit 
only proteinases belonging to one of the four classes 
of proteinases. The other group contains -macro- 
globulin (or strictly, the family of ci^-macroglobulins) , 
which bind and inhibit the majority of proteinases from 
all four catalytic classes (Kirschke et al,, 1982).
For the classification of the plasma enzyme at 
least one inhibitor from each class of proteinase 
inhibitor, as well as was used.
5,3.1. Inactivation of plasma enzyme with penstatin
Pepstatin is a low molecular weight, strong inhibitor 
of acid proteinases, with a Ki value of approximately 
1 X 10"^^M, and generally a chemical structure of 
isovaleryl-L valyl-L-valyl-stayl-alanyl-statine 
Marciniszyn et al,, (1977). Pepstatin was found in 
the culture filtrate of various species of actino- 
mycetes (Umezawa et al,, 1970). Production of 
individual pepstatins depends on the fermentation 
conditions. In casein medium the main pepstatin con­
tains n-caproyl group and in peptone medium, pepstatin 
contains an isovaleryl group. There are other 
pepstatin producing strains of streptomyces, but most 
work has been done with the pepstatin containing an 
isovaleryl group (Umezawa, 1976),
Kunimoto et al., (197U) suggested that the 
modification of the carboxy group of pepstatin has no 
effect in its inhibitory activity, but acétylation of
its hydroxyl groups drastically reduces its inhibition 
of acid proteinases. Synthetic analogues have been
1 1 8 .
prepared and used to determine the mechanistically 
important groups on the molecule by Rich et al.,
(1 9 8 0). In one compound the C-terminal -hydroxy 
propionic acid group was deleted. There was no 
difference in its activity in comparison with pep­
statin, supporting the work of Kunimoto et al,, (1974). 
When the hydroxyl groups of the statine residues in 
position 3 and 5 were deleted the new compound was 
at least 2000 fold less effective than pepstatin in 
its inhibition of pepsin. Carrying this work further, 
they found that removal of a single hydroxyl group in 
the fifth residue of pepstatin had no effect, but 
the third residue of pepstatin is essential for its 
inhibitory activity. They also reported that the 
length of the acyl group on the amino group of 
statine is important too. As the chain length was 
extended from an acetyl group to an iso valeryl- 
val group, the dissocation constant decreased 10,000 
fold,
Pepstatin is not an irreversible inactivator, 
but binds strongly to the enzyme. Marciniszyn 
et al.^  (I97f) suggested that since pepstatin inhibits 
all the acid proteinases, and not the other groups 
of proteinases, there must be a common transition 
state which is a result of a common catalytic 
mechanism for acid proteinases.
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5.3.1.1. Assay method
Pepstatin was dissolved first in methanol (Agoyagi 
et al,* 1 9 7 1), and diluted with ^fo (w/v) monochloro- 
acetic acid. Different amounts of pepstatin 
(0 -1 0 0 ng/assay tube) were added to fibrin clot 
in acid medium in the presence of plasma enzyme.
The proteolytic activity of plasma enzyme was 
measured as 3.2.5. As Pig, 5 . 7  shows, 250 ng of 
pepstatin completely inhibited the proteolytic 
activity of 0 . 2  ml of plasma enzyme.
5 .3 .2 . Inhibition of plasma enzyme with p-bromophenac.vl 
bromide
p-bromophenacyl bromide is a specific inactivator of 
pepsin, causing 7 3-80% loss of activity with haemo­
globin (Hb) as substrate, and causing complete 
inactivation with carbobenzoxy-L-^glutamyl-L 
phenylalanine as substrate (Srganger et al., 19&7).
The /^-carboxyl group of a residue of aspartic acid 
is esterified during the reversible inactivation of 
pepsin by p-bromophenacyl bromide (Gross and Morell,
19 6 6).
5 .3 .2.1. Method
The method used was based on that of Erlanger et
al,, (1 9 6 5, 1 9 6 7). The sample was dialysed against
0 .0 0 3 3 M HCl, and different concentrations of the
-5sample were mixed with 0.1 ml of 5.7 x 10 M 
p-bromophenacyl bromide. The mixtures were stirred 
either for 2 h at 25°C, and allowed to stand for a
Fig. 5,7 INHIBITION OF PROTEOLYTIC ACTIVITY OF 
PLASMA ENZYME BY PEPSTATIN
Graph of % activity versus range of 
pepstatin concentration
substrate - fibrin clot
enzyme - DEAB cellulose step Table 4.7.
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further 20 h, or the mixtures were incubated at 
37°C for 3 h. Then aliquots of the samples were 
assayed, using denatured haemoglobin as substrate.
As a control, 10 mg hog pepsin in 3.2 ml of 0.0033 
M HCl (2.75 X 10 ^ M) were mixed with 0.1 ml of 
p-bromophenacyl bromide and the mixture was treated 
as above,
5.3.2.2. Result
Semi-purified plasma enzyme was treated with p- 
bromophenacyl bromide as '5.3.2.1. The enzyme 
activity was tested against Hb substrate. No 
inhibition was detected. However, pepsin activity 
was 70-80% reduced. To determine whether the plasma 
enzyme is insensitive to the inhibitor or the con­
dition which was ideal for pepsin was not optimal 
for the enzyme, a series of experiments was set up, 
varying parameters such as pH, incubation time, 
enzyme, and substrate concentration. Still no in­
hibition occurred in any of the experiments. The 
above experiments were repeated using fibrin clot 
as a substrate.
50% inhibition was obtained when the plasma 
enzyme was incubated with the inhibitor at 37^0 
for 3 h. However, when the concentration of 
inhibitor was increased by 10-fold, under the same 
conditions up to 100% inhibition was achieved,
Pig. 5.8.
Fig. 5.8. INHIBITION OF PROTEOLYTIC ACTIVITY OF 
PLASMA ENZYME BY p-BROMOPHENACYL 
BROMIDE
Graph of % inhibition versus range of 
enzyme volume.
substrate - fibrin clot
enzyme - DEAE-cellulose step Table 4.7.
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5.3.3. Inhibition of plasma enzyme with ^ ^^-macroglobulin
16.2-M)
cJLg M is a plasma glycoprotein of high molecular 
weight. It is capable of binding many proteinases, 
mostly serine proteinases (Ogston and Bennett, 1977). 
Now it is believed that o(g M will bind to enzymes of 
the other three classes of proteinases (Barrett and 
Starkey, 1973). For example, thiol proteinase 
cathepsin B, and a carboxyl proteinase cathepsin D. 
oLg M does not bind to the inactive gorm of protein­
ases or other enzymes.
As Barrett and Starkey (1973) reported that 
M binds to cathepsin D, it was used to find out 
whether it would bind to plasma enzyme. M was
prepared (Virca et al., method, 1978) and was mixed 
with plasma enzyme, and the mixture was assayed for 
proteolytic activity using fibrin clot assay (3.2.5,). 
There was no change in the enzyme activity. The 
results could be interpreted that either the M 
did not bind to the enzyme or it was dissociated 
from enzyme at low pH.
5.3.4. Inhibition of plasma enzyme with 5 -amino caproic 
acid ( ^ -amino hexanoate') (BACA)
EACA is a synthetic fibrinolytic inhibitor. It
differs from lysine only in the lack of an oL-amino
group. It is a competitive inhibitor of plasminogen
activation at concentrations of 10 ^ M and higher.
—2At concentration above 5 x 10 M EACA is also 
a non-competitive inhibitor of plasmin and other
123.
proteolytic enzymes, including pepsin and trypsin 
(McNicol and Douglas, 1976). Woessner (1971), 
reported that EACA at 0.1 M inhibits the digestion of 
protein polysaccharide, light chain (PPOL) by 
cathepsin D but does not inhibit its action on 
Hb-substrate.
Because of the inhibitory effect of BACA on 
pepsin and cathepsin D, it was decided to find its 
effect on plasma enzyme.
Different concentrations of EACA (O.O - 0,1 M) 
were mixed with plasma enzyme and the proteolytic 
activity of the enzyme was measured using fibrin clot 
assay (3.2.5).
No change in enzyme activity was detected up to 
0,02 M EACA, but at about O.Oh M, the enzyme proteolytic 
activity was completely abolished.
The inhibitory effect of EACA (at high concen­
tration) on plasma enzyme could be due to physical 
interference in the enzyme substrate interaction 
rather than to specific blocking of an active centre 
(Woessner, 1971). Or the inhibitory effect of EACA 
on plasma enzyme could be due to the fact that the 
BACA in high concentration changed the pH and salt 
concentration of the test solution. To overcome the 
problem of pH and salt concentration, aprotinin was 
used instead of EACA,
5.3.5. Inhibition of plasma enzyme with aprotinin (trasylol) 
Aprotinin is a polypeptide of molecular weight of 
6,500 from bovine lung. It is a competitive
12U,
inhibitor of plasminogen activation and a non­
competitive inhibitor of plasmin, Aprotinin also 
inhibits kallikrein, trypsin, chymotrypsin and throm­
boplastin formation. Because of its anti-fibrino­
lytic and anti-coagulant activities, and its low 
toxicity, it could have possible therapeutic use for 
the defibrination syndromes of unascertained 
aetiology (McNicol and Douglas, 1975).
Since there was no conclusive result with BACA 
(5 .3 .5), aprotinin was used. Different concen­
trations (5 0-5 0 0ju/ml) of aprotinin were mixed with 
plasma enzyme at pH 8.0 and the proteolytic activity 
of enzyme was measured using fibrin clot assay.
There was no change in plasma enzyme activity,
5 .3 .6 . Inhibition of plasma enzyme with phenyl methane 
sulnhonvl fluoride (Pms-P)
Pms-P is a serine proteinase inhibitor. The inhi­
bition is caused by sulphonylation of an active-site 
serine hydroxyl group (Means and Feeney, 1971).
Although Pms-P is primarily an inhibitor of 
serine proteinases, it will also inhibit thiol 
proteinases, but the inhibition, unlike that of 
serine proteinases, is reversible by dithiothreitol 
(Barrett, 1977).
Method
Stock solution
Stock solution of 100 mM Pms-P was prepared in 
isopropyl alcohol and kept in a dark bottle at 
4°C. Pms-P was mixed with plasma enzyme with the
1<5.
final concentration of 1,0 mM, The mixture of 
samples and the inhibitor were incubated at 4°C,
22°0 and 37^0 for 48 h. Controls were set up, by 
adding isopropyl alcohol to the enzyme without the 
Pms-P, At the end of the incubation pefiod the 
samples were tested for enzyme activity using the 
fibrin clot assay, 3.2.5.
No significant changes in enzyme activity 
were detected.
5.3 .7 . Inhibition of enzyme with N-ethylmaleimide (NËM)
NEM is used for sulphydryl group modification. It 
has been used for the determination of the number of 
sulphydryl groups present in many different proteins.
It also reacts with amino groups. The reaction is 
pH dependent. For example, at pH 7*0 its reaction 
with simple thiols is approximately 1000-fold greater 
than that of corresponding simple amino groups,
(Means and Feeney, 1971).
Method
A stock solution of 100 mM NEM was prepared in O.O5 M 
Tris-HCl, pH 8.0.
The NEM was mixed with plasma enzyme, with the 
final concentration of 10 mM. The mixture was 
added to the fibrin clot in acid media, and the 
proteolytic activity of the enzyme was measured as 
under the above experimental conditions. NEM had 
no effect on the enzyme proteolytic activity.
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5.3.8. Inhibition of plasma enz.vme with ethvlenediamine 
tetraacetic acid (BDTA).
Métallo proteinases are usually inhibited by EDTA, 
There are also some serine proteinases which are 
inhibited by chelating agents (Barrett, 1977).
Method
A stock solution of 200 mM BDTA in 0.05 M Tris-HCl, 
pH 8,0 was prepared. BDTA was mixed with plasma 
enzyme at a final concentration of 5 mM.
The proteolytic activity of the enzyme was 
measured using fibrin clot assay. No change was 
detected in the proteolytic activity of the plasma 
enzyme.
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5*4. Effect of chemical modification of amino groups of
fibrin clot on its susceptibility to lysis hv plasma 
enzyme in acid media
Amino groups of proteins have been modified by 
different reagents, Riordan and Vallee (1972) used 
acetic anhydride for acétylation of amino groups, 
while Wang et al,, (1978) used dinitrofluorobenzene 
(DNPB) or 2,4,6“trinitrobenzenesulfonic acid (TNBS) and 
potassium cyanate v/as used by Chu et al., (1969). In 
this project potassium cyanate was used to modify amino 
groups of fibrin clot, Cyanate reacts with o[, 8-amino 
groups of protein as well as SH group, to form car- 
bamyl derivatives. In the presence of excess cyanate, 
protein can be completely carbamylated.
5.4.1. Amino group modification 
Method
The method used was based on that of Chu et al,,
(1969).
Fibrin clots were prepared as 3.2,4. Ten 
clots were added to 20 ml of 0,5 ^ Tris-HCl, pH 8.0, 
in 4 0 water bath. 10 mg potassium cyanate was 
added every hour, for a period of 4 h. The 
incubating mixtures were kept at 40^0 for a further 
2 h. The pH of the solution was kept constant, 
using 0.1 M NaOH, Controls were prepared at the 
same time, by incubating clots in Tris buffer without 
the addition of cyanate. At the end of 6 h, clots 
were washed in distilled water for 18 h.
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5.4.2, Results of effect of amino groups modification
Amino groups of fibrin clots were modified as 5.4.1. 
The effect of modification was determined by fibrin 
clot assay in the presence of plasma enzyme. As 
Table 5.3 shows, modified clots were more resistant 
to lysis in the presence of plasma enzyme.
ON ITS SUSCEPTIBILITY TO LYSIS IN ACID MEDIA
% lysis of control fibrin clot in monochloroacetic acid
Substrate No enzyme 
18 & 48 h 1 6 h 48 h
Modified fibrin clot 0 14.5 40
Unmodified fibrin clot in buffer 0 68 90
Unmodified fibrin clot in HgO 0 63 86
As the above results indicate, clots were not 
completely resistant to lysis. Different experiments 
were set up to obtain an optimal condition for making 
fibrin clot 100^ resistant to lysis. Different 
concentration of potassium cyanate was used, and the 
modification was carried out as 5.4.1. By increasing 
the concentration of potassium cyanate the modified 
clots become completely resistant to lysis, Table 
5.4.
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To determine the extent of modification of 
lysine groups, which caused the clot to become 
completely insoluble, the modified clots were treated 
with trinitro benzene sulphonic acid (TNB8).
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Table 5.U
EFFECT OF CYANATB CONCENTRATION ON THE %
OF AMINO GROUPS MODIFICATION OF FIBRIN CLOT 
AND ITS STABILITY IN ACID MEDIA IN THE 
PRESENCE OF THE PLASMA ENZYME
Cyanate % Lysine % Lysis in monoohloro aceticconcentration(a) modification(L) acid Plasma enzyme 
2U h U8 h
0 0 he 58
10 20^ 10 26
25 38$^ 0 10
50 50^ 0 0
(a) mg KCNO added 
(b.) estimation as
at each hourly 
5.5.1.
interval
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5.3. Determination of the Extent of Amino Group Blockage 
by Potassium Cyanate using 2.U.6-Trinitro Benzene 
Sulphonic acid (TNBS),
The method used was based on that of Habeeb (1966) and 
Kakade and Liener (1969)
TNBS reacts with free amino groups of amino acids 
to form trinitro phenyl (TNP) derivatives. Sulphite in 
TNBS is displaced by an attacking nucleophile NHg.
TNBS does not react with tyrosine or histidine side 
chains.
5.5.1. Method
Fibrin clots were modified, using potassium cyanate, 
as 5.4.1. For each fibrin clot 2 ml of distilled 
water, 1 ml of U% (w/v) NaHGO^, pH 8.5, and 1 ml of 
0.25^ (w/v) TNBS were used. NaHCO^ and TNBS 
solutions were prepared fresh, just before use. The 
solutions containing fibrin clots were incubated at 
40^0 for 2 h.
Fibrin clots were hydrolysed by adding each clot 
to 3 ml of 12 M HCl, and autoclaving at 120^0, 15-17 lb/ 
inch pressure for 1 h (Wang et al., 1978).
The hydrolysates were left at room temperature 
to cool, 5.0 ml of distilled water was added to 
each vial and were extracted twice with 10 ml ethyl 
ether to remove TNP-N terminal amino acids, excess 
TNBS, peptides and picric acid, which had been produced 
during the reaction.
The excess ether was removed by placing the 
aqueous solution in boiling water for about 5 min.
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The absorbance of the aqueous solution was measured 
at 335 nm, against a blank which had been treated as 
the test except that protein was replaced by distilled 
water. The amount of free amino groups is usually 
calculated from standard curve which has been con­
structed by using varying concentration of 8-TNP-L- 
lysine, and has been treated under the same condition 
of test. If this standard is not available, the 
value of 1.46 x 10^ cm”  ^ for molar absorption of 
6T-TNP-lysine can be used for the calculation of 
lysine in protein,If the sample has been hydrolysed, 
value of 1.56 X 10^ Cm”  ^ is used. To determine 
the sensitivity of the method bovine serum albumin 
(BSA) and lysozyme(muramidase) were used as standards. 
They were treated under the same conditions of the 
test. The number of amino groups per protein mole­
cule was worked out. Standards were used with and 
without hydrolysis, Pig. 5.9.
As the results show. Table 5.4, 50% modification 
of lysine groups in fibrin clot was sufficient to 
make it insoluble in acid media in the presence of 
plasma enzyme.
Fig. 5.9 REACTION OF BOVINE SERUM ALBUMIN AND 
LYSOZYMB WITH TNBS
A graph of variation of absorbance with 
concentration of BSA (O - O) and 
lysozyme (•-§).
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5.6. Effect of Carboxyl Group Modification of Fibrin Clot 
on its Susceptibility to L.vsis by Plasma Enzyme in 
Acid Media
5.6.1. Method
The method used was based on that of Hoare and 
Koshland, 196?.
Fibrin clots were made as 3.2,U, Each fibrin 
clot contained approximately 2.5 mg protein. 15 
clots were added to i+O ml solution of 1.3 M glycine 
ethyl ester, 7.5 M urea, pH 4,75. The solution was 
equilibrated in 25°C water bath for 30 min. 13.5 
ml of 0.4 M carbodiimide in 7.5 M urea was added, to 
initiate the reaction. The pH of the mixture was 
maintained constant at pH 4.75 by the addition of 
0.5 M HCl, using radiometer pH stat assembly. Acid 
addition had ceased by 3 h at which point the clots 
were removed, and washed in 0.001 M HCl for 48 h.
The test was also carried out using dansyi cadaverine 
(7 mg in 10 ml of 0.2 M HCl containing 7.5 M urea 
pH 4.7) instead of carbodiimide.
For both methods controls were prepared as 
follow: l) clots kept in distilled water at 25°C;
II) clots were incubated at 25°G in 7.5 M urea.
5.6.2. Result
Effect of carboxyl group modification of fibrin clot 
on its susceptibility to l.vsis in acid media 
Fibrin clots were modified as 5.6,1. The modified 
clots and controls both became resistant to lysis,
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Table 5.3, which suggests that some chemical changes 
have taken place in urea solution as well as carboxyl 
group modification. Stark et al., (i9 6 0), reported 
that the chemical changes of ribonuclease in urea 
solution was due to the presence of cyanate. Also 
as previously (5.4) described, filurin clots were 
modified with cyanate, the urea was acid washed as
5.6 .3 . The results did not change, i.e. at least 
cyanate at that concentration was not responsible.
It is known that urea causes some physical dis­
ruption of protein, which could result in confor­
mational changes. Because of the action of urea on 
fibrin clots interpretation of the results was not 
possible,
5 .6 .3 . Preparation of cyanate free urea
The method used was based on that of Stark et al., 
(1 9 6 0), Cyanate is known to react with amino groups, 
and a stable product is formed. The reaction takes 
place between unprotonated amino groups and the 
electrically neutral cyanic acid.
Method
To remove the cyanate from urea, the pH of 8 M urea 
was brought to pH 2.0 by using concentrated HCl.
The urea was kept at room temperature for 1 h 
before use,
Cyanate is unstable at low pH and it breaks 
down to CO2 and ammonium ion. The urea at low pH 
contain less than 0.001 M cyanate.
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Table 5.5
EFFECT OF CARBOXYL GROUP MODIFICATION OP FIBRIN 
CLOT ON ITS SUSCEPTIBILITY TO LYSIS BY PLASMA 
ENZYME IN MONOOHLORO ACETIC ACID
% lysis
Fibrin clot in dis H^o 56
Fibrin clot in urea ' 0
Fibrin clot in urea/dansylcadaverine 0
/ ^Fibrin clot in urea/cagodiimide 0
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5.7. SDS Polyacrylamide Gel Electrophoretic Patterns of 
Fibrin Degradation by Plasma Enzyme at Various 
Stages of Proteolysis
Fibrin clots were incubated in 1% (w/v) monochloro 
acetic acid in the presence of plasma enzyme at 
37°C. Clots were removed at different time intervals. 
The clots were washed in 0,9$*^  (w/v) NaCl, and reduced 
as 2,1.11 before being subjected to gel electrophoresis. 
Controls were set up by incubating fibrin clots in 1% 
(w/v) monochloro acetic solution, without the enzyme. 
Also, to apply the same amount of protein to gels, 
duplicates were set up and protein concentrations were 
measured simultaneously each time a clot was removed 
for application to SDS gel.
As the results show. Fig. 5.10, -chain was the 
most susceptible to lysis by plasma enzyme, followed 
by ^-Vdimer, and the least amount of lysis was from 
chain.
Comment
The results are rather interesting, since it may help 
to explain the reason why fibrin clot is a better 
substrate for plasma enzyme than casein, Chapter III. 
Jolies et al,, (1978) comparing the structure of cow 
and sheep K-casein with V-chain of fibrinogen, 
found that 80^ of whole protein of K-casein is 
homologous to -chain. All homologies were limited 
to the N-terminal half of the x-ohain. Although 
there is a great similarity between the two, under the 
same condition chymosin splits only peptide bonds
Pig. 5.10 DBNSITOMETRIC SCAN OP FIBRIN DEGRADATION BY 
PLASMA ENZYME AT VARIOUS STAGES OF 
PROTEOLYSIS
5.10. I Fibrin clot in acid media in the presence 
of Plasma enz.vme
Time = zero
Peak 1 polymer (intermediate)
Peak 2 V-Vdimer
Peak 3 ^  -chain
Peak U -chain
=» ro
Fig. 5.10. II Densitometric scan of fibrin degradation
b.v plasma enzvme
Fibrin clot in acid media in the presence 
of plasma enzyme 
after 3 h
Peak 1 Y- dimer
Peak 2 ^-chain
Peak 3 -chain
fO
CO
Pig, 5.10. Ill Densitometric scan of fibrin
degradation "bv plasma enzyme
Pibrin clot in acid media in the 
presence of plasma enzyme
after 9 h
Peak 1 Y- V dimer 
Peak 2 ©(-chain
Peak 3 -chain
Peak U \-chain
+
Pig. 5.10 IV Densitoinetric scan of fibrin degradation
"by plasma enzyme
Pibrin clot in acid media in the presence 
of plasma enzyme,
after 16 h
Peak 1 V -  V dimer
Peak 2 -chain
Peak 3 -chain I
Peak U -chain !
Peak 5 fibrin degradation
+CO
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105-106 of K-casein but rapidly splits several 
peptide bonds of the Y -chains.
The same statement as above could thus be 
true for plasma enzyme, i.e. like chymosin it 
can split more peptide bonds ofc^-chains of fibrin 
than casein. Plasma enzyme not only hydrolyses the 
V-chains but also hydrolyses the -chains at a faster 
rate.
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5.8, Comparison of Plasma Enz.vme with Other Proteinases 
In all the experiments in which plasma enzyme was 
compared with pepsin, a fixed concentration of plasma 
enzyme and pepsin which showed the same amount of pro­
teolytic activity in the fibrin clot assay were chosen. 
Usually 5-10 ng pepsin hydrolysed the same amount of 
fibrin clot as 0.2 M of plasma enzyme. Also, as the 
plasma enzyme was not completely pure, to overcome the 
difficulty of the interpretation of the results, peps in 
was mixed with inactivated semi-purified enzyme before 
being subjected to the test system.
5.8.1. Comparison of plasma enzyme with human pepsin using 
different substrates
Pibrin clot, denatured haemoglobin, Azo -casein and 
synthetic substrate (N-acetyl phenylanalyl^L- 
diiodotyrosine) were used. A fixed concentration 
of plasma enzyme which gave the same amount of activity 
with fibrin clot was used, as mentioned before,
3.2.5, Pepsin digests synthetic substrate, while 
the plasma enzyme had no effect.
Pepsin had greater activity on azo-casein and 
denatured haemoglobin is,at least 20 times more 
susceptible to pepsin than plasma enzyme. Pig. 5.11.
Fig 5.11 COMPARISON OP ACTIVITIES AGAINST DENATURED 
HAEMOGLOBIN AND PIBRIN CLOT SUBSTRATE
pepsin
-0 plasma enzyme (DEAE-cellulose step, Table U.7).
280 nm
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3.8.2. Effect of temperature on plasma enzyme and pepsin 
proteolytic activity
Plasma enzyme and pepsin, were added to fibrin clots 
in acid media in different tubes and were incubated 
at different temperatures for 16 b. Then the 
proteolytic activity of the enzymes was measured.
As results show. Pig. 5.12, plasma enzyme is 
not stable at U5°C, while pepsin does not lose its 
proteolytic activity at that temperature.
5.8.3. Comparison of pH activity profile of plasma enz.vme 
and pepsin
Proteolytic activity of plasma enzyme and pepsin were 
measured at different pH values using azo-casein as 
substrate.
As results show. Pig. 5.13, there is a slight 
difference between the pH optima of two enzymes 
pH 3.2 and 2,6 for plasma enzyme and pepsin res­
pectively.
5.8.4. Comparison of effect of salt concentration on plasma 
enzyme and pepsin proteolytic activity on fibrin clot 
Proteolytic activity of plasma enzyme was compared 
with pepsin, using fibrin clot assay in the presence 
of different concentrations of NaCl.
As results show. Pig. 5.14, in contrast to plasma 
enzyme activity which was completely suppressed at 
salt concentration of 5 mM, the proteolytic activity 
of pepsin was increased as the salt concentration of 
the salt increased up to 7 mM. At higher salt
Pig. 5.12 EPPECT QF TEMPERATURE ON PLASMA ENZYME AHD 
PEPSIN PROTEOLYTIC ACTIVITY - SUBSTRATE - 
PIBRIN CLOT
0 plasma enzyme
^  pepsin 5 n.g
^  pepsin 10 ng
650 nm
H<D3■o
O
roO
o
roo
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o
enO
Pig. 5.15 pH activity PROFILES OP PLASMA ENZYME (# # )
AND PEPSIN (0 —  0^  SUBSTRATE - AZQCASEIN
Graph of proteolytic activity versus a range 
of pH.
The pH optimum of the plasma enzyme and 
pepsin were approximately 3.2 and 2,6 
respectively.
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Pig. 5.1U EFFECT OF SALT CONCENTRATION ON PLASMA 
ENZYME AND PEPSIN USING FIBRIN CLOT AS 
SUBSTRATE
A graph of salt concentration versus 
enzymes Proteolytic activity. (NaCl)
plasma enzyme (DEAE- cellulose step Table 4.7)
-0 peps in
2-4
—o
1*6
Ec
oin(O<
0-8
5-0 1 0
sal t  conc.
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concentration (7-IO mM) no further increase in the 
proteolytic activity of pepsin was detected.
3 .8 .5. Effect of inhibitor. n-bromophenacyl-bromide on 
plasma enzyme and pepsin
Proteolytic activity of plasma enzyme was compared 
with pepsin, using fihrin clot assay in the presence 
of inhibitor as 5 .3.2.1.
As results show, Table 5.6, a higher concen- |
tration of inhibitor is needed to inhibit plasma |
enzyme to the same extent as pepsin inhibition. I
I
Table 5.6. EFFECT OF INHIBITOR. p~BRQMO PHENACYL-BROMIDE }
ON PLASMA ENZYME AND PEPSIN 1I
   % Inhibition_____________ j
Inhibitor concentration 5.7 x 10”^ M 5.7 x 10”^ M ^
Plasma enzymeBlue-Sephar ose step-Tab le 14..7 50/^- 100% i
Pepsin 100% 100% }
5 ,8 .6 . Effect of inhibitor pepstatin on plasma enzyme. 
pepsin and gastriesin
Proteolytic activity of plasma enzyme (DEAE-cellulose 
step, Table 4.7) was compared with pepsin and gastric- 
8in using fibrin clot assay, in the presence of 
different concentrations of pepstatin.
As the results show. Pig. 5.13, pepstatin is 100- 
fold more effective on inhibiting pepsin than 
gastricsin, while only 20 times more effective in 
inhibiting plasma enzyme.
Fig. 5.15 EFFECT OP INHIBITOR PEPSTATIN ON PLASMA
ENZYME o— 0 . PEPSIN □ o AND
GASTRICSIN o  o
Fibrin clot was used as substrate
ro
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5.8.7. Comparison of the effect of amino group
modification of fibrin clot on its susceptibility 
to lysis in acid media in the presence of plasma 
enzyme and pepsin
Proteolytic activity of plasma enzyme (Blue- 
Sepharose step. Table 4.7) and pepsin were estimated 
using modified fibrin clot, 5.4.1.
Table 5.7
% lysis in monochloroacetic acid
Substrate plasma enzyme pepsin
24 h 48 h 24 h 48 h
Modified fibrin clot 14.5 40 39 100
Unmodified fibrin clot 68 90 70 100
As above results show. Table 5.7, modified 
clots are more resistant to plasma enzyme than to 
pepsin. Even after increasing the concentration of 
potassium cyanate (modifying reagent), Table 5.8, 
the modified clots were not completely resistant to 
pepsin in contrast to plasma enzyme. That was not 
surprising as Powers et. al,,. (1977) analysed the 
nature of substrate binding site of pepsin, by 
studying all the papers published during 1967-1972
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in Biochemistry, J. Biol. Chem. and Biochem J. 
where information had "been given regarding the 
cleavage of proteins and peptides by pepsin. The 
examination of data showed that the majority of 
the peptide bonds with high cleavage probabilities 
have aromatic or hydrophobic amino acids. They 
found some examples of positively (Met-Lys, Trp-Lys, 
His or Lys) or negatively charged (Asp or Glu) amino 
acids in bondswhich have been split by pepsin.
However, when fibrin clots were modified with 
TNBS under optimal conditions, they became completely 
resistant to lysis in the presence of pepsin. Even 
with a very high concentration of pepsin (0.1 M g/ml) 
in pH ranges of 2-5 at 37°C for 72 h, no lysis took 
place. This can be due to the fact that the actual 
nature and the site of cleavage is not the only 
factor, but other amino acid residues in either side 
of the bond can play an important role, e.g. confor­
mational changes, or due to their charges.
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5 .8*8. Comparison of immunocross reactivity of fibrin
degradation products by plasma enzyme and pepsin
with fibrinogen fragments D and E
Human plasma was used to prepare fibrin clot.
Plasma enzyme and pepsin were added to fibrin clots 
in 1/0 (w/v) monochloro acetic acid in 37°C. Once 
fibrin clots were completely degraded (visually), 
samples were removed and tested against rabbit anti­
sera to human fibrinogen as 2,4. At the same time 
fibrinogen fragments D and E were tested. As the 
results show, fibrin degradation by plasma enzyme 
and pepsin are not distinguishable immunologically.
The fragments produced showed no identity with 
fragment D and partial identity with fragment E.Figgjg.
5.8,9. Comparison of BPS gel electrophoretic pattern of 
proteolytic derivatives of fibrin clot by plasma 
enzyme and pepsin
Fibrin clots were incubated in 1% (w/v) monochloro 
acetic acid at 37°C in the presence of plasma enzyme, 
human pepsin and hog pepsin for different time 
intervals. At each interval, the supernatents were 
removed, mixed with equal amounts of ure^SDS as
2.1.11, and boiled for 5 min, prior to the application 
to the gel. As the results show. Pig, 5.17, the two 
enzymes do not react exactly the same. However, 
there are similarities between the degradation 
products of both enzymes. Pepsin breaks more 
bounds as an extra fragment with molecular weight 
of approximately 82,000 was detected, Table 5.9.
PIG. 5 . 1 6 COMPARISON OF IMMUNOCROSS REACTIVITY
PATTERNS OF FIBRIN DEGRADATION PRODUCTS
(FDP) BY PLASMA ENZYME (a) AND PEPSIN
(b) WITH FIBRINOGEN FRAGMENT D AND E
USING ANTISERA TO WHOLE HUMAN FIBRINOGEN
A
1 FDP (b)
2 -
3 FDP (b)
k Fragment D
5 FDP (a)
6 Fragment E
B
1 FDP (b)
2 Fibrinogen
3 Fragment D
k Fragment E
5 FDP (a)
C
1 PDF (b)
2 o  _• L / - o >
3 FDP (a) 5 N1/(^3
U PDF (a) #45 Fragment D
6 FDP (a)
Anti fibrinogen antiserum in the centre wells
Fig. 5.17 COMPARISON OF SDS GEL ELECTROPHORESIS 
PATTERNS OF PROTEOLYTIC DERIVATIVES OF 
FIBRIN CLOT BY PLASAIA ENZYME AND PEPSIN 
AT DIFFERENT TIME INTERVALS.
a) Plasma enzyme (DEAE-Cellulose 
step Table 4.7)
b) Human pepsin
Time sequence: 4,10,22,51,86 and 140
(a)
P
{m h I
i
r ,
(b)
i #
T"'
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Table 5.9 MOLECULAR WEIGHT OF FIBRIN DEGRADATION 
PRODUCTS BY PLi^SMA ENZYME AND PEPSIN
Enzyme Approximate molecular weight (10^) of
Plasma enzyme 150 150 58 48 36 18
Human pepsin 150 150 82 58 48 36 18
Hog pepsin 150 150 82 58 48 36 18
5.8.10. Comparison of the action of plasmin and plasma 
enzyme on fibrinogen/fibrin
At least three types of fibrin can be formed in 
vitro and probably in vivo as well (- Gaffney,
1978), non cross-linked fibrin, partly cross-linked 
( V-VC ) chain and totally cross-linked (
The order in which the chains are split by plasmin 
differs in each case. Table 5.10.
The proteolytic cleavage pattern of a fibrin 
clot by plasma enzyme is different to the action of 
plasmin on fibrin clot, Table 5.10.
5.8.11. Comparison of plasma enzyme with human pepsin and 
gastricsin:mobility on polyacrylamide gradient gel 
electrophores is
Plasma enzyme, human pepsin, gastricsin, and a mixture 
of these enzymes were applied to gel gradient as 
2.2.1 .
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Table 5.10 COMPARISON OP PROTEOLYTIC ACTION OF PLASMA 
ENZYME AND PLASMIN ON FIBRIN CLOTS
Substrate Enzyme Order of polypeptide
Fibrinogen
Non cross linked fibrin 
Partly cross linked fibrin 
Totally cross linked fibrii 
Partly cross linked fibrin
Plasmin A oL — ^ Y (a)
Plasmin oc f) — >y (a)
Plasmin cx — > Û — » Y (a) 1
Plasmin P? or X — > oc (a)
Plasma ^  Yenzyme
(DEAE-cellulosestepTable 4.7)
(a) P.J, Gaffney (1978)
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As the results show. Pig. 5.18, plasma enzyme 
travels slower than pepsin and gastricsin, while 
there was no difference in the mobility of gas­
tricsin and pepsin.
5.8.12. Comparison of the mobility of plasma enzyme and
pepsin on insoluble haemoglobin-polyacrylamide gel 
Plasma enzyme (blue-sepharose step Table 4.7) and 
hog pepsinogen were applied to the haemoglobin gel 
as 3.5.3.3. As Pig, 5.19 shows, plasma enzyme showed 
clear band with the mobility of 0.84, while the 
pepsinogen band had a mobility of 0.95.
Different concentrations of pepsinogen 
(0.01 - 100 ng/ml were prepared and 20 ul (2 pg- 
2 ng) were applied to the gels. All showed clear 
bands with the mobility of 0.95 “ 0.98, When the 
concentration of pepsinogen was in ng/ml range, 
more than one clear band was detected, in accord­
ance with the results of Samloff (1969).
The lower concentration of pepsinogen (pg/ml 
range) gave one distinct clear band at 0.95 in 
contrast to plasma enzyme where the clear band 
corresponded to a mobility of 0,84.
Electrophoresis was carried out following the 
addition of pepsinogen to normal plasma. The 
mixture showed (Fig. 5.19) clear bands in both 
positions, indicating that the mobility of pepr 
sinogen is not affected by the presence of the 
plasma proteins.
Fig. 5.18 POLYACRYLAMIDE GRADIENT GEL ELECTRO­
PHORESIS PATTERNS OF PLASMA ENZYME. 
HUMAN PEPSIN AND GASTRICSIN
1. Human pepsin
2. Blue Sepharose step. Table 4.7
3. Gastricsin
4. Pepsin
5. Blue Sepharose step. Table 4.7
6. Gastricsin
7. DEAE (incomplete)step. Table 4.7
8. Pepsin + Blue Sepharose
9. Gastricsin + Blue Sepharose
V •
i
1 2  3 4 5  6 7 8 9
I
Fig. 5.19 DENSITOMBTRIC SCAN OF PLASMA ENZYME AND 
PEPSIN ON HAEMOGLOBIN-POLYACRYLAMIDE GEL
The clear zones are shown by trough
A Plasma enzyme 
B Plasma enzyme + pepsin 
C Pepsin
DO
—&
ro
1U7.
5.8.13. Comparison of plasma enzyme pattern with other 
acid proteinases: elution from Hb-Sepharose
column
Smith and Turk (197U) used Hb-Sepharose UB to 
purify cathepsin D from bovine spleen and thymus. 
Cathepsin D was eluted at about pH 6.2, Chou et al., 
(19.7 8), also used a similar technique to separate 
human renin and pseudo renin (cathepsin D). They 
reported that renin did not bind to the column at 
pH 3.5> but pseudo renin did, and was eluted at 
about pH 6.2,
To study the elution patterns of plasma enzyme 
and pepsin, two Hb-Sepharose UB columns were set 
up under the same conditions as U.il-.3.2.
Plasma enzyme (Blue-^ epharose step. Table 4.7) 
was applied to one column and a mixture of plasma 
enzyme and hog pepsin to the other. As results 
show. Pig. 5 .2 0, both enzymes were bound to the 
column at pH 3.5 in contrast to renin and were 
eluted at a similar position to cathepsin D 
(pH 5.9 - 6 .5).
Fig. 5.20 Hb-SEPHAROSE COLUMN CHROMATOGRAPHY OF
PLASMA ENZYME AND PEPSIN
Graph A o o absorbance at 280 nm plasmaenzyme
e # plasma enzyme proteolyticactivity
Graph B o— o absorbance at 280 nm pepsin 
4 pepsin proteolytic activity
Fibrin clot was used as substrate
A280 nmoK) o<3) o Odb ro
-4%“t01of*"o3 ♦3Ow
o o fO ro
6 50 nm
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5.8,14. Comparison between plasma enzyme and pepsin 
elution pattern from Amberlite column 
An amberlite column was set up under the same con­
dition as was used for human pepsin and gastricsin 
purification (2,14.2). A sample of plasma enzyme 
(Blue-Sepharose fraction) was dialysed against 
0,2 M sodium citrate, pH 3.0, and was applied to the 
column. The plasma enzyme was eluted between 
pH 5.4 - 5.6, Pig, 5.21, in contrast to pepsin 
and gastricsin which were eluted at pH 4.2 and 4.4 
respectively.
Pig. 5.21 AMBERLITE COLUMN CHROMATOGRAPHY OP PLASMA 
ENZYME. PEPSIN AND GASTRICSIN
^ absorbance at 280 nm plasma enzyme
-o absorbance at 280 nm pepsin and gastricsin
fractions with activity, pepsin pH 4.2
II fractions with activity,gastricsin, pH 4.4
III fractions with activity,plasma enzyme, pH 5.5
2 8 0  nm
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GENERAL DISCUSSION
There is some evidence for the presence of acid 
proteinases in human plasma. Also, different acid pro- 
teinases have been discovered in various cellular components 
of blood as well as tissues,
Samloff et al., (1975), used a radio immuno assay 
(developed by Samloff and Leibman, 1974), to measure 
specifically Group I pepsinogens in serum, a.s they believed 
that usual proteolytic assay method measures Group I pep­
sinogen, Group II pepsinogen plus other acid proteinases.
Rotter et al., (1979) also reported the presence of two 
immuno chemicaly distinct groups of pepsinogen (I and II) 
in serum.
Vete et al,, (I9 6 9) compared different substrates for 
measurement of pepsin and pepsinogen in blood and urine.
Serum from normal and patients with various diseases hydrolysed 
haemoglobin and casein with highest activity at pH about 
3-4* Commercial crystalline pepsin, however, digested these 
two substrates optimally at pH 2,0. Therefore they suggested 
that it is rather difficult to accept that the proteolytic 
activity of serum in pH range of 3-4 is totally due to pepsin 
and pepsinogen.
They introduced a new substrate, serum protein (the 
autologus aerum was treated at pH 2.0, then adjusted to 8.0, 
ensuring the destruction of pepsin. Blood hydrolysed its 
own (autologous) serum protein optimally at pH 2.0. Also, 
crystaline pepsin digested the serum protein at pH 2.0.
They concluded that serum protein is a better substrate for
151.
blood pepsin and pepsinogen determination.
Mirsky et al., (1952) reported that the plasma of 
patients with duodenal ulcers has a higher pepsinogen content 
than normal. There is also a higher rate of pepsinogen 
excretion in the urine. Conversely the plasma pepsinogen 
levels are very lov/ in patients with pernicious anemia and 
there is a negligible amount of excretion in urine. They 
assayed the proteolytic activity of the plasma at pH 1.5, 
using haemoglobin as substrate, and concluded that the major 
proportion of the total activity at this pH is due to pep­
sinogen. However, a small portion of the activity is due to 
enzymes other than pepsin,
Ruenwongsa and Chulavatnatol (1975) isolated an acid 
proteinase from human seminal plasma, which they originally 
thought was pepsin because its catalytic properties were 
similar to hog pepsin. It hydrolysed denatured haemoglobin 
at the same rate of hog pepsin, but was slightly less 
inhibited by p-bromophen-acyl bromide and 1,2- epoxy-3- 
(p-nitro-phenoxy) propane than was hog pepsin. When N- 
acetyl-L-phenylalanyl-L-diiodotyrosine was used as a substrate 
the acidic proteinase was 100-fold less active than hog 
pepsin, which might suggest a different active site from that 
of hog pepsin.
Rpenwongsa and Chulavatnatol (1977) compared the amino 
acid composition of the active proteinase and the proenzyme 
in seminal plasma, with bovine pepsin and pepsinogen, and found 
some similarity and differences. During the conversion of 
pepsinogen to pepsin 40 residues which carry most of the basic 
amino acids were released, while in acid proteinase of seminal
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plasma 69 residues which contain about of basic amino 
acids were released.
Morris and Lumberg (1972) reported the presence of an 
acid stable factor in amuniotic fluid which has similar 
properties to pepsin. It activates renin at pH 3.3-3.6, 
is stable at pH 1.5» but loses its activity at pH 7.5.
Nackman and Ferris (1968), reported that intracellular 
granules of platelets contain proteases capable of the hy­
drolysis of undenatured human fibrinogen (pH optima 6-8), 
denatured haemoglobin (pH 6.5-7.8) and casein (pH 4.8 and 
8.4).
They concluded that the proteolytic activity of platelet 
enzyme(s) was not due to plasmin as trypsin inhibitor, pan­
creatic trypsin inhibitor or EACA had no effect on the enzyme 
activity. In addition, the enzyme(s) were completely 
inactivated by heating to 60°C for 15 min. and proteolytic 
products were different from those of plasmin. At least 
one of the enzymes was regarded as cathepsin A, as it 
hydrolysed haemoglobin at pH 3.5, lost its activity on moderate 
heating, and did not require cystine for its activation. Nor 
was it inhibited by iodoacetamide, and it specifically 
hydrolysed the synthetic substrate N-CBZ-o4-L-glutamyl-L- 
tyrosine at pH 5.0.
Reichelt et al., (1974) purified a proteolytic enzyme 
with molecular weight of 55,000 from human erythrocytes,
This enzyme hydrolysed denatured haemoglobin with the highest 
activity at pH 2.8. The enzyme had no effect on denatured 
albumin, nor on the synthetic substrates specific for 
cathepsin A, B and C. The effects of SDTA and metal ions
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on the enzyme activity were insignificant, and dithiothreitol 
in high concentration caused the inhibition of the enzyme 
activity, suggesting the presence of an essential disulphide 
group. However, they classified the enzyme as a cathepsin D, 
in that its origin was not lysosomal but mainly membrane 
bound.
Levy et al., (1974), and Levy and Chou (1974) studied the 
proteinases in Plasmodium falciparum and the red cell ghosts 
of its host aotus monkey, also Plasmodium knowlesi and its 
host rhesus monkey, and found that each species of parasite 
had a protease which degraded haemoglobin optimally at pH 3.6, 
Another proteinase from Plasmodium berghei degraded haemo­
globin at pH 2.5ito 3.0. They also found proteases in 
ghost cells of the hosts which were distinct from the para­
sites. The proteases in hosts and parasites were rather 
unusual in being susceptible to pepstatin, chymostatin, anti 
pain and leupeptin, with pepstatin being the most potent 
inhibitor. From their results they suggested that the major 
acid proteinases of both the hosts and parasites were like 
cathepsin D, because of their pH optimum and sensitivity to 
pepstatin.
Yago and Owers (1975) reported the presence of cathepsin 
D type proteinases in the rat thoracic duct lymphocytes and 
lymphoid tissues, with molecular weight of approximately 
95,000 and 45,000. Both enzymes differed from cathepsin D 
by being more sensitive to inhibition by pepstatin, and they 
were not inhibited by antiserum which inhibited the rat liver 
cathepsin D. The reason for believing the enzymes were 
cathepsins was that the pH curves, using denatured haemoglobin 
were similar to that of cathepsin D. Haemoglobin was the
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best substrate. The high molecular weight enzyme (95,000) 
was not cathepsin E as it hydrolysed bovine serum albumin 
more efficiently than human serum albumin.
Woessner, (1973), purified an enzyme with proteolytic 
activity from elastic cartilage of young rabbit ears and 
hyaline cartilage from the legs of chick embryos, Woessner 
identified the enzyme as cathepsin D. Cathepsin D rapidly 
degraded protein-polysaccharide light chain. The pH optimum 
for this process is about 4.0. The protein-polysaccharide 
complex digestion was almost completely inhibited (97^ o) by 
pepstatin, and also inhibited by BACA at high concentration, 
Woessner also suggested that apart from cathepsin D there are 
other proteases in cartilage which act at very low pH and 
neutral pH.
Sapolsky et al», (1974), reported that human articular 
cartilage contained two or more distinct proteases. One of 
the enzymes was cathepsin D which digests haemoglobin at 
pH 3.2 and proteoglycan at pH 5.0, while the other was a 
neutral protease, Cathepsin D has no activity at neutral 
pH and therefore its role in cartilage matrix breakdown must 
either be via intracellular digestion in the lysosomal system 
or occur in localised regions of low pH.
Barrett and McDonald, (1980b),reported the presence of 
cathepsin E, a proteolytic enzyme in bone marrow, polymorpho­
nuclear leucocytes, macrophages and human platelets. Cath­
epsin E has a molecular weight of 100,000, and digests 
albumin and haemoglobin with highest activity at pH 2,5 in 
contrast to cathepsin D which has pH optimum of 3.5.
For many years the proteinases of tissues and leucocytes
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which were active at mild acid pH (approximately 3.5) were 
called cathepsins until i9 6 0, when Press et al, isolated a 
proteolytic enzyme from bovine spleen which had pH optimum 
of 3.0 on denatured haemoglobin and 4.2 with denatured al­
bumin. The enzyme was heat labile and lost its activity
below pH 2 .5 , The enzyme was present at least in 10withdifferent forms, but/the same properties. They called the 
enzyme cathepsin D. Although different molecular weights 
(4 0 ,0 0 0 - 6 0,0 0 0) have been given for cathepsin D in the 
literature, Barrett and McDonald, (I98O), reported that the 
generally accepted molecular weight of cathepsin D is close 
to 4 2 ,0 0 0 and also defined cathepsin D as proteolytic enzyme 
present in all mammals and a very wide range of other animals. 
It is located in lysosomes and red cell membranes. Its 
usual and the most sensitive substrate is haemoglobin and it 
has a pH optimum of 2.8-5.0 depending on the substrate.
From the above statements one can cast doubts as to 
whether all the protolytic enzymes classified in the literature 
as cathepsin D were really cathepsin D. As Barrett (1977b), 
mentions, there are similarities'between carboxyl proteinases 
in their pH dependence, inhibitors, substrate specificity 
which all suggests that they show a common catalytic mechanism. 
For example, since the discovery that renin is a carboxyl 
proteinase, much attention has been focussed on its simil­
arities to cathepsin D. Leckie, (1981) reported that 
although renin and cathepsin D have molecular weights of 
approximately 42,000, isoelectric points of approximately 
4 .5-5 .5 with multiple forms, and are present in lysosomes, 
comparisons of the amino acid sequence of renin of mouse
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submaxillary glands with cathepsin D have sh®wn the two are 
distinct proteinases,
Inagarai et al., (1974), suggested that renin may be an 
acid proteinase. It was not inhibited by inhibitors of 
serine, thiol or metalo-peptidases, but was inhibited by 
pepstatin. In addition renin from the mouse sub maxillary 
gland and renin from hog kidney were inactivated by diazo- 
acetyl-D, L-norleucine methyl ester, in the presence of 
cu prie ions.
McKnown and Gregerman, (1974), also suggested that 
renin is related to acid proteinases. Human renin activity 
was inhibited by diazo acyl compounds such as diazo acetyl 
glycine ethyl ester,
Hsueh, et al., (198O), reported that normal plasma 
contains inactive renin which becomes activated by acidi­
fication or treatment with pepsin or trypsin, et al,.Inagami/(1977), reported that renin isolated from kidney 
is in one or two molecular weight forms, big renin (molecular 
weight of 6 1,0 0 0) and big-big renin (molecular weight of 
1 4 0,0 0 0). There is an inverse relationship between the 
molecular weight and activity. Tang suggested that the 
big renin is the precursor of the active enzyme, i.e. big-big 
renin— ^big renin— >renin.
Ondetia. and Cushman, (I9 8 2), reported that renin occurs 
in several forms with different molecular weight, and with 
different degrees of activity, from active form (molecular 
weight of 4 0 ,0 0 0) to partially or inactive form. They also 
reported that renin is a highly specific proteinase, which 
cleaves a Leu-Leu sequence in its only natural substrate the
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plasma o(-globalin, angiotensinogen to produce the decapeptide 
angiotensin I, which is converted by other enzymes to the 
vasoconstrictor octa peptide angiotensin II.
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CONCLUSION
A proteolytic enzyme which showed the ability to 
dissolve fibrin clots in acid environment, and to a lesser 
extent denatured haemoglobin, azo-casein but not synthetic 
substrate . N-acetyl-phenylalanyl-L-diiodotyrosine, was 
almost purified from normal human plasma. Enzymological 
studies using different group-specific inactivators of 
proteinases indicated that plasma enzyme belongs to the class 
of acidic proteinases. Plasma enzyme was inhibited by 
pepstatin and p-bromophenacyl-bromide. It was stable at 
-20°C for a long period but heat labile. The enzyme activity 
was influenced by the ionic strength of the assay medium when 
fibrin clot assay was used. CDS gel electrophoresis of 
concentrated DEAE-cellulose fractions (Table 4.7) showed a 
major band of 52,000-54,000 and a minor band of approximately 
90,000, These apparent molecular weights did not change 
following reduction of disulphide bonds.
In 1979, Law, in attempting to purify the same plasma 
enzyme, suggested that the enzyme differed from pepsin as 
during the course of purification, using Al(OH)^ gel, the 
activity isolated was in a different fraction to the one which 
Ikemori et al,, (1975), followed and called the enzyme pepsin.
In this project Law*s work was confirmed, and on further 
work more dissimilarities become apparent.
I The digestion products of fibrin clot by two enzymes 
differed, 5.8.10.
II They had different mobility on gradient gels, 5.8.12.
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III They had different mobility on haemoglobin gels, 5.8.13.
IV They were eluted at different pH from amberlite 
column,5.8 .14.
'V Fibrin blot was the best substrate, while denatured
haemoglobin was more sensitive to the pepsin proteolytic 
activity,5.8.1.
Plasma enzyme differs from renin in that it bound to 
the Hb-sepharose column at pH 3.5 and was eluted at 
approximately pH 6,0, while renin does not bind to the Hb- 
sepharose at pH 3.5 (Chou et al., 1978). The pH optimum 
of plasma enzyme was 2.h-3.5 using three different substrates 
while the pH optimum for renin is approximately 6.5.
Plasma enzyme hydrolyses haemoglobin and bovine fibrin
iwhile haemoglobin is a potent inhibitor of renin (ki=2 x 10” ) |
and bovine fibrinogen is a weak inhibitor of renin (ki=1 x 10 ^ M) | 
(Workman et al., 1974). I
Plasma enzyme also differs from cathepsin D as it has a 
molecular weight of approximately 54,000, while cathepsin D 
molecular weight is approximately 4 2 ,0 0 0.
Fibrin clot is a more sensitive substrate than haemoglobin 
for plasma enzyme, while the opposite is true for cathepsin D 
and cathepsin E,
Lebez et al., (1971), examined the hydrolytic activity 
of cathepsin D and cathepsin B towards different protein sub­
strates ,
The absorbance of hydrolysed haemoglobin was taken as 
100/t hydrolytic activity, and the hydrolysis of other proteins 
were expressed as percentage of haemoglobin hydrolysis.
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Substrate Cathepsin D Cathepsin E
Haemoglobin 100 100
Fibrinogen 5 - 1 0  19
Fibrin 5 - 1 0  9
Comparison of hydrolytic activities of cathepsin D
and cathepsin E from beef spleen,
Lebez et al., 1971
The pH optimum of plasma enzyme being about 2.4-3.5, 
makes it rather difficult to relate its role in physiological 
conditions, where the blood pH is about 7.35-7.4 and even in 
a very severe acidosis the fall of pH is to about 7.0 
(Copley et al,, 1980). However, most biological cells and 
surfaces, such as the endothelial wall are negatively charged 
and pH at these areas will be lower than bulk pH. Usually 
charges occur in patches, or clusters, and in these micro­
regions, the pH could be 2, 3 or more pH units lower than in
bulk (Copley et al., 1980). At pH below 6.5, the rigidity
of fibrinogen surface layers is markedly increased and con­
formational changes in fibrinogen could trigger gel 
formation which appears indistinguishable from fibrin. 
Therefore there is a possibility of non-enzymic (no thrombin) 
aggregation of fibrinogen on the endothelium in micro- 
circulation and initiation of thrombus formation (Copley, 
1980). Thrombus formation at these areas of low pH could 
happen in one of two ways. Where there is cellular damage, 
resulting in low pH, the flow properties of the blood in the 
proximity of damaged cells or tissue will be affected.
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causing rigidity of red cells, and consequent red cell clumping, 
gelation of fibrinogen and thrombus formation. Thrombi 
could occur without an injury to the vascular wall as high 
wall shear forces of different blood vessels could cause 
conformational changes of fibrinogen at certain sites in the 
circulation. These sites may be where there is a lowering 
of the pH (Copley et al., 1980).
As there is a possibility of thrombus formation at 
localized areas where the pH is low, one can hypothesise 
that a plasma enzyme which is inactive at physiological pH 
could become active at low pH* Fig.. 6,1. This.j.s a similar 
picture to simultaneous fibrin -clot formation and activation 
of plasminogen to plasmin, Fig. 6.2.
Another hypothesis is that the plasma enzyme is acti­
vated by other proteinases once in the region of acid media 
or when fibrin clot is formed in acid region similar to the 
work of Leckie, (1981). On reviewing inactive renin in 
human plasma he reported that endogenous serine proteinases 
which are involved in coagulation and fibrinolysis activate 
renin. Leckie found out that plasma defficient in pre- 
kallikrein could not activate in active renin, also that plasmin 
activates renin, but plasma def icient in plasminogen has 
normal acid activation. Therefore Leckie suggested as
kallikrein and plasmin are rapidly inactivated by inhibitors 
in circulating blood, the only possible way of activating 
inactive renin is in restricted sites, e.g. within fibrin 
clot or close to vessel walls.
Derk et al., (1979) reported that activated Factor XII 
not only initiated the clotting, fibrinolysis, conversion of 
pre-kallidrein to kallikrein and kinin system, but is also
Fig. 6.1-. FIBRINOLYSIS BY PLASMA ENZYME (HYPOTHESIS)
Low pH 
(damaged tissue )
activation of plasma enzyme (proteinase)
Low pH 
(local microcirculation)
conformational changes of fibrinogen
thrombus formation 
 ^
fibrin degradation
Fig. 6.2 SIMILARITY IN BROAD OUTLINE BETWEEN FIBRINOLYSIS
AND TI-IS PLASMA COAGULATION SEQUENCE
Injury to blood vessel injury to blood vessel
prothrombin plasminogen
plasminthrombin
fibrindegradationproducts.
fibrinogen
G.N. Chesterman, 1978.
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involved in renin-angiotensin system. Sealy et al., (1978), 
also reported that urinary kallikrein is a very potent 
activator of inactive renin.
Considering most of the reports through the literature, 
plasmin can no longer he thought of as the only enzyme con­
cerned in the physiological degradation of fihrin(ogen) . 
Although it may he the most important enzyme involved in the 
degradation of fihrin/fihrinogen, the possible action of 
other proteinases including ’acid proteinases’, should not 
be ignored.
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